MikeLigalig.com

BestPlaces.net, a small firm in Portland Oregon, has released several data sets to help health professionals and policymakers gain insights into how severely COVID-19 might impact counties, metro areas, and states. BestPlaces has amassed an unparalleled collection of data on every city, town, state, metro area, county, and zip code in the U.S. and is sharing their work to fight the Coronavirus.
In creating the Coronavirus Risk Assessment Toolkit (CRAT), the data team at BestPlaces assembled statistics for a variety of health resources and risk factors that can be used in forecasting models, geographic information systems (GIS) or spreadsheets. The CRAT seamlessly covers the entire United States, with comparable data on all 51 states, 383 metropolitan areas, 3143 counties, and a special table focused on rural counties.
Anyone can view the data set online and copy the data for their own analysis.
Here are the metrics of the Toolkit, which have been identified by the health community as key resources or risk factors affecting the impact of the Coronavirus: 

Population

Hospitals

Hospital beds

ICU beds

Percent of population over 65 years

Percent of population over 80 years

Percent of population with poor or fair health

Percent of population with diabetes

Percent of population over with obesity

Population density

One important feature of the CRAT is the inclusion of metropolitan area data. Other data sets have been at the state or county level but this also aggregates data at the metro area. This is significant because even if there are no hospitals or ICU beds in some of the smaller counties of a metro area, its health resources are commonly available to all residents of the metro.
Each of the geographies is coded with standard Census FIPS codes so the data can easily be combined with other datasets or visualized with any GIS application. Counties which are part of the 383 U.S. metropolitan areas are tagged with the name and code of its metro area, relating it to the Metro Area table.
This is a valuable resource for a variety of groups: 

National health officials can use it to identify potential hot spots before they flare up.

State and local health officials can compare their locale against areas of known infection, to assess the possible future impact on their region.

Policymakers and politicians can gain insights from the statistics which can help them gain better insights into the magnitude of the impact.

The media can use the data for stories about the resources available in their area, how local risk factors compare with the rest of the state and nation, and helping to power data-driven journalism.

The public is able to do their own assessment, perhaps finding some of their own answers to questions that have been raised by recent waves of Coronavirus news.

No Risk Index?
One thing that the BestPlaces team is not doing is taking the final step of creating a Coronavirus Risk Index. To do that, they would assign a level of weighting to each of the risk factors, and this is best done by health experts and scientists. Assigning a Risk Index for a particular place may have serious repercussions. A high Risk Index for a county or city could lead to increased fear and anxiety, and a low Risk Index may give a false sense of security. Accordingly, BestPlaces will leave this calculation of a Risk Index in the hands of the scientific community and policymakers.
However, BestPlaces has used their expertise in ranking and comparing places to create an additional risk assessment scoring model. In the BestPlaces scoring model, the Coronavirus data has been normalized across the categories to create a set of indexes, and each metric can be assigned a level of importance (weighting). BestPlaces is making this model available to any group to aid in their work to combat the Coronavirus. Requests for the scoring model may be sent to "crat@bestplaces.net" with "Scoring model" in the subject, and include the name of the organization in the message.
For interviews or follow-up questions email crat@bestplaces.net or call 503-777-1636.
About BestPlaces 
For over 35 years, BestPlaces has focused on helping people find their own best place to live. On their Bestplaces.net web site, millions of monthly visitors research, compare and rank every city, town and zip code in the United States.
With its unparalleled collection of data sets about the United States, BestPlaces is excited to use its resources in the fight against the Coronavirus. By releasing its data toolkit to the public, it hopes that it will aid health experts and policy officials in preparation for the coming storm.
###

[https://ww1]
Coronavirus Risk Map of United States

In creating the Coronavirus Risk Assessment Toolkit (CRAT), the data team at BestPlaces assembled statistics for a variety of health resources and risk factors that can be used in forecasting models, geographic information systems (GIS) or spreadsheets



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

President Trump is meeting with oil company executives today to discuss impacts of COVID-19 and how the plunge in petroleum prices is roiling America's oil industry. This is a critical time for the industry, which provides the energy needed to combat the pandemic and plays a key role in helping America sustain our national security.
The actions necessary to slow the infection rate of the COVID-19 pandemic have wide-reaching effects that will ripple through our culture and economy. Protecting citizens' health and safety is the top priority, and that should include mitigating economic impacts and preserving national security. Congress and the President took a great first step with the $2.2 trillion economic stimulus package, which will offer some help to businesses and families.
The Petroleum Equipment & Services Association (PESA) represents the oilfield equipment and services sector (OFS), which has been hit incredibly hard by demand loss due to the simultaneous effects of COVID-19 and the supply flood from Saudi and Russian overproduction. This sector represents all the companies involved in oilfield equipment manufacturing, drilling, completions, pressure pumping and more.
They are energy technology companies, providing the innovations that keep the U.S. and our allies from relying on foreign sources of energy. Most importantly, the OFS sector is critical in driving the breakthroughs that will deliver an increasingly lower-carbon future to the world. The OFS culture is to solve problems with technology. Deployment of automation, artificial intelligence and digital solutions are helping the energy industry tackle water recycling, volatile organic compounds and flaring, as well as addressing methane and CO2 emissions.
This sector is hit hardest by reductions in operations as their customers, the oil and gas producers, have aggressively curtailed spending and demanded price reductions because of demand loss and the supply flood. America's OFS sector, which employs more than half a million men and women, will feel the biggest impact with hundreds of thousands of jobs potentially lost.
There are several policies lawmakers could enact to help this critical sector and offer temporary support to an industry that's been jolted by the triple threat of the COVID-19 pandemic, foreign-induced market oversupply and demands for price concessions by oil and gas producers.
First, and most importantly, OFS facilities must be designated as critical infrastructure by Department of Homeland Security and state and local governments when shelter-in-place or "lockdowns" are ordered. DHS guidance includes most oilfield services operations, but state and local governments don't always follow these guidelines when enacting their own lockdowns. A consistent power supply is essential for public health facilities and for the millions working and taking classes from home. We cannot afford disruption to the energy supply during a pandemic.
There are also aspects of the recently passed stimulus package that could provide short-term financial help such as loan guarantees and other economic stabilization measures from the Department of Treasury. These should be available to all affected sectors, including OFS. These funds may help OFS companies sustain operations and retain employees during the slowdown, as well as preserve America's strategically important ability to produce its own energy supply. It's critical that access to these resources remains in place as policies are implemented.
On tariffs, the OFS sector would be helped by extending for one year the 301 product exclusions already granted by the United States Trade Representative. These exclusions are due to expire soon and would impose additional costs on companies already struggling to deal with an unprecedented crisis.
Finally, lawmakers could provide tax credits for companies forced to restructure manufacturing facilities due to supply chain disruptions – in many cases shifting from overseas suppliers to domestic manufacturers. Nearly every business is experiencing supply chain disruptions, and the OFS sector is no exception. Manufacturing and production are continuing even as companies manage around supply chain challenges and protect worker health and safety.
Our industry has a critical role in helping turn back the historic pandemic and emerging stronger on the other side. Times are difficult right now, and the OFS sector could use some short-term help. The world will get past COVID-19, diplomacy will help rectify the oversupply situation, and the OFS sector will be critical technology leaders in a smart energy transition. The US needs this sector to stay healthy, and the federal government can assist.

[https://ww1]
Most energy jobs come from America's oilfield services and equipment services sector. Here's how the federal government can help keep them employed.

President Trump is meeting with oil company executives today to discuss impacts of COVID-19 and how the plunge in petroleum prices is roiling America's oil industry. This is a critical time for the industry, which plays a key role in combating the pandemic and in America's energy indepdence



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

In a new collaborative study out of the University of Maryland (UMD) and Cornell University, researchers find that as little as 10 minutes of leisure time experiencing nature can measurably improve your mental health and well-being. With suicide rates on the rise alongside increased urbanization, there has been a boom in recent research showcasing the positive health benefits of natural settings on mental and physical health markers. However, little work has been done to quantify the actual "dose" of nature you need to experience these effects. With this new paper published in Frontiers in Psychology, researchers are hoping to guide future research and establish dosages to help revolutionize what a prescription to reduce stress and improve mental health can look like, particularly among the highly stressed college student population.
"This question about dosage gets asked a lot, and what's exciting to me is that we used to have to demonstrate that nature was restorative," explains Naomi Sachs, assistant professor of Landscape Architecture at UMD. "For the most part, those benefits are accepted. But now the question is: How does nature do this? How much? In what way?"
In this scoping review of the current literature on the topic, Sachs and colleagues at Cornell have pulled together studies from around the world to help determine how much nature is the minimum dosage, and identify what the field needs to continue to answer these questions. As a larger goal, researchers hope to move towards a more holistic approach to health that prescribes time in nature alongside or as an alternative to traditional pharmacological options.
"We rely greatly in our culture on pharma approaches to both physical and mental health problems, and as we know, those medications come with very specific dosages," says Donald Rakow, associate professor of horticulture at Cornell. "Until recently, there has been nothing analogous to prescribing time in nature, but this review helps move us in that direction."
In fact, Rakow not only heads up a program called NatureRx@Cornell that directs students to particularly beautiful natural settings around campus for stress relief and mental wellbeing, but he also heads the Campus NatureRx Network of 20 colleges around the country and in Canada that are adopting similar programs, including UMD. At Cornell, health center practitioners are already prescribing time in nature as part of students' electronic health records, and the goal is to do the same at UMD with our NatureRx@UMD program, led by Jennifer Roberts, assistant professor in the School of Public Health.
Roberts explains, "NatureRx@UMD is an initiative that emphasizes the benefits of the natural environments throughout and around the UMD campus in an effort to address the array of health and well-being issues faced by students and greater campus community. The rising trends in mental health issues, specifically suicide, among college students is presented as one of the many reasons for the need of NatureRx@UMD and the like across college campuses. The gains from NatureRx@UMD are both promising and endless."
Rakow adds, "While our entire culture is showing evidence of increased stress, we feel that college students are particularly susceptible to psychologically related disorders: everything from the social isolation caused by social media, to intense competition, to grades and academic success, to financial vulnerability. These and other factors cause incredibly high stress among college aged students."
According to Healthline, mental illness and stress levels among college students are reportedly high, with recent reports showing up to 40% of college students struggling with at least one diagnosable mental illness, and the rate of suicidal thoughts jumping to 11%. Suicide is the second leading cause of death among college students, spurring on UMD's commitment to this type of research and programs like NatureRx.
"If a student can know that nature is good for them and has 10 minutes to go to lunch or get to class, they can choose to take a more nature rich path and pay a little bit more attention to their surroundings to be in that natural experience and get the benefits," says Sachs. "And that benefit is not just an emotional benefit, it is also a cognitive benefit. Test scores improve, they can better retain and process information - all these things that college students really need." Rakow adds, "Every campus, no matter how urban, has some greenspaces, and students and other members of the campus community just need to seek those out."
UMD has many advantages as a green campus, including its distinction as a nationally recognized Arboretum & Botanical Garden. "The whole campus is an arboretum, which is amazing that we have that resource here," says Sachs. With UMD striving to maintain a richly green campus among continued growth as an institution and added connectivity brought by the construction of a new DC metro line, this research can help give credence to initiatives like the AgroEcology Corridor. This multidisciplinary initiative spearheaded by the College of Agriculture & Natural Resources and supported across the university reimagines UMD's campus as a living-learning environment prioritizing interactive and educational green space.
Meg Smolinski serves as outreach coordinator for the Arboretum & Botanical Gardens at UMD, and is on the UMD board for NatureRx. "There are countless studies citing the immense pressures college students face, but also an equal number of studies showing that time in nature can help alleviate stress. Our students have the benefit of living and studying in an award-winning arboretum. As part of the NatureRx team and a supporter of the AgroEcology Corridor, the Arboretum provides hands-on opportunities to plant a tree, grow vegetables, or simply take a walk with one of our arborists and learn about our campus ecosystem."
One of Sachs' graduate students in Landscape Architecture, Sarah Wallace, is working to design a new therapeutic space for the AgroEcology Corridor. In addition to this work, Sachs and the team at Cornell will continue to explore the many benefits of exposure to nature, looking for more specifics on how different types of natural settings affect people's health, as well as how socializing in nature versus active engagement with your surroundings affects the dosage and benefits received.
This paper entitled, "Minimum Time Dose in Nature to Positively Impact the Mental Health of College-Aged Students, and How to Measure It: A Scoping Review," is published in Frontiers in Psychology. https://doi.org/10.3389/fpsyg.2019.02942

[https://ww1]
Clarice Smith Performing Arts Center Green Space, University of Maryland, College Park

"This question about dosage gets asked a lot, and what's exciting to me is that we used to have to demonstrate that nature was restorative," explains Naomi Sachs, UMD. "For the most part, those benefits are accepted. But now the question is: How does nature do this? How much? In what way?"



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

Because of limited access to veterinary care, new guidance from the State of Pennsylvania temporarily allows licensed veterinarians to provide telemedicine support to their residents during the COVID-19 pandemic. whiskerDocs, the national leader in telehealth services for domestic pets (currently dogs and cats), is making 24 hour a day clinical support available to pet owners across the state that need access to veterinary care during the Stay at Home order. Pet owners can reach a licensed veterinarian or credentialed veterinary technician by phone or online 24 hours a day to get immediate help with medical issues and care questions about their dog or cat.
Deb Leon, Founder and CEO, said, "Our veterinary team is standing by to provide virtual clinical guidance to Pennsylvania pet owners during this pandemic. This is an unprecedented period for our country; the State of Pennsylvania is leading the way for others to follow, helping to deliver much needed care to pet owners and veterinary clinics 24 hours a day. We are so honored to be able to help pet families that need support; it is a passion for all of us here at whiskerDocs."
whiskerDocs provides real-time support through phone, video, live chat and email for pet owners so that they can get help with problems or symptoms their pets are experiencing. With Pennsylvania opening up the law, whiskerDocs has revised their patented protocols to be able to stabilize mildly ill or uncomfortable pets based upon the presenting conditions and previous medical history.
Nicole Rogers, Vice President of Operations, said, "Pet owners are just as concerned about the welfare of their pets as they are about their other family members. We have been providing on-demand support to millions of pets since 2013, and our number one priority is safety for the pet and the family. Due to the increased need for veterinary support, we have doubled our staff and expanded our services to support Pennsylvania families as their regular veterinary clinics are forced to reduce hours and in many cases, close completely. It is our mission to provide support to pet owners as well as their primary veterinarians by filling in the gaps during this most challenging time."
Accessing whiskerDocs services is easy; a pet owner can call, email, mobile message, or chat with our expert veterinary team 24 hours a day. If a video consult with a veterinarian is indicated, we will connect the pet owner with one of our licensed veterinarians for a more in-depth virtual exam. Care, Compassion, and Competence are the essential qualities of every whiskerDocs telehealth specialist. And real-time, convenient, access in seconds is how we deliver support to families with pets.
ABOUT
whiskerDocs, the leader in telehealth services for pets, has been trailblazing telehealth with innovative on-demand solutions since 2013. Serving pet parents in U.S. and Canada, with nearly 4 million pets covered by client partners, whiskerDocs delivers access within seconds to its 24/7 services via the telephone, video, email, mobile messaging, and live chat. whiskerDocs' team of veterinary telehealth specialists is comprised of veterinarians and veterinary technicians, who are enabled to deliver a seamless experience with the primary care provider through whiskerDocs patented processes and proprietary technology. whiskerDocs is a member of the American Telehealth Association, and has satisfied the accreditation requirements for telehealth call centers for both the National Committee for Quality Assurance (NCQA)* and the Utilization Review Accreditation Commission (URAC)*. For more information, visit http://www.whiskerdocs.com.
*Standards for both organizations have not yet been applied to the pet sector; standards met are for human telehealth.

[https://ww1]

Due to the increased need for veterinary support for pets in Pennsylvania, whiskerDocs has increased staffing and expanded our veterinary telemedicine services to support pet owners as their regular clinics are forced to reduce hours and in many cases, close completely



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

The Prem Rawat Foundation (TPRF) is giving more than $150,000 in grants to provide life-saving care to vulnerable groups around the world who are suffering from the COVID-19 pandemic.
After extensive research, TPRF is providing initial grants of $50,000 each to three nonprofit organizations that are in a strong position to help people in need. Doctors Without Borders / Médecins Sans Frontières (MSF) and International Medical Corps will use the funds to care for patients and provide crucial training and medical equipment to fragile communities across the globe. Cesvi will focus on assisting the elderly and handicapped who are suffering from the crisis in northern Italy.
The humanitarian aid is made possible by the generosity of donors in over 50 countries who support TPRF's mission of advancing dignity, peace and prosperity. TPRF supporters continue to donate toward the COVID-19 relief initiative, which will provide more funding for additional grants to help more people.
"Thanks to each of you who support TPRF and make this vital aid possible. Together, we are making a difference in the lives of people who need critical care," says Linda Pascotto, TPRF Board Chair.
In addition to the humanitarian aid, TPRF Founder Prem Rawat is offering uplifting daily video messages to address the trying times caused by the pandemic. A renowned author and speaker, his new video series, "Lockdown," is available to watch for free in several languages at premrawat.com.
"Offer each other kindness and understanding. This is the time for empathy, clear thinking and courage," says Prem in one of the recent messages.
Since he founded TPRF in 2001, the nonprofit has awarded hundreds of grants to partner organizations in 40 countries, providing millions of dollars for diverse humanitarian initiatives, from disaster relief, medical care and water infrastructure to computer labs for students.
TPRF also helps people emerge from poverty through the Food for People program, and helps people discover personal peace through the Peace Education Program. Independent evaluators Guidestar and Charity Navigator give TPRF their highest rankings for transparency, fiscal responsibility, results and management.
Learn more about TPRF here.

[https://ww1]
The Prem Rawat Foundation (TPRF) is giving more than $150,000 in grants to provide life-saving care to vulnerable groups around the world who are suffering from the COVID-19 pandemic.

Offer each other kindness and understanding. This is the time for empathy, clear thinking and courage



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

All Benchmark Research clinical sites and call centers are working with Sponsors and CROs in following the CDC COVID-19 safety guidelines to ensure patient and employee safety while continuing to enroll subjects for ongoing studies during this pandemic. Having our own call center and extensive database of potential subjects positions our company to provide rapid support to any emergent novel research program addressing COVID-19 or related therapies.
Benchmark Research is a network of therapeutically diverse centers that specialize in vaccine research; since 1997 we have set the standard for excellence, having conducted more than 1063 studies and enrolled in excess of 38,000 subjects. Our partners can be assured we are prepared to meet all our obligations while maintaining safety during this unprecedented event.
With corporate offices located in Austin, Texas, the company operates sites in Texas, (2 in Austin) (Fort Worth) (San Angelo), Louisiana (Metairie) (Covington), and California (Sacramento)
Sponsors and CROs interested in learning more about Benchmark Research, please contact Van Johnson, Executive Director of Business Development
vanjohnson@benchmarkresearch.net or 469.854.029


* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

AgingChoices is the latest innovation from LifeStyleCX, a women-owned business that was founded by Terri Sullivan and Brenda Limone based on their own experiences navigating the arduous process of finding senior living solutions for their loved ones. In shaping their company and its mission, these co-founders also draw on years of experience in the senior living and care industry.
AgingChoices.com features the Choice! Wizard, the first and most comprehensive tool available to help users find senior living and care options that align with their needs and preferences. After completing a brief lifestyle survey, consumers receive a list of service providers in their area that most closely matches what they're looking for.
Users have the opportunity to connect with an AgingChoices Guide who can introduce them to a home care provider or local market advisor in their area. These local experts know their markets well and can assist consumers. There is never a charge to seniors or their families, as fees are paid by the providers that benefit from the placements.
"After our own experiences, we realized there needs to be more clarity and transparency about senior living and care—that it really needs to be demystified," said Terri Sullivan, Founder and CEO of AgingChoices. "Our mission is to provide unbiased educational information and useful tools that help aging adults and their families make decisions that they can feel good about," Sullivan said.
"You can find more information online about hotel rooms than senior care options—and we want to change that," said Brenda Limone, Co-founder and COO of AgingChoices.
The AgingChoices team strives to provide unbiased advice by offering customers options based on their physical and emotional needs, likes and dislikes, and goals for the next chapter of their lives—which is translated into actionable steps through their answers on the Choice Wizard.
"In this time of uncertainty, we hope to empower aging adults and their loved ones by providing them with the education, tools, and one-on-one support they need to plan for senior living and care—whether their timing is immediate or still down the road a bit," Limone said.
LifeStyleCX based in Rocky Hill, CT. with an office in Cambridge, MA., educates consumers and helps match them with senior living and senior care options through AgingChoices.com. To learn more about the service AgingChoices provides, visit AgingChoices.com.

[https://ww1]

Our AgingChoices Guide was diligent about ensuring that our community was right for his client—who is now our resident. AgingChoices made such a difference in this man's life, which was noticed by our staff and his family alike. Hattie Russell - Olympics West Senior Living



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

To maintain good mental health during this current time of isolation, ensure some structure to your day. Although it is common to complain about train delays, not having time to do things because of work, having to pick the children up at a specific time etc. these aspects of working and family life keep us on track, keep us busy and our minds focused on meeting all of these demands. When that structure is removed, even temporarily, we need to invent a structure of our own.
I strongly suggest those who are concerned about their mental health should make a schedule of daily activities and stick to it. Include time slots for exercise, for which I would recommend four times daily for 10-15 minutes each slot, preparation of meals, dining, communication with friends and family, work (if you can work from home or good old fashioned chores around the house and garden), list all the odd jobs you never find time for, and aim to complete at least one each day.
Stay in touch by electronic means with people who are upbeat and who you have a shared sense of humour with; laughter is truly a medicine for the mind, body and soul. Avoiding individuals who make you feel bad about yourself is a wise choice. If you have to be in touch with such people, keep it brief, and stay upbeat yourself.
Make every day count, you want to look back at the day and recognise and validate your own productivity.
For those who experience difficult emotions during this time, try to see it from an objective viewpoint, acknowledge the emotion and recognise that it is not who you really are but rather some mechanism you have fallen into at that moment and which you can come out of with a little effort. Even putting your attention outside (look out of the window) and noticing things like clouds or stars in the sky, road markings, parked cars, individual windows of buildings and the like, can bring one's thoughts under better control.
Keep your attention on the fact that this is not a forever situation but rather a very rare time of increased freedom to do things you would not otherwise be able to.
Training your thoughts onto future goals you would like to achieve would be much more beneficial. Get yourself ready for the return of normality.
Why we need to take vitamin D more than ever
Vitamin D regulates immunity, which is why almost all supplement companies are now out of stock for the foreseeable future! However, Vitamin D is advantageous in many other, less-known ways. It is more closely related to a hormone in its functions and is also involved in the health of the mind, both neurological and cognitive, and our mood is strongly influenced by our Vitamin D status. Vitamin D contributes to the health of the gut, bones, joints, muscles, lungs, heart and vascular system, the reproductive system, and weight management.
How to anti-age your brain encompassing easy ways to do so with exercise, mental exercise and also foods
Exercise: 
Regular physical activity increases the delivery of nutrients, including oxygen and nitric oxide, as well as fats, proteins, carbohydrates and the plethora of micronutrients called Vitamins, Minerals and phytonutrients to all areas of the body including the brain. This increased circulation and delivery of nutrients occurs alongside the removal of toxins from cells.
Physical activity stimulates the release of endorphins that lift the mood, which in itself can help to keep one's perspective younger than one's years. It doesn't have to be a full on workout 3-4 times per week at the gym to achieve the benefits. Short bursts of exercise, if undertaken regularly can be more health-giving and especially help to keep brain function at full potential. Even those who have limitations on mobility can exercise with a little imagination and determination. I highly recommend the sedentary folk experiment for just one week, exercising for 5 minutes, 4 times per day and assess their health and mental well-being after 7 days. There are good reasons why people can become 'addicted' to exercise and it's not just for a slimmer, fitter body.
Mental exercise: 
Brain games keep the neurons firing! They can be easily found with a search online, but for those who cannot access the internet some suggestions would be crossword puzzles, sudoku, and others found in most newspapers, jigsaw puzzles, strategy games like chess, backgammon, and other board games are all helpful at keeping the brain cells active. Number work is excellent cognitive exercise; remember the sums you did at school, all by yourself without a calculator? Just a little practice daily could see your mental calculator working faster after just a few sessions. Learning a new skill is a total workout for the brain!
A key factor in brain health, that is often overlooked and under estimated, is good quality sleep for a sufficient amount of time every single night. For most adults that is between 7 and 9 hours, and for teenagers up to ten hours, for the children aged between six and twelve, it is closer to eleven hours nightly. Insufficient sleep can impair memory, learning, concentration and stress-management.
Diet: 
Nutrition should focus on real food (unprocessed), and avoidance of sugar-laden foods including alcohol. The diet needs to supply sufficient fats (the brain is made of fat and functions much better if it uses fat for fuel as opposed to glucose), and plenty of antioxidants. As a guide, foods to feed your brain include: oily fish (salmon, sardines, herring, sea bass, halibut, haddock etc.) coconut oil, cold-pressed extra virgin olive oil, avocado, eggs, dairy products like butter, cheese, kefir and yoghurt; walnuts, pecans, broccoli, celery, green leafy veg like spinach, kale, chard, and lettuces; beetroot, raspberries, blueberries, and strawberries. Herbs and spices are also beneficial especially Rosemary and Turmeric. Herbal teas, especially Green Tea, and dark chocolate that provides a minimum of 70% cocoa solids are also recommended for their health-giving! This list is by no means complete in what the diet should provide for all round health, but the foods listed are especially helpful for brain health."


* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

MyAdvisor, a holistic wellness technology company powered by Three Wire Systems, LLC (Three Wire), is uniting with the Yellow Ribbon Fund (YRF) to offer mental health and care coordination services to over 1,500 veteran caregivers that work with the organization. By continuing an ongoing partnership to launch a new initiative throughout the global COVID-19 pandemic, MyAdvisor and YRF hope to help alleviate the mental health burdens faced by veteran caregivers during this time.
Three Wire first began serving military personnel and veterans in 2007 when the veteran-owned business began VetAdvisor, a program that provides comprehensive wellness solutions that protect, support and advocate for our nation's heroes. In 2019, it expanded its offerings to private sector employees to provide wellness, career development, financial literacy and navigational advocacy support. Additionally, as an American Association of Suicidology (AAS) Certified crisis center, care coordinators are trained to identify crisis situations and take the appropriate steps to assess and triage services for individuals.
In the past year, the company has over doubled in growth, employing more than 200 representatives who answer more than 40,000 calls a month out of its coordinated care facilities in Pennsylvania.
YRF is a veteran service organization. Headquartered in Bethesda, Maryland, YRF provides housing and transportation to severely wounded, ill and injured post-9/11 service members from every branch of the U.S. military. YRF also provides family and caregiver support services in 12 other locations throughout the US. MyAdvisor's president, Jennifer Christman, serves on YRF's board and in December, Three Wire sponsored the "Country Music Writer Showcase," which raised more than $38,000 in one event to support wounded, ill and injured Veterans and their families.
"At MyAdvisor, we've designed technology solutions to make it easier for individuals to access and utilize care coordination," said Christman. "No-barrier access to care is especially vital in the wake of the novel coronavirus, which can cause an undue strain on the population's mental health. While we started out serving uniformed personnel, we're on a mission to reach all in need of our services across the country."
Please visit http://www.threewiresys.com/myadvisor to learn more about MyAdvisor.
About Three Wire Systems, LLC 
Founded in 2006, Three Wire Systems, LLC (Three Wire) is the trusted source for government agencies and military organizations looking to modernize with innovative and efficient technology solutions. As part of its health and human solutions initiatives, MyAdvisor provides holistic care to all those who provide service and their family members, with access to one-on-one care coordination sessions in behavioral health, wellness, navigational advocacy, financial literacy and career development. The MyAdvisor division also includes VetAdvisor, an American Association of Suicidology (AAS) accredited program, with over a decade of experience in health and wellness serving military veterans, active duty service members, national guardsmen and reservists.
About Yellow Ribbon Fund (YRF) 
Yellow Ribbon Fund was founded in 2005 to serve the wounded coming back from the wars in Iraq and Afghanistan. Since then, our mission is to provide practical support for wounded, ill and injured service members and their caregivers. We recognize the importance of keeping families together during the critical recuperation phase, because the presence of family and friends accelerates recovery and rehabilitation and makes for a successful transition back to civilian life. The YRF provides two critical programs: The Crossroads Program (Housing and Transportation) and the Keystone Program (Family + Caregiver Support Services).


* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

Visiun, the leader in laboratory analytics, announced the release of a report conforming to the newly mandated federal reporting of COVID-19 testing that must be submitted to HHS and FEMA on a daily basis.
On March 29, 2020, Vice President Pence announced that all hospitals report data on COVID-19 testing performed by "in-house" laboratories (academic/university/hospital) daily to HHS and FEMA using a specific template. Performance Insight, Visiun's laboratory analytics tool, now has the capability to populate all the required COVID-19 testing data directly into the assigned template for this daily submission and automatically email it to HHS/FEMA. This will allow laboratories to quickly and efficiently generate the necessary data points to meet the daily requirements of the federal government.
In addition to this newly released report, Visiun has also developed additional analytics for laboratories to respond to COVID-19. These capabilities enable laboratories to monitor volumes of positive and negative test results by laboratory location, identify new positive cases from repeat positive results, and distinguishes high volume areas based on zip codes. Importantly, this tool can also be used for laboratories to monitor their COVID-19 test turnaround times and trending volumes.
Compatible with every major LIS on the market, Performance Insight provides laboratory management with business intelligence and analytics to help their teams monitor key service commitments and improve workflow, quality, and financial performance. With Performance Insight, laboratories can eliminate manual reporting processes and see everything that is happening in the lab on a daily basis including turnaround time, quality, productivity/workflow, blood product utilization, test utilization, and more.
About Visiun, Inc.
Visiun is the leading provider of performance analytics to the laboratory industry. Headquartered in Ann Arbor, Michigan, Visiun has been providing services to the laboratory industry for over ten years, with hundreds of laboratories installed across the United States. Performance Insight, Visiun's core product, provides laboratory managers with a comprehensive suite of analytics that deliver immediate improvements in performance, efficiency, and quality. For more information, please visit http://www.visiun.com.


* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

Care Oncology, a UK-based company, today reports higher demand for telemedicine from cancer patients now undergoing treatment. The company notes that new patient inquiries rose sharply by 35% since March 11 as growing uncertainty related to the Coronavirus COVID-19 outbreak rose.
"Cancer patients feel safer with our telemedicine delivery," says Jason Butcher, Director of Operations, US, and Canada. "We provide all of our consultations online via a secure video conferencing platform. Given the present state of stress on medical offices and hospitals, telemedicine is the preferred method of communication among patients who are concerned about exposure to the Covid-19 virus." 
Patients choose Care Oncology for their unique metabolic therapies that augment the standard of care cancer treatments. Services and communication go through the clinic's online telemedicine platform. New and existing patients are evaluated at a distance without the need for them to travel to brick and mortar clinics. Medications are sent to patients' homes within a few days after their initial oncological consult. Treatments continue for as long as the patient sees a benefit to their health.
"I believe this is the future for cancer treatment that can be taken at home, and I also believe that the Covid-19 crisis will speed acceptance for this delivery model," says Dr. Charles Meakin, Care Oncology's chief medical officer. "First, telemedicine is far more efficient for both patient and provider when the patient does not have be seen in person and when medicines can be administered from home. Second, patients have greater access to consultation. They don't have to wait weeks or months for appointments. Third, and most important, telemedicine reduces the risk of exposure to secondary exposure to bacterial and viral infection, when this option is viable."
Meakin points out that the most significant risk many cancer patients have is associated with exposure to bacterial or viral infections during a time when they are undergoing standard cancer therapies that can leave them with moderate to severe immune dysfunction.
"Many cancer treatments, radiation, and chemo-therapies, for example, are known to reduce the body's natural ability to fight off the effects of common flu and colds," he says. "The Covid-19 virus presents a far more significant threat to cancer patients than it does to the general population. And the risk presents itself every time a patient goes to a physical office for a visit." 
According to Meakin, an award-winning radiation oncologist who has treated patients in clinics and hospitals for more than 35 years, the physical office visit unfolds, "an enormous burden of risk to the cancer patient."
Meakin believes that patients and their oncologists must decide whether they can continue treatment given the strain that hospitals are under with treating people with the Coronavirus. 
"Two factors that make the risk untenable for cancer patients," he explains. "One, the physical office visit is not always necessary, and two, patients sit in a waiting room for long periods where the risk to exposure to the Covid-19 virus increases with each minute."
Every individual situation is different, and the decision about treatment is a personal one that should be taken together with the local viral risk, Meakin notes. 
According to literature distributed by Care Oncology, the "COC Protocol" does not cause immunosuppression and therefore does not change patient risk to the Covid-19 virus. The reason is that Care Oncology's treatment targets cancer cell metabolism.
"In a very literal sense, the COC Protocol starve cancer cells and inhibits their growth," says Meakin. He suggests that some patients who elect to pause their standard cancer treatments may consider using the COC Protocol to help weaken their cancer.
ABOUT THE COC PROTOCOL 
The COC Protocol was developed by sister organization, Care Oncology Clinic, based in London, UK. The COC Protocol is an adjunctive cancer treatment that is designed to work with standard-of-care cancer treatment. In one published study, the COC Protocol doubled survivability for patients suffering from Glioblastoma, a form of brain cancer. Patients that showed improvement received both the protocol and standard-of-care cancer treatment (chemo, radiotherapies). Care Oncology US offers the protocol for all forms of cancer to US and Canadian patients. 
According to Butcher, COC Protocol is not a form of targeted therapy nor is it intended to replace standard of care. "Our researchers called it 'adjunctive therapy' because the protocol is used in conjunction with standard-of-care therapies (genetic, chemo, radiation)," he says.
Medications used in the COC Protocol have been in use for more than 20 years and are safe, even with all types of current cancer treatments. The medications have been repurposed because they have been found to be effective in interfering with the metabolic processes that are common in all cancer cells, regardless of their tissue of origin.
"The drugs in the COC Protocol have an established safety profile and significant population-based data suggesting they may improve outcomes when combined with standard of care," says Butcher. "The medications in the protocol target the dis-regulated metabolism of cancer cells, a feature that is common to all types of cancer."
For more information, visit http://www.careoncology.com Or call 800-392-1353. 
Care Oncology operates in the United States as an online, telemedicine provider. The company has a research and treatment clinic in the UK located at 40 Harley Street, London, W1G 9PP.

[https://ww1]
Care Oncology US

Telemedicine reduces the risk of exposure to secondary exposure to bacterial and viral infection



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

Care Oncology, a UK-based company, today reports higher demand for telemedicine from cancer patients now undergoing treatment. The company notes that new patient inquiries rose sharply by 35% since March 11 as growing uncertainty related to the Coronavirus COVID-19 outbreak rose.
"Cancer patients feel safer with our telemedicine delivery," says Jason Butcher, Director of Operations, US, and Canada. "We provide all of our consultations online via a secure video conferencing platform. Given the present state of stress on medical offices and hospitals, telemedicine is the preferred method of communication among patients who are concerned about exposure to the Covid-19 virus." 
Patients choose Care Oncology for their unique metabolic therapies that augment the standard of care cancer treatments. Services and communication go through the clinic's online telemedicine platform. New and existing patients are evaluated at a distance without the need for them to travel to brick and mortar clinics. Medications are sent to patients' homes within a few days after their initial oncological consult. Treatments continue for as long as the patient sees a benefit to their health.
"I believe this is the future for cancer treatment that can be taken at home, and I also believe that the Covid-19 crisis will speed acceptance for this delivery model," says Dr. Charles Meakin, Care Oncology's chief medical officer. "First, telemedicine is far more efficient for both patient and provider when the patient does not have be seen in person and when medicines can be administered from home. Second, patients have greater access to consultation. They don't have to wait weeks or months for appointments. Third, and most important, telemedicine reduces the risk of exposure to secondary exposure to bacterial and viral infection, when this option is viable."
Meakin points out that the most significant risk many cancer patients have is associated with exposure to bacterial or viral infections during a time when they are undergoing standard cancer therapies that can leave them with moderate to severe immune dysfunction.
"Many cancer treatments, radiation, and chemo-therapies, for example, are known to reduce the body's natural ability to fight off the effects of common flu and colds," he says. "The Covid-19 virus presents a far more significant threat to cancer patients than it does to the general population. And the risk presents itself every time a patient goes to a physical office for a visit." 
According to Meakin, an award-winning radiation oncologist who has treated patients in clinics and hospitals for more than 35 years, the physical office visit unfolds, "an enormous burden of risk to the cancer patient."
Meakin believes that patients and their oncologists must decide whether they can continue treatment given the strain that hospitals are under with treating people with the Coronavirus. 
"Two factors that make the risk untenable for cancer patients," he explains. "One, the physical office visit is not always necessary, and two, patients sit in a waiting room for long periods where the risk to exposure to the Covid-19 virus increases with each minute."
Every individual situation is different, and the decision about treatment is a personal one that should be taken together with the local viral risk, Meakin notes. 
According to literature distributed by Care Oncology, the "COC Protocol" does not cause immunosuppression and therefore does not change patient risk to the Covid-19 virus. The reason is that Care Oncology's treatment targets cancer cell metabolism.
"In a very literal sense, the COC Protocol starve cancer cells and inhibits their growth," says Meakin. He suggests that some patients who elect to pause their standard cancer treatments may consider using the COC Protocol to help weaken their cancer.
ABOUT THE COC PROTOCOL 
The COC Protocol was developed by sister organization, Care Oncology Clinic, based in London, UK. The COC Protocol is an adjunctive cancer treatment that is designed to work with standard-of-care cancer treatment. In one published study, the COC Protocol doubled survivability for patients suffering from Glioblastoma, a form of brain cancer. Patients that showed improvement received both the protocol and standard-of-care cancer treatment (chemo, radiotherapies). Care Oncology US offers the protocol for all forms of cancer to US and Canadian patients. 
According to Butcher, COC Protocol is not a form of targeted therapy nor is it intended to replace standard of care. "Our researchers called it 'adjunctive therapy' because the protocol is used in conjunction with standard-of-care therapies (genetic, chemo, radiation)," he says.
Medications used in the COC Protocol have been in use for more than 20 years and are safe, even with all types of current cancer treatments. The medications have been repurposed because they have been found to be effective in interfering with the metabolic processes that are common in all cancer cells, regardless of their tissue of origin.
"The drugs in the COC Protocol have an established safety profile and significant population-based data suggesting they may improve outcomes when combined with standard of care," says Butcher. "The medications in the protocol target the dis-regulated metabolism of cancer cells, a feature that is common to all types of cancer."
For more information, visit http://www.careoncology.com Or call 800-392-1353. 
Care Oncology operates in the United States as an online, telemedicine provider. The company has a research and treatment clinic in the UK located at 40 Harley Street, London, W1G 9PP.

[https://ww1]
Care Oncology US

Telemedicine reduces the risk of exposure to secondary exposure to bacterial and viral infection



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

In a time of strife, baby brand SwaddleDesigns has turned their baby blanket manufacturing facility into a factory producing non-medical cloth facemasks.
On March 18th when SwaddleDesigns (located in Seattle, WA) learned the CDC crisis strategy to approve the use of non-medical cloth face masks if no medical-grade facemasks were available, SwaddleDesigns founder& CEO, Lynette Damir R.N. knew her company could be of help. "I started to review published studies that compared the filtration effectiveness of different fabrics. I knew I could do better than the bandana or scarf that was being recommended."
Lynette spent the next several days designing, fine tuning, test fitting and washing her design. The end result was a well-fitting mask that would stay secure. On the following Monday, she started the process to switch SwaddleDesigns baby blanket production facility in Seattle to making 2-layer cotton masks for non-medical applications. The masks, designed to filter airborne particles, are made from 2-layers of USA Cotton Flannel, which is soft, lightweight and breathable. The masks can be machine washed and used over and over again.
"With the recommendation for the general public to wear non-medical cloth masks, many people are sharing DIY mask instructions and patterns, but many American do not have a sewing machine," says Damir. "Initially, we were donating masks, and I've donated all that I can afford, being a small business, but still have the materials and sewists to make more. We are doing our best to keep-up." SwaddleDesigns is hiring additional employees to keep up with the demand for face masks.
Currently, SwaddleDesigns is selling the masks, and offering wholesale discounts for those who wish to purchase 100+. For more info, click here: 
https://www.swaddledesigns.com/collections/cloth-fabric-face-masks

[https://ww1]
SwaddleDesigns' 2-Layer Cotton Cloth Non-Medical Fabric Facemask

"With the recommendation for the general public to wear non-medical cloth masks, many people are sharing DIY mask instructions and patterns, but many American do not have a sewing machine," says Lynette Damir, R.N., Founder & CEO



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

This week, the Arizona-based national nonprofit Parkinson & Movement Disorder Alliance (PMD Alliance) launches the "Cheer Call!" initiative, tasking ambassadors, support group leaders, board members and staff with calling hundreds of its community members around the country. Living with or caring for someone with a movement disorder can be so isolating and PMD Alliance remains committed to providing resources, education, support and connection during this uncertain time. At its core, this initative hopes to spread smiles and goodwill, and continue social connections for those living with and caring for people with movement disorders.
"We are all in this together," has always been the motto of the Parkinson & Movement Disorder Alliance, long before COVID-19. In light of calls for social distancing and separating to prevent the spread of coronavirus, PMD Alliance is staying true to one of it's core values – connection.
"I started making the calls and folks are so appreciative. It is a truly wonderful thing to do," shares one ambassador. "I have always thought when I don't know who I am (as in that I am having struggles and the past two days I have felt extremely vulnerable) that is the time to serve others and make a difference. It works! I feel more myself and lighter."
In addition to making these calls, PMD Allliance also launched: 

Resilience Update: Twice-weekly email newsletters featuring articles from doctors, including tips on staying physically and socially active during the COVID-19 crisis.

Online Programming: They have also increased their online programming, featuring dozens of national experts who are providing free interactive, educational livestreams nearly everyday.

"Tech Time" Sessions: Can't figure out the computer? PMD Alliance also offers weekly "Tech Time" sessions to teach people how to use video chats and be able to log onto these transformative sessions.

For more information on how you can become involved with Cheer Calls!, the Resilience Update or take advantage of any of PMD Alliance's free programs, visit the "2020 At A Glance" section of their website at http://www.pmdalliance.org
About Parkinson & Movement Disorder Alliance 
Parkinson & Movement Disorder Alliance is an independent, national nonprofit dedicated to providing opportunities for people to learn, live more fully and spark meaningful connections around them. PMD Alliance serves people across the United States and is not affiliated with any medical practice or institution. PMD Alliance is committed to keeping our community safe and healthy. We are actively monitoring local health department recommendations and COVID-19 activity. Decisions to postpone or continue events will be made on a case by case basis and communicated by email and on our website at https://www.pmdalliance.org/coronavirus-alert


* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

As the world scrambles to handle the huge wave of COVID-19 infections, urgent needs arise for medical supplies, diagnostics, and treatments. Shortages of such supplies are plaguing hospitals and care-givers, putting the lives of patients and medical professionals at risk.
Tran & Associates supports the fight against COVID-19 and encourages every-day citizens to apply their ingenuity to this global pressing problem. To support innovative solutions in this trying time, until May 5, 2020, we will provide grants covering patent preparation professional fees for up to ten best ideas that solve shortages in medical supplies, diagnostics, telemedicine, and treatments. We also recommend that inventors download and use free provisional patent application filing software at http://www.inventiv.org, a 501c3 non-profit, which can supplement inventor help resources and other publications at the USPTO. Inventors can also view "how-to" videos at our Youtube Channel that answer basic questions such as how to patent an idea, how to patent a product, how much does a patent cost, what is a patent, how to patent, and how to search patents, among others.
The COVID grant continues the Tran & Associates tradition of giving back, as we have also donated our resources to non-profits and other volunteer organizations.
For more information on the grants, please contact us at https://www.tranassoc.com/contact.html
Connect with us at 
Facebook 
LinkedIn 
Twitter

[https://ww1]
Tran & Associates

"Human ingenuity is the best thing we have in the fight against COVID-19."



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

Operative IQ's Inventory and Asset management solutions help first responders manage critical medical supply inventory and equipment efficiently in real-time amidst the Coronavirus Pandemic.
First Responders must regularly perform vehicle checks, inventory counts, expiration date audits, restock orders and verify equipment location and condition. Operative IQ is aiding agency readiness by standardizing processes and capturing information to assist in decision making that will ensure the availability of needed supplies and equipment.
Using an integrated Operative IQ check sheet, front-line providers capture availability and usage data which is used to calculate ideal stocking quantity for each item in any given supply room. The Manage Inventory Levels tool in Operative IQ analyzes average weekly usage along with demand variability for each item to calculate suggested stocking parameters. With increased national supply demand and longer order lead times, this tool enables providers to accurately forecast supply needs to stay ahead of the ordering curve.
With ideal stock levels and on-hand inventory counts established, Operative IQ assists agencies in ordering needed supplies by generating a draft purchase requisition for review. Orders can be submitted to suppliers in a variety of ways, but electronic processing of approved POs through Operative IQ's integrated suppliers saves time, improves accountability and reduces errors. Integrated suppliers include Bound Tree Medical, Life-Assist, Moore Medical, McKesson Medical, Medline, Grainger and Office Depot.
Status Boards and reports provide first responders quick access to real-time supply levels, orders and status updates. EMS managers analyze detailed views of available inventory, expiration dates, supply usage and trends through Operative IQ to make sound decisions. Streaming access to this live, critical data allows agencies to proactively manage scarce resources in this rapidly evolving public health situation.
From Florida to Washington State, departments are currently taking advantage of Operative IQ's RFID Automation Technology to quickly and accurately reconcile supply room on-hand inventory counts. Automation of this manual process saves time and improves inventory accuracy while freeing up field staff to provide medical care.
RFID handheld and fixed readers capture live inventory counts and expiration dates within minutes allowing logistics to restock needed supplies at outlying stations keeping them service ready. Operative IQ is also helping providers account for critical assets and life-saving equipment in the field. Crew can account for assets using an electronic check sheet on any device and Operative IQ's RFID handheld reader takes it a step further by automating the verification of assigned assets on each unit within minutes through a quick scan of the truck.
In this public health crisis, Operative IQ is being used by thousands of public safety professionals on the front line and behind the scenes to ensure our first responders remain ready to serve.
EMS Technology Solutions offers cutting edge, affordable operations management software and products designed with First Responders in mind. Operative IQ Operations Management Software offers modules that include: Inventory Management & Asset Management, Integrated Purchasing, Fleet Maintenance, Service Desk Ticketing System and RFID Tracking. EMS Technology Solutions has won four consecutive EMS World Top Innovation Awards for its operations management software.


* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

CC Wellness is passionate about health and wellness, and we believe that a healthy body leads to a healthier mind. That's why during this coronavirus crisis, we're producing 800,000 bottles every month, contributing to healthy bodies while quelling fears and anxiety, one bottle at a time," says Catherine Corsaro, Director of Marketing & Product Development at CC Wellness, the parent company of Muse Intimacy.
With drug stores unable to keep germ-killing products on the shelf, CC Wellness has begun ramping up their Muse Intimacy Hand Sanitizer which is expected to reach 6,400,000 ounces by the end of April. CC Wellness specializes in the development and production of pharmaceutical-grade OTC's (over the counter) and Class 2 medical devices, and their intimate wellness brand #LubeLife is a best seller with a number one ranking on Amazon.com.
"So much feels out of control with the spread of the coronavirus, but there is one thing that every individual has control over – and that's making sure our hands are germ-free! That's something our wellness brand can help with," Corsaro says. "Our goal is to help everyday people who are looking to slow the spread of the virus, but can't find hand sanitizer on the shelf at their local drug store."
Muse Hand Sanitizer kills 99.9% of germs, including the COVID-19 bacteria, and also contains Vitamin E (Tocopheryl Acetate), which has proven antioxidant effects, enhances moisturization and strengthens the skin barrier. It comes in a simple 8oz bottle with a white and robin's egg blue label and a snap shut no-drip cap. It's portable, easy to use – and most importantly – can help save lives! To use hand sanitizer properly, treat it as a 'wash,' using a nickel-sized dollop and wetting every part of your hands and fingers, including in and around the nail beds.
Not every intimate wellness manufacturer is able to instantly produce hand sanitizer, because the high alcohol content puts it in a different licensing category, but because CC Wellness holds both an OTC license from the FDA as well as the license to purchase alcohol, they are in a unique position to meet the growing demand for hand sanitizer. CC Wellness stands ready to help combat COVID-19 nationwide with their Muse Intimacy Hand Sanitizer, which thankfully, is available for order now.
Muse Intimacy Hand Sanitizer is available now for purchase at http://www.museintimacy.com,.
About CC Wellness 
At CC Wellness, consumer health and wellness has been our passion since 2003. We strive to anticipate the needs of consumers, focusing on finding solutions that make a difference with innovation and agility, bringing products to the market faster than large corporations. 
With fifteen FDA clearances and product profiles spanning cosmetics, OTC and Class II medical devices, CC Wellness operates from our facility in Valencia, California, with start to finish in-house product development, registration and production. Using USDA approved organic products, cruelty-free practices and 100% recyclable packaging, we strive to do our part to build a more sustainable, clean future while creating the highest quality products in a socially and environmentally conscious manner. CC Wellness consistently achieves top three brand positioning on Amazon in its class and is widely recognized as both a pioneer and a leader in the field of health and intimate wellness


* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

News Broadcasting Corporation (NBC) today announced that with the ongoing Covid-19 crisis, the company is not silent and taking all precautionary measures and support while assuring health and safety of its employees and society as part of its Corporate Sustainable Responsibility.
A. Bhowmik, CEO of NBC today wrote to all the employees about company's various efforts in dealing with the ongoing crisis and announced couple of ways NBC is trying to ensure its support to its employees during this hard time. In his email to all his employees he has stated that NBC has already instructed all its employees to work from home except employees who are working in the critical area of their role and all of them are to be provided with adequate resource to ensure safety and hygiene at workplace. NBC has already sourced 7,000 face masks and adequate quantity of sanitizers to be placed across all areas of the work field. New measures of cleaning and sanitation has also been taken which is periodically done in the office campus. Besides the company has also ensured that, adequate amount of hygienic food for consumption and food supplies are being sourced to the office campus so that employees can access and consume such supplies.
"We are living through trying times and your safety and financial well-being is of utmost importance to us. Keeping this in mind employees will also be supported with various other efforts to cope up with the financial crisis and hardships they might face due to the following situation," said CEO Bhowmik and announced for its employees' children education reimbursement in where employees having children studying in high schools and colleges, fees and educational expense would be borne by the company for next two months and employees who are having any kind of ongoing home loan or any personal loan, portion of their Loan EMI would be reimbursed by the company for next one month.
"Besides taking care of our employees, our responsibility also remains for the society where we are living now and we cannot deny the fact about how personnel associated with local and medical authorities, law and enforcement and other emergency services are working tirelessly to save and protect us from the pandemic," said by CEO Bhowmik, while he announced that around 15,000 face masks, Personal Protective Equipment (PPE) are being sourced for the local health and safety officials and providing them necessary support like food supplies and clean drinking water.
News Broadcasting Corporation has also humbly donated an undisclosed amount to PM CARES fund, West Bengal State Emergency Relief Fund and to World Health Organization (WHO) towards the Covid-19 Relief fund as a gesture of small contribution to fight this pandemic that has spread across the world.

"Besides taking care of our employees, our responsibility also lies for the society where we are living now and we are also doing our best to ensure our society and neighbourhood can also be supported in proper ways"



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

Given the current pandemic and economic crisis, it is important to manage our finances and start looking for better prices for essential services. Insurance expenses can rise to several thousand dollars per year. It all depends on several factors, including the model of the vehicle, driving experience and history, coverage limits, annual mileage and so on. Drivers can get better rates if they: 

Look for discounts. The auto insurance market provides a high number of discounts. However, each company grants them after meeting certain demands. Ask the current carrier for a list of discounts and check for how many the requirements are met. The most common discounts include affinity discount, no-claims discount, safety gear discount, and low-mileage discount.

Improve credit score. Having an Excellent FICO credit score will also increase the insurability score. Companies place more trust into people who have proven that they can manage their payments. Ask for credit score reports first and check if everything is fine. If things are not that bright, look for ways of repairing the score, like using balance transfer credit cards.

Bundle policies and plans under the same contract. In many cases, signing for home and auto insurance with the same company will help drivers get a generous discount. Also, providing coverage for multiple vehicles from the same company will also grant access to a discount.

Adjust deductible limits. By increasing the deductible levels, drivers assume more financial responsibility. When filing a claim, clients pay first the sum of money agreed upon, then the company covers the rest. Selecting a high deductible will lower the premiums.

Park the car in a garage. Insurance companies usually provide lower premiums to those that keep their car in a garage. Using a garage has multiple advantages. Car theft becomes less probable. Another advantage is the lower chance for your vehicle to be damaged by severe weather, vandalism or rioters.

Keep a clean driving record. Clients can qualify for a good driver discount if they keep a clean driving record for 3-5 years. That means no claims or traffic violations. The discount ranges from 10 to 20 percent.

Keep a good credit score. Persons with average or poor credit scores pay more than those with an excellent score. There are several ways to improve credit score, including taking a short-term loan from a Credit Union.

Drive fewer miles. People who retire, use mass public transportation or carpooling should consider asking for low-mileage discounts.

Compare-autoinsurance.org is an online provider of life, home, health, and auto insurance quotes. This website is unique because it does not simply stick to one kind of insurance provider, but brings the clients the best deals from many different online insurance carriers. In this way, clients have access to offers from multiple carriers all in one place: this website. On this site, customers have access to quotes for insurance plans from various agencies, such as local or nationwide agencies, brand names insurance companies, etc.
For more information, please visit http://compare-autoinsurance.org.

[https://ww1]

"Drivers can get better car insurance rates if they become safe drivers and make smart coverage selections.", said Russell Rabichev, Marketing Director of Internet Marketing Company.



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

INTRODUCTION
As the world's first AI-biopharma company that has discovered and publicized the precise aetiology and pathology of COVID-19[1], we are committed to the non-profit dissemination of our COVID-19 discoveries and the public validation of our COVID-19 clinical predictions.
The SARS-CoV-2-mediated post-entry suppression of ACE2 mRNA expression in host cells is one of our contrarian pathology-based clinical predictions, because it appears to be self-conflicting for SARS-CoV-2 to bind ACE2 via S to enable viral entry on the one hand[2], and to suppress ACE2 expression to enhance viral replication on the other hand[1]:
"After entry, SARS-CoV-2 hijacks the PI3K signaling of ACE2-expressing host cells to drive viral replication. Furthermore, SARS-CoV-2 enhances the activation of the distal promoters of the ACE2 gene in the host cells, which further suppresses the ACE2 expression in the host cells and disrupts the normal homeostatic functions of the host cells."[1]
"The ACE2 distal promoter transcript (DPT) is an evolutionarily conserved binding motif of ACE2 inhibitors, whereas the ACE2 proximal promoter transcript (PPT) is an evolutionarily conserved binding motif of ACE2 enhancers[5]. The DPT/PPT ratio is tissue-specific such that the DPT is significantly more than the PPT in the lung (>49-fold), whereas the PPT is significantly more than the DPT in the kidney, brain, and heart (>20-fold)[6]. It is unusual that the ACE2 DPT/PPT ratio, rather than the ACE2 genotype, determines ACE2 transcript levels." [1]
We also shared the further pathology-based clinical prediction that ACE2 deficiency is a core causal co-driver of COVID-19 clinical outcomes[3]:
"The clinical outcomes of COVID-19 are driven by the tissue-specific and patient-specific co-development of ACE2-deficiency-induced injury and innate-adaptive-imbalance-induced lymphocytopenia." [1]
"Therefore, lungs are selectively vulnerable to ACE2 deficiencies induced by COVID-19, and lung injuries are the predominant clinical features of COVID-19." [1]
When that pathology-based prospective prediction was first announced to the public on March 7, 2020[3], it was also contrarian to the mainstream view that (i) populations with lower baseline ACE2 expression level are less prone to SARS-CoV-2 entry and infection, and (ii) East Asians are more vulnerable to COVID-19 than Europeans/Americans because the human genomic data published on February 24, 2020, show that East Asians have much higher allele frequencies in most of the gain-of-function eQTL variants of ACE2 (Figure 1).
DATA VALIDATION
Those two contrarian prospective clinical predictions can be validated by analyzing the relationship between population-specific ACE2 genome data and population-specific COVID-19 mortality data.
As of April 4, 2020, there are 13 countries categorized into four region-specific populations following the definitions in Figure 1—Chinese (CHN), Non-Chinese East Asians (EAS), Europeans (EUR) and AdMixed Americans (AMR)—with each country having reported more than 10,000 confirmed COVID-19 cases (Table 1).
As of April 4, 2020, the total number of confirmed COVID-19 deaths per million population in those 13 countries are presented in Table 2.
Furthermore, the population-specific allele frequencies of 11 common eQTL variants associated with high expression of ACE2 in tissues are presented in Table 3.
Now we can start analyzing the relationship between population-specific ACE2 genome variants and population-specific COVID-19 mortality rates (Table 4).
Both the population covariance (-6.46) and the Pearson correlation (-0.88) clearly indicate that the population-specific ACE2 mRNA levels have a strong negative relationship with the population-specific COVID-19 mortality rates.
In other words, populations with higher baseline ACE2 mRNA levels (e.g., East Asians) would be less prone to the ACE2-deficiency-driven development of critical COVID-19 clinical outcomes, whereas populations with lower baseline ACE2 mRNA levels (e.g., Europeans) would be more prone to the ACE2-deficiency-driven development of critical COVID-19 clinical outcomes.
Therefore, the real-world data have validated our contrarian pathology-based clinical prediction that ACE2 deficiency is a positive driver of COVID-19 clinical outcomes[3], and thus invalidated the mainstream belief that ACE2 deficiency is a negative driver of COVID-19 clinical outcomes.
The real-world data further demonstrate that AI-based disease modelling and clinical predictions can deliver much better predictive power and explanatory power than conventional approaches for novel diseases with limited clinical data and short response timeframes.
PREDICTIVE BIOMARKER
Based on our pathology-based clinical predictions which are validated both by the real-world data as above and by the ex vivo data in human organoids[7], we thus further propose that ACE2 mRNA level can serve as a predictive biomarker of COVID-19 mortality rate, and even a surrogate biomarker of COVID-19 clinical progression.
Hospitalized COVID-19 patients can be stratified on admission based on their ACE2 mRNA levels, so that the corresponding level of care can be prepared well in advance.
Suspected COVID-19 patients can be stratified if they can receive the test of ACE2 mRNA levels at the same time when they receive the test of SARS-CoV-2 RNA levels.
TREATMENT PRIORITY
Contrary to the mainstream belief, COVID-19 would have a much more rapid and severe progression in Americans/Europeans compared with East Asians, because Americans/Europeans have much lower baseline ACE2 expression than East Asians due to their much lower allele frequencies in most of the gain-of-function eQTL variants of ACE2[4].
As our aetiology and pathology show that COVID-19 suppresses ACE2 expression for viral replication, Americans/Europeans with much lower baseline ACE2 expressions are much more prone to developing critical clinical outcomes than East Asians.
Therefore, on top of increasing the supply of masks and ventilators, it is much more important and urgent for European and American countries to prioritize the discovery and development of effective and scalable treatments for critically ill patients than for Asian countries.
Critically ill COVID-19 patient population has a 61.5% mortality rate[8] with sepsis (100%), respiratory failure (98%), and ARDS (93%) as the top 3 clinical outcomes of non-survivors[9], and there will be more critically ill patients of younger age groups in European and American countries due to the population-specific lower baseline ACE2 expression levels.
It is equally essential to discover scalable treatments that are cost-effective and globally available to reduce the mortality rate of COVID-19 in various European and American countries of different infection control capabilities.
REFERENCES
1.    Lovetrue, B. The AI-Discovered Aetiology of COVID-19 and Rationale of the Irinotecan+Etoposide Combination Therapy for Critically Ill COVID-19 Patients. (2020). doi:10.20944/PREPRINTS202003.0341.V1 
2.    Wrapp, D. et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science (80-. ). 367, 1260–1263 (2020). 
3.    Demiurge AI Discovers the Complete Aetiology of COVID-19 and the Optimal Treatment Strategy for COVID-19. Available at: http://www.prweb.com/releases/demiurge_ai_discovers_the_complete_aetiology_of_covid_19_and_the_optimal_treatment_strategy_for_covid_19/prweb16966447.htm. (Accessed: 1st April 2020) 
4.    Cao, Y. et al. Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations. Cell Discov. 6, 4–7 (2020). 
5.    COVID-19 Map - Johns Hopkins Coronavirus Resource Center. Available at: https://coronavirus.jhu.edu/map.html. (Accessed: 1st April 2020) 
6.    Coronavirus deaths: The stark differences in countries' case fatality rates, explained - Vox. Available at: https://www.vox.com/2020/4/1/21203198/coronavirus-deaths-us-italy-china-south-korea. (Accessed: 2nd April 2020) 
7.    Monteil, V., Kwon, H., Prado, P., Hagelkrüys, A. & Wimmer, R. A. Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2. (2020). doi:10.1016/j.cell.2020.04.004 
8.    Yang, X. et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir. Med. 2600, 1–7 (2020). 
9.    Zhou, F. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan , China : a retrospective cohort study. Lancet 6736, 1–9 (2020).
About Demiurge Technologies
Demiurge Technologies is a research-based AI-biopharmaceutical company that transforms publicly available life science data into precise disease models in areas with unmet medical needs. The company pioneers a self-correcting scientific approach that validates disease models with the accuracy of AI-based predictions of phase 3 clinical trial outcomes. The company also pioneers a self-sustaining business that commercializes disease models by accelerating the AI-based discovery and development of innovative medicines. Demiurge started in 2016 with headquarters in Switzerland.
AI has been an emerging powerful approach to deeper disease understanding and faster drug discovery, yet it must be put to the most rigorous test to prove its worth under public scrutiny. Demiurge has predicted the outcomes of more than 90 phase 3 clinical trials across multiple therapeutic areas and achieved more than 80% accuracy. Furthermore, we have been inviting the public to witness our future predictions of clinical trial outcomes on Twitter (@DemiurgeTech).
Therefore, we officially put forward AI-based discoveries of the precise aetiology and pathology of COVID-19 and the candidate treatments for COVID-19 as scientific hypotheses only and invite the world to validate their potential to solve the unprecedented global crisis posed by COVID-19.
Demiurge urges everyone to refrain from believing in the efficacy and safety of any COVID-19 candidate treatments before any clinical data come in.
Disclaimer 
This material is intended for information purposes only and is provided without any warranty of any kind, either expressed or implied. These statements are not guarantees of future performance, condition or results. Figures and graphs in this presentation are for illustration only and are may not match the actual scale. Actual results may differ materially from those in the forward‐looking statements as a result of a number of factors. Demiurge Technologies AG ("Demiurge") undertakes no duty or obligation to publicly update or revise the forward‐looking statements or other information contained in this document. You should not view information related to the past performance of Demiurge or its affiliated funds or information about the market, as indicative of future results, the achievement of which cannot be assured. While some information used in this document may have been obtained from various published and unpublished sources considered to be reliable, Demiurge Technologies AG neither guarantees its accuracy or completeness nor accepts liability for any direct or consequential losses arising from its use. Amounts and percentages may reflect rounding adjustments and consequently, totals may not appear to sum.

[https://ww1]

ACE2 mRNA level can serve as a predictive biomarker of COVID-19 mortality rate. Hospitalized COVID-19 patients can be stratified on admission based on their ACE2 mRNA levels, so that the corresponding level of care can be planned and prepared well in advance



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

As the world scrambles to handle the huge wave of COVID-19 infections, urgent needs arise for medical supplies, diagnostics, and treatments. Shortages of such supplies are plaguing hospitals and care-givers, putting the lives of patients and medical professionals at risk.
Tran & Associates supports the fight against COVID-19 and encourages every-day citizens to apply their ingenuity to this global pressing problem. To support innovative solutions in this trying time, until May 5, 2020, we will provide grants covering patent preparation professional fees for up to ten best ideas that solve shortages in medical supplies, diagnostics, telemedicine, and treatments. We also recommend that inventors download and use free provisional patent application filing software at http://www.inventiv.org, a 501c3 non-profit, which can supplement inventor help resources and other publications at the USPTO. Inventors can also view "how-to" videos at our Youtube Channel that answer basic questions such as how to patent an idea, how to patent a product, how much does a patent cost, what is a patent, how to patent, and how to search patents, among others.
The COVID grant continues the Tran & Associates tradition of giving back, as we have also donated our resources to non-profits and other volunteer organizations.
For more information on the grants, please contact us at https://www.tranassoc.com/contact.html
Connect with us at 
Facebook 
LinkedIn 
Twitter

[https://ww1]
Tran & Associates

"Human ingenuity is the best thing we have in the fight against COVID-19.



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

Operative IQ's Inventory and Asset management solutions help first responders manage critical medical supply inventory and equipment efficiently in real-time amidst the Coronavirus Pandemic.
First Responders must regularly perform vehicle checks, inventory counts, expiration date audits, restock orders and verify equipment location and condition. Operative IQ is aiding agency readiness by standardizing processes and capturing information to assist in decision making that will ensure the availability of needed supplies and equipment.
Using an integrated Operative IQ check sheet, front-line providers capture availability and usage data which is used to calculate ideal stocking quantity for each item in any given supply room. The Manage Inventory Levels tool in Operative IQ analyzes average weekly usage along with demand variability for each item to calculate suggested stocking parameters. With increased national supply demand and longer order lead times, this tool enables providers to accurately forecast supply needs to stay ahead of the ordering curve.
With ideal stock levels and on-hand inventory counts established, Operative IQ assists agencies in ordering needed supplies by generating a draft purchase requisition for review. Orders can be submitted to suppliers in a variety of ways, but electronic processing of approved POs through Operative IQ's integrated suppliers saves time, improves accountability and reduces errors. Integrated suppliers include Bound Tree Medical, Life-Assist, Moore Medical, McKesson Medical, Medline, Grainger and Office Depot.
Status Boards and reports provide first responders quick access to real-time supply levels, orders and status updates. EMS managers analyze detailed views of available inventory, expiration dates, supply usage and trends through Operative IQ to make sound decisions. Streaming access to this live, critical data allows agencies to proactively manage scarce resources in this rapidly evolving public health situation.
From Florida to Washington State, departments are currently taking advantage of Operative IQ's RFID Automation Technology to quickly and accurately reconcile supply room on-hand inventory counts. Automation of this manual process saves time and improves inventory accuracy while freeing up field staff to provide medical care.
RFID handheld and fixed readers capture live inventory counts and expiration dates within minutes allowing logistics to restock needed supplies at outlying stations keeping them service ready. Operative IQ is also helping providers account for critical assets and life-saving equipment in the field. Crew can account for assets using an electronic check sheet on any device and Operative IQ's RFID handheld reader takes it a step further by automating the verification of assigned assets on each unit within minutes through a quick scan of the truck.
In this public health crisis, Operative IQ is being used by thousands of public safety professionals on the front line and behind the scenes to ensure our first responders remain ready to serve.
EMS Technology Solutions offers cutting edge, affordable operations management software and products designed with First Responders in mind. Operative IQ Operations Management Software offers modules that include: Inventory Management & Asset Management, Integrated Purchasing, Fleet Maintenance, Service Desk Ticketing System and RFID Tracking. EMS Technology Solutions has won four consecutive EMS World Top Innovation Awards for its operations management software.


* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

CC Wellness is passionate about health and wellness, and we believe that a healthy body leads to a healthier mind. That's why during this coronavirus crisis, we're producing 800,000 bottles every month, contributing to healthy bodies while quelling fears and anxiety, one bottle at a time," says Catherine Corsaro, Director of Marketing & Product Development at CC Wellness, the parent company of Muse Intimacy.
With drug stores unable to keep germ-killing products on the shelf, CC Wellness has begun ramping up their Muse Intimacy Hand Sanitizer which is expected to reach 6,400,000 ounces by the end of April. CC Wellness specializes in the development and production of pharmaceutical-grade OTC's (over the counter) and Class 2 medical devices, and their intimate wellness brand #LubeLife is a best seller with a number one ranking on Amazon.com.
"So much feels out of control with the spread of the coronavirus, but there is one thing that every individual has control over – and that's making sure our hands are germ-free! That's something our wellness brand can help with," Corsaro says. "Our goal is to help everyday people who are looking to slow the spread of the virus, but can't find hand sanitizer on the shelf at their local drug store."
Muse Hand Sanitizer kills 99.9% of germs, including the COVID-19 bacteria, and also contains Vitamin E (Tocopheryl Acetate), which has proven antioxidant effects, enhances moisturization and strengthens the skin barrier. It comes in a simple 8oz bottle with a white and robin's egg blue label and a snap shut no-drip cap. It's portable, easy to use – and most importantly – can help save lives! To use hand sanitizer properly, treat it as a 'wash,' using a nickel-sized dollop and wetting every part of your hands and fingers, including in and around the nail beds.
Not every intimate wellness manufacturer is able to instantly produce hand sanitizer, because the high alcohol content puts it in a different licensing category, but because CC Wellness holds both an OTC license from the FDA as well as the license to purchase alcohol, they are in a unique position to meet the growing demand for hand sanitizer. CC Wellness stands ready to help combat COVID-19 nationwide with their Muse Intimacy Hand Sanitizer, which thankfully, is available for order now.
Muse Intimacy Hand Sanitizer is available now for purchase at http://www.museintimacy.com,.
About CC Wellness 
At CC Wellness, consumer health and wellness has been our passion since 2003. We strive to anticipate the needs of consumers, focusing on finding solutions that make a difference with innovation and agility, bringing products to the market faster than large corporations. 
With fifteen FDA clearances and product profiles spanning cosmetics, OTC and Class II medical devices, CC Wellness operates from our facility in Valencia, California, with start to finish in-house product development, registration and production. Using USDA approved organic products, cruelty-free practices and 100% recyclable packaging, we strive to do our part to build a more sustainable, clean future while creating the highest quality products in a socially and environmentally conscious manner. CC Wellness consistently achieves top three brand positioning on Amazon in its class and is widely recognized as both a pioneer and a leader in the field of health and intimate wellness


* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

News Broadcasting Corporation (NBC) today announced that with the ongoing Covid-19 crisis, the company is not silent and taking all precautionary measures and support while assuring health and safety of its employees and society as part of its Corporate Sustainable Responsibility.
A. Bhowmik, CEO of NBC today wrote to all the employees about company's various efforts in dealing with the ongoing crisis and announced couple of ways NBC is trying to ensure its support to its employees during this hard time. In his email to all his employees he has stated that NBC has already instructed all its employees to work from home except employees who are working in the critical area of their role and all of them are to be provided with adequate resource to ensure safety and hygiene at workplace. NBC has already sourced 7,000 face masks and adequate quantity of sanitizers to be placed across all areas of the work field. New measures of cleaning and sanitation has also been taken which is periodically done in the office campus. Besides the company has also ensured that, adequate amount of hygienic food for consumption and food supplies are being sourced to the office campus so that employees can access and consume such supplies.
"We are living through trying times and your safety and financial well-being is of utmost importance to us. Keeping this in mind employees will also be supported with various other efforts to cope up with the financial crisis and hardships they might face due to the following situation," said CEO Bhowmik and announced for its employees' children education reimbursement in where employees having children studying in high schools and colleges, fees and educational expense would be borne by the company for next two months and employees who are having any kind of ongoing home loan or any personal loan, portion of their Loan EMI would be reimbursed by the company for next one month.
"Besides taking care of our employees, our responsibility also remains for the society where we are living now and we cannot deny the fact about how personnel associated with local and medical authorities, law and enforcement and other emergency services are working tirelessly to save and protect us from the pandemic," said by CEO Bhowmik, while he announced that around 15,000 face masks, Personal Protective Equipment (PPE) are being sourced for the local health and safety officials and providing them necessary support like food supplies and clean drinking water.
News Broadcasting Corporation has also humbly donated an undisclosed amount to PM CARES fund, West Bengal State Emergency Relief Fund and to World Health Organization (WHO) towards the Covid-19 Relief fund as a gesture of small contribution to fight this pandemic that has spread across the world.

"Besides taking care of our employees, our responsibility also lies for the society where we are living now and we are also doing our best to ensure our society and neighbourhood can also be supported in proper ways"



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

Given the current pandemic and economic crisis, it is important to manage our finances and start looking for better prices for essential services. Insurance expenses can rise to several thousand dollars per year. It all depends on several factors, including the model of the vehicle, driving experience and history, coverage limits, annual mileage and so on. Drivers can get better rates if they: 

Look for discounts. The auto insurance market provides a high number of discounts. However, each company grants them after meeting certain demands. Ask the current carrier for a list of discounts and check for how many the requirements are met. The most common discounts include affinity discount, no-claims discount, safety gear discount, and low-mileage discount.

Improve credit score. Having an Excellent FICO credit score will also increase the insurability score. Companies place more trust into people who have proven that they can manage their payments. Ask for credit score reports first and check if everything is fine. If things are not that bright, look for ways of repairing the score, like using balance transfer credit cards.

Bundle policies and plans under the same contract. In many cases, signing for home and auto insurance with the same company will help drivers get a generous discount. Also, providing coverage for multiple vehicles from the same company will also grant access to a discount.

Adjust deductible limits. By increasing the deductible levels, drivers assume more financial responsibility. When filing a claim, clients pay first the sum of money agreed upon, then the company covers the rest. Selecting a high deductible will lower the premiums.

Park the car in a garage. Insurance companies usually provide lower premiums to those that keep their car in a garage. Using a garage has multiple advantages. Car theft becomes less probable. Another advantage is the lower chance for your vehicle to be damaged by severe weather, vandalism or rioters.

Keep a clean driving record. Clients can qualify for a good driver discount if they keep a clean driving record for 3-5 years. That means no claims or traffic violations. The discount ranges from 10 to 20 percent.

Keep a good credit score. Persons with average or poor credit scores pay more than those with an excellent score. There are several ways to improve credit score, including taking a short-term loan from a Credit Union.

Drive fewer miles. People who retire, use mass public transportation or carpooling should consider asking for low-mileage discounts.

Compare-autoinsurance.org is an online provider of life, home, health, and auto insurance quotes. This website is unique because it does not simply stick to one kind of insurance provider, but brings the clients the best deals from many different online insurance carriers. In this way, clients have access to offers from multiple carriers all in one place: this website. On this site, customers have access to quotes for insurance plans from various agencies, such as local or nationwide agencies, brand names insurance companies, etc.
For more information, please visit http://compare-autoinsurance.org.

[https://ww1]

"Drivers can get better car insurance rates if they become safe drivers and make smart coverage selections.", said Russell Rabichev, Marketing Director of Internet Marketing Company.



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

INTRODUCTION
As the world's first AI-biopharma company that has discovered and publicized the precise aetiology and pathology of COVID-19[1], we are committed to the non-profit dissemination of our COVID-19 discoveries and the public validation of our COVID-19 clinical predictions.
The SARS-CoV-2-mediated post-entry suppression of ACE2 mRNA expression in host cells is one of our contrarian pathology-based clinical predictions, because it appears to be self-conflicting for SARS-CoV-2 to bind ACE2 via S to enable viral entry on the one hand[2], and to suppress ACE2 expression to enhance viral replication on the other hand[1]:
"After entry, SARS-CoV-2 hijacks the PI3K signaling of ACE2-expressing host cells to drive viral replication. Furthermore, SARS-CoV-2 enhances the activation of the distal promoters of the ACE2 gene in the host cells, which further suppresses the ACE2 expression in the host cells and disrupts the normal homeostatic functions of the host cells."[1]
"The ACE2 distal promoter transcript (DPT) is an evolutionarily conserved binding motif of ACE2 inhibitors, whereas the ACE2 proximal promoter transcript (PPT) is an evolutionarily conserved binding motif of ACE2 enhancers[5]. The DPT/PPT ratio is tissue-specific such that the DPT is significantly more than the PPT in the lung (>49-fold), whereas the PPT is significantly more than the DPT in the kidney, brain, and heart (>20-fold)[6]. It is unusual that the ACE2 DPT/PPT ratio, rather than the ACE2 genotype, determines ACE2 transcript levels." [1]
We also shared the further pathology-based clinical prediction that ACE2 deficiency is a core causal co-driver of COVID-19 clinical outcomes[3]:
"The clinical outcomes of COVID-19 are driven by the tissue-specific and patient-specific co-development of ACE2-deficiency-induced injury and innate-adaptive-imbalance-induced lymphocytopenia." [1]
"Therefore, lungs are selectively vulnerable to ACE2 deficiencies induced by COVID-19, and lung injuries are the predominant clinical features of COVID-19." [1]
When that pathology-based prospective prediction was first announced to the public on March 7, 2020[3], it was also contrarian to the mainstream view that (i) populations with lower baseline ACE2 expression level are less prone to SARS-CoV-2 entry and infection, and (ii) East Asians are more vulnerable to COVID-19 than Europeans/Americans because the human genomic data published on February 24, 2020, show that East Asians have much higher allele frequencies in most of the gain-of-function eQTL variants of ACE2 (Figure 1).
DATA VALIDATION
Those two contrarian prospective clinical predictions can be validated by analyzing the relationship between population-specific ACE2 genome data and population-specific COVID-19 mortality data.
As of April 4, 2020, there are 13 countries categorized into four region-specific populations following the definitions in Figure 1—Chinese (CHN), Non-Chinese East Asians (EAS), Europeans (EUR) and AdMixed Americans (AMR)—with each country having reported more than 10,000 confirmed COVID-19 cases (Table 1).
As of April 4, 2020, the total number of confirmed COVID-19 deaths per million population in those 13 countries are presented in Table 2.
Furthermore, the population-specific allele frequencies of 11 common eQTL variants associated with high expression of ACE2 in tissues are presented in Table 3.
Now we can start analyzing the relationship between population-specific ACE2 genome variants and population-specific COVID-19 mortality rates (Table 4).
Both the population covariance (-6.46) and the Pearson correlation (-0.88) clearly indicate that the population-specific ACE2 mRNA levels have a strong negative relationship with the population-specific COVID-19 mortality rates.
In other words, populations with higher baseline ACE2 mRNA levels (e.g., East Asians) would be less prone to the ACE2-deficiency-driven development of critical COVID-19 clinical outcomes, whereas populations with lower baseline ACE2 mRNA levels (e.g., Europeans) would be more prone to the ACE2-deficiency-driven development of critical COVID-19 clinical outcomes.
Therefore, the real-world data have validated our contrarian pathology-based clinical prediction that ACE2 deficiency is a positive driver of COVID-19 clinical outcomes[3], and thus invalidated the mainstream belief that ACE2 deficiency is a negative driver of COVID-19 clinical outcomes.
The real-world data further demonstrate that AI-based disease modelling and clinical predictions can deliver much better predictive power and explanatory power than conventional approaches for novel diseases with limited clinical data and short response timeframes.
PREDICTIVE BIOMARKER
Based on our pathology-based clinical predictions which are validated both by the real-world data as above and by the ex vivo data in human organoids[7], we thus further propose that ACE2 mRNA level can serve as a predictive biomarker of COVID-19 mortality rate, and even a surrogate biomarker of COVID-19 clinical progression.
Hospitalized COVID-19 patients can be stratified on admission based on their ACE2 mRNA levels, so that the corresponding level of care can be prepared well in advance.
Suspected COVID-19 patients can be stratified if they can receive the test of ACE2 mRNA levels at the same time when they receive the test of SARS-CoV-2 RNA levels.
TREATMENT PRIORITY
Contrary to the mainstream belief, COVID-19 would have a much more rapid and severe progression in Americans/Europeans compared with East Asians, because Americans/Europeans have much lower baseline ACE2 expression than East Asians due to their much lower allele frequencies in most of the gain-of-function eQTL variants of ACE2[4].
As our aetiology and pathology show that COVID-19 suppresses ACE2 expression for viral replication, Americans/Europeans with much lower baseline ACE2 expressions are much more prone to developing critical clinical outcomes than East Asians.
Therefore, on top of increasing the supply of masks and ventilators, it is much more important and urgent for European and American countries to prioritize the discovery and development of effective and scalable treatments for critically ill patients than for Asian countries.
Critically ill COVID-19 patient population has a 61.5% mortality rate[8] with sepsis (100%), respiratory failure (98%), and ARDS (93%) as the top 3 clinical outcomes of non-survivors[9], and there will be more critically ill patients of younger age groups in European and American countries due to the population-specific lower baseline ACE2 expression levels.
It is equally essential to discover scalable treatments that are cost-effective and globally available to reduce the mortality rate of COVID-19 in various European and American countries of different infection control capabilities.
REFERENCES
1.    Lovetrue, B. The AI-Discovered Aetiology of COVID-19 and Rationale of the Irinotecan+Etoposide Combination Therapy for Critically Ill COVID-19 Patients. (2020). doi:10.20944/PREPRINTS202003.0341.V1 
2.    Wrapp, D. et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science (80-. ). 367, 1260–1263 (2020). 
3.    Demiurge AI Discovers the Complete Aetiology of COVID-19 and the Optimal Treatment Strategy for COVID-19. Available at: http://www.prweb.com/releases/demiurge_ai_discovers_the_complete_aetiology_of_covid_19_and_the_optimal_treatment_strategy_for_covid_19/prweb16966447.htm. (Accessed: 1st April 2020) 
4.    Cao, Y. et al. Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations. Cell Discov. 6, 4–7 (2020). 
5.    COVID-19 Map - Johns Hopkins Coronavirus Resource Center. Available at: https://coronavirus.jhu.edu/map.html. (Accessed: 1st April 2020) 
6.    Coronavirus deaths: The stark differences in countries' case fatality rates, explained - Vox. Available at: https://www.vox.com/2020/4/1/21203198/coronavirus-deaths-us-italy-china-south-korea. (Accessed: 2nd April 2020) 
7.    Monteil, V., Kwon, H., Prado, P., Hagelkrüys, A. & Wimmer, R. A. Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2. (2020). doi:10.1016/j.cell.2020.04.004 
8.    Yang, X. et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir. Med. 2600, 1–7 (2020). 
9.    Zhou, F. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan , China : a retrospective cohort study. Lancet 6736, 1–9 (2020).
About Demiurge Technologies
Demiurge Technologies is a research-based AI-biopharmaceutical company that transforms publicly available life science data into precise disease models in areas with unmet medical needs. The company pioneers a self-correcting scientific approach that validates disease models with the accuracy of AI-based predictions of phase 3 clinical trial outcomes. The company also pioneers a self-sustaining business that commercializes disease models by accelerating the AI-based discovery and development of innovative medicines. Demiurge started in 2016 with headquarters in Switzerland.
AI has been an emerging powerful approach to deeper disease understanding and faster drug discovery, yet it must be put to the most rigorous test to prove its worth under public scrutiny. Demiurge has predicted the outcomes of more than 90 phase 3 clinical trials across multiple therapeutic areas and achieved more than 80% accuracy. Furthermore, we have been inviting the public to witness our future predictions of clinical trial outcomes on Twitter (@DemiurgeTech).
Therefore, we officially put forward AI-based discoveries of the precise aetiology and pathology of COVID-19 and the candidate treatments for COVID-19 as scientific hypotheses only and invite the world to validate their potential to solve the unprecedented global crisis posed by COVID-19.
Demiurge urges everyone to refrain from believing in the efficacy and safety of any COVID-19 candidate treatments before any clinical data come in.
Disclaimer 
This material is intended for information purposes only and is provided without any warranty of any kind, either expressed or implied. These statements are not guarantees of future performance, condition or results. Figures and graphs in this presentation are for illustration only and are may not match the actual scale. Actual results may differ materially from those in the forward‐looking statements as a result of a number of factors. Demiurge Technologies AG ("Demiurge") undertakes no duty or obligation to publicly update or revise the forward‐looking statements or other information contained in this document. You should not view information related to the past performance of Demiurge or its affiliated funds or information about the market, as indicative of future results, the achievement of which cannot be assured. While some information used in this document may have been obtained from various published and unpublished sources considered to be reliable, Demiurge Technologies AG neither guarantees its accuracy or completeness nor accepts liability for any direct or consequential losses arising from its use. Amounts and percentages may reflect rounding adjustments and consequently, totals may not appear to sum.

[https://ww1]

ACE2 mRNA level can serve as a predictive biomarker of COVID-19 mortality rate. Hospitalized COVID-19 patients can be stratified on admission based on their ACE2 mRNA levels, so that the corresponding level of care can be planned and prepared well in advance



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

In the midst of crisis, the entire NC textile industry is banding together to help our healthcare industry. Nufabrx, a proprietary biomaterial company that seamlessly embeds active ingredients including vitamins, supplements and medications into fabrics, in partnership with Bossong Medical and Manufacturing Solutions Center, has shifted production for a new line of reusable copper medical masks called TheraMasks. These masks are powered by CuTEC copper, a material that is known to be naturally antibacterial.
Founder and CEO Jordan Schindler decided to quickly retool a textile product to create a reusable face mask. "Tired of feeling helpless on the sidelines, we wanted to do something that would make a difference. With our Nufabrx technology, Bossong Medical and Manufacturing Solutions Center, everyone has linked arms and committed to help in this crisis. TheraMasks is the first-of-its-kind, reusable, CuTEC copper powered mask that lasts up to 30 washes. Already overwhelmed by inquiries, we will be prioritizing distribution to healthcare workers and first responders," states Schindler. The products are not only beneficial to medical facilities but also to nursing homes, home care attendants, senior communities and more. They are currently being used by hospitals, NY police and fire departments, Catawba County EMS, police, fire and county officials. We are sending them out overnight delivery as quickly as we can make them.
Copper has been shown to be a natural deterrent on bacterial growth. These medical masks are designed to help reduce the spread of germs through the natural benefits of copper; the fabric also creates a healthier environment for the wearer by reducing facial contamination. The products are durable enough to be machine washed and dried, or by hand with hot water. TheraMasks are environmentally friendly, and are not intended to be thrown away daily like disposable masks. Products have been tested for antibacterial (AATCC 100) and air permeability, and all data is available online. Additional testing is underway and all data will be shared with the public as soon as it is available. Products can be purchased online at http://www.TheraMasks.com or in bulk by emailing sales@theramasks.com (while supplies last).
Achieving overall health and wellness is simplified by using any Nufabrx product, as a result of replacing the hassle and cost of using medications, patches or creams. The materials are specifically designed for comfort and breathability, providing a close fit and ease-of-wear, while simultaneously delivering a controlled dose of medicine to the problem area. Developed in tandem with Department of Defense and MIT grant funding, this patented technology allows ingredients like capsaicin, a natural pain reducing ingredient, to be delivered directly through fabric. This technology is rolling out to Walmart nationwide in early April.
About Nufabrx and TheraMasks 
Founded in 2011, Nufabrx was created by Founder Jordan Schindler after discovering his pillowcase was contributing to his acne. Teaming up with MIT scientists, Jordan spent seven years developing proprietary technology to embed active ingredients into clothing to make medicinal application easier and more efficient. As a way to help our healthcare workers, reusable copper medical masks were a natural transition; TheraMasks was founded as a division of nufabrx. For more information visit http://www.Nufabrx.com and http://www.theramasks.com.
About Bossong Medical 
Bossong Medical is committed to being a world class designer and manufacturer of innovative medical textile products made in the USA for the global market. Bossong Medical was founded to design, manufacture and distribute innovative medical textile products. Bossong Medical's competitive advantage is providing compression therapy products that are of world class quality utilizing the guidelines of ISO 13485 certification and FDA registration for Class I and Class II medical devices. http://www.bossongmedical.com
About the Manufacturing Solutions Center
The Manufacturing Solutions Center was established 27 years ago to transition hosiery workers from mechanical to electronic machines. Today, companies are hiring computer designers, software engineers, and people trained to program and operate the increasingly complex knitting machines. The Manufacturing Solutions Center specializes in applied research and development, prototyping, testing, domestic sourcing, and training for 21st-century textile jobs. https://www.manufacturingsolutionscenter.org/


* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

Olive Fertility Centre is delighted to have been chosen the Best Fertility Clinic in Vancouver in the Vancouver Courier Stars of Vancouver Award.
We want to extend our heartfelt thanks to all our wonderful patients who chose Olive to help them create their families and voted us Best Fertility Centre in Vancouver.
Olive Fertility is dedicated to being the best fertility centre in Canada. "We are extremely proud of our world-class lab and having some of the best pregnancy rates of any fertility centre in North America," says clinic co-director, Dr. Beth Taylor.
Just as important as Olive's success rates is their exceptional patient-centred care. Everyone at Olive, from the receptionists at the front desk, to the patient care coordinators, the nurses, the embryologists and the doctors, strive to make sure that patients have the best experience possible.
"This award is also a testament to all that goes on behind the scenes at Olive," says Dr Taylor. "We are always trying to improve on our IVF lab design, processes and technology in order to create the best possible environment to ensure excellent outcomes and patient safety."
The rate of infertility in Canada has doubled over the last 20 years according to a Stats Canada report, in part because more women are delaying pregnancy until they are in their 30's and even 40's.
"Frequently women don't know that fertility declines more quickly after 35 and that a woman over 35 and her partner should have a full fertility workup if they haven't conceived after six months of unprotected intercourse," says Dr. Taylor. "The biological clock starts ticking much more quickly at this age. So, the sooner a problem is diagnosed, the more quickly the treatment can start."
Fertility evaluation and testing is fully covered by MSP in British Columbia with a referral from a family physician or a doctor at a walk-in clinic.
Located in Vancouver, BC, Olive Fertility Centre is one of Western Canada's largest IVF and prenatal diagnosis centres. With an advanced IVF lab, and innovative programs that include Comprehensive Chromosome Screening (CCS), egg freezing, and prenatal NIPT testing, Olive Fertility provides comprehensive fertility care to infertile couples, single women, and same-sex couples.


* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

Lake Bellevue Chiropractic, a modern chiropractic care facility, is fully operational and committed to helping patients amid the coronavirus pandemic.
During this crisis, it's not only important to deliver crucial patient care but to ease the burden of overcrowded hospitals and emergency rooms. That is why Dr. Matthew J. Dunn at Lake Bellevue Chiropractic continues to treat musculoskeletal injuries, allowing doctors on the frontline to focus on the public health emergency.
"I recently treated a patient suffering from extreme back and leg pain after an 18-hour shift working from home," said Dr. Dunn, a chiropractor, registered nurse and emergency medical technician, who has been treating back and neck pain for over 10 years. "Luckily, I was able to immediately ease her pain and save her a trip to our inundated local ER."
The numbers are staggering: 101.3 million adults suffer from neck and low back pain and musculoskeletal problems account for 19% of all doctor's visits, according to the U.S. Bone and Joint Initiative. Fortunately, officials have identified chiropractors as essential service providers during the pandemic so they can continue serving their communities.
With health and safety a top priority, Lake Bellevue Chiropractic continues to treat all forms of back and neck pain, including herniated discs, sciatica, peripheral neuropathy and whiplash injuries, while adhering to all CDC public health guidelines.
About Lake Bellevue Chiropractic:
Dr. Dunn's cross-disciplinary training as a chiropractor, RN and EMT gives him a unique medical perspective and allows him to treat patients for a wide range of conditions. He offers short term treatment for back pain, neck pain and many other musculoskeletal conditions and is an In-Network Preferred Provider for most insurance companies.

"Luckily, I was able to immediately ease her pain and save her a trip to our inundated local ER."



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

AJ Manufacturing – a leading manufacturer of critical environment HVAC products – has introduced a portable version of its Reverse Flow Criti-Clean Ultra Fan Filter Unit (FFU) to quickly and easily create patient isolation rooms. The new units were specifically developed to help protect healthcare workers treating COVID-19 patients and to help reduce the spread of the virus.
Like the original ceiling-mounted model, the portable Reverse Flow Criti-Clean Ultra FFU connects to existing ductwork and creates a negative pressure environment that removes the air from a patient room and cleans it via the unit's built-in HEPA filter, keeping airborne contaminants from escaping. The unit comes on wheels for easy movement and can be plugged into a standard electrical wall outlet.
"We're proud to be able to do our small part to help protect healthcare workers who are treating the growing number of coronavirus patients," said Rob Haake, president of AJ Manufacturing. "Our plant is 100% focused on producing both our permanent and portable FFU models for as long as they are needed to help stop the spread of the virus."
In addition to reverse flow units that take in air and remove it from a room, standard FFU models – both ceiling mounted and portable – are also available to bring HEPA filtered air into a room. AJ's ceiling mounted FFUs offer the industry's lowest plenum height of just 13.7″, allowing easier retrofitting into existing ceiling spaces.
For more information, contact AJ Manufacturing at 816-231-5522 or visit http://www.ajmfg.com.
About AJ Manufacturing 
AJ Manufacturing is an industry leader in stainless steel air distribution products for critical environments, such as hospitals, laboratories, pharmaceutical plants and many others. The company offers a wide range of both standard and custom products, including filter and non-filter diffusers, supply and return grilles, dampers, louvers and more.

We're proud to be able to do our small part to help protect healthcare workers who are treating the growing number of coronavirus patients.



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

LifeLink today announced it recently deployed a new conversational chatbot solution to serve as the "Coronavirus digital front door" for Jefferson Health patients seeking information or treatment for COVID-19.
The technology allows Jefferson clinical teams to remotely screen and prioritize cases without risk of exposure, provides massive scale in frontline response capabilities, and optimizes care utilization across the Jefferson network. The bot also digitizes the clinical intake process to streamline appointment scheduling for COVID-19 testing.
"With LifeLink, we can provide our community with another touchpoint for people to safely assess their risk from home," shares Lisa Griffin, Senior Vice President of Seamless Access at Jefferson Health.
The conversational interface uses simple, interactive messaging to collect patient information—processes that were previously done via time consuming phone calls or in-person interactions. The LifeLink-powered chatbot automates three key workflows: 

Conducts a risk assessment based on patient symptoms and exposure profile

Connects screened patients with recommended care pathways and action steps

Automates the clinical intake process for patients who need to schedule appointments

"We must find ways to engage a high volume of patients that are coming to us for help," said Neil Gomes, Executive Vice President and Chief Digital Officer at Jefferson Health. "LifeLink chatbots have already proven to be effective for us at increasing digital appointment requests."
LifeLink's conversational platform is designed for rapid configuration and scale. The COVID-19 solution relies on several existing, proven workflow modules that were optimized to handle patient risk assessment and intake across a range of demographic and care scenarios.
"Our priority is to make sure our community is empowered to make decisions about their health, and the chatbot is another way we have expanded our Telemedicine capabilities. In every way we can, and using any technology we can leverage, we are going to be here for our community with accurate information about COVID-19," states Efrat Kean, Clinical Instructor of Emergency Medicine at Jefferson Health.
"We are thrilled to be able to deliver this kind of important, meaningful technology that will make a difference for the Jefferson staff and their patients during this unprecedented time," added Greg Johnsen, CEO at LifeLink. "Although it took this particular crisis to uncover the need, conversational infrastructure is a must-have for all healthcare systems and the use cases go well beyond COVID-19 screening and intake."
The bot is live on the Jefferson Health appointments website (http://appointments.jefferson.edu/) and available for any website visitor to use. Jefferson recommends all patients use the chatbot before calling or visiting one of its facilities.
About LifeLink 
LifeLink builds mobile conversational chatbots for healthcare. Large hospitals, pharmaceutical companies and healthcare service providers use LifeLink technology to engage patient populations at scale, across a spectrum of workflows and scenarios. For more information, visit http://www.lifelink.com.

"Conversational infrastructure is a must-have for all healthcare systems and the use cases go well beyond COVID-19 screening and intake



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

Bravrr, a company dedicated to providing wearable diagnostic and digital therapeutic technologies to clinicians and patients, has launched BruxRelief, an innovative assessment tool for bruxism disorders. 
The BruxRelief system is a wearable headband incorporating patent-pending sensors that connect with an app on a dental patient's smartphone. These sensors detect the activity of the temporalis muscle caused by the clenching and grinding behaviors associated with bruxism. "More than 90% of bruxism patients go undiagnosed," said Brock Predovich, CEO and founder of Bravrr. "Bruxism can lead to deterioration of the dentition, TMJ dysfunction, migraines, vertigo, tinnitus, and localized pain in the neck, jaw, or teeth."
"The way in which bruxism is currently diagnosed is less than ideal. Rather than being able to intervene early, dentists must wait to observe wear on a patient's teeth. At this point, the damage is already done," said Dr. Chris Salierno. In his role as Chief Development Officer for Cellerant Consulting Group, Dr. Salierno has advised Bravrr on the clinical development of the BruxRelief system from early stages to launch.
A typical BruxRelief assessment involves the patient wearing the headband for three nights in the comfort of their own home. The data is recorded to the smartphone app providing both the patient and clinician with a clear picture of the frequency and duration of unconscious temporalis muscle contractions associated with bruxism behavior. 
"Patients rarely acknowledge that they have a bruxism disorder as they are not acutely aware of their clenching/grinding behavior," added Dr. Salierno. "BruxRelief provides the dentist with objective data to demonstrate to the patient the presence of a parafunctional condition. Having this data makes it easier for the patient to accept the need for a nightguard appliance to minimize further damage caused by bruxism."
Future iterations of the device will seek to include a biofeedback mechanism. Mr. Predovich adds, "the cognitive-behavioral training and muscle reeducation possible with a biofeedback loop can play a huge role in reducing or even eliminating the pain associated with this undesired behavior. While assessment is the first step, Bravrr embraces the opportunity to help patients better control their parafunctional habits, leading to an improved quality of life."
For more information on the BruxRelief assessment device, please visit http://www.bruxrelief.com. To learn more about Bravrr, visit http://www.bravrr.com.
About Bravrr 
Founded and led by Brock Predovich, an individual who personally suffered from a bruxism disorder, Bravrr Inc. is committed to conceiving, developing, manufacturing, and marketing wearable diagnostic and digital therapeutic technologies for clinicians and patients. The company is located in Cañon City, Colorado.
Bravrr Press Contact 
Mr. Brock Predovich, CEO Bravrr Inc. Phone: 720-258-6699 info@bravrr.com http://www.bravrr.com
About Cellerant Consulting Group 
Founded and led by CEO Lou Shuman, DMD, CAGS Cellerant provides strategic dental market insights, clinical expertise, and implementation resources to accelerate growth for client dental companies. Cellerant services include product development, accelerated market awareness due to intimate relationships with the media community, new concept incubation, clinical product evaluation, manufacturing, seed funding, continuing education program development and CE sponsorship, 510k support, strategic branding and marketing, corporate social media, website development and online marketing resources, lead generation and dental media relations management. As an orthodontist and former owner of a 10-doctor multi-specialty private group practice, Dr. Shuman guides clients to develop offerings that connect with and engage dental customers on a relationship level that provides sustained differentiation. Cellerant operates under a unique model that merges leading voices in clinical product evaluation and strategic partner companies to provide a menu of services from one easily accessible network.
Cellerant Press Contact 
Thais Carter Cellerant Consulting Group Phone: 800-884-5707 ext. 108 info@cellerantconsulting.com http://www.cellerantconsulting.com

More than 90% of bruxism patients go undiagnosed



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

MolecularMatch, a leading clinical informatics company providing Precision Medicine software solutions, has updated the MolecularMatch search engine with new features and content to support customers' response to the novel coronavirus pandemic. Updates include access to hundreds of clinical trials and thousands of publications that are applicable to coronavirus and COVID-19.
With the built-in search features of the MolecularMatch search engine, users can locate the most appropriate clinical trials and publications for individual patients, including filtering clinical trials for inclusion and exclusion criteria based on patient-specific clinical details and narrowing search results to trial sites by a patent's geographic location. Institutions can also upload private trials to the MolecularMatch database that are not yet indexed in the public registries.
"Our team has been working overtime to add support for coronavirus and COVID-19 clinical trials and publications," said Eric Pulaski, CEO of MolecularMatch. "Although the focus of our curated content has been on oncology, the versatility of our core platform enabled us to quickly add support for new content in this area of infectious disease. We're stepping up to the plate to do our part to support researchers, labs, healthcare providers, and others in the global fight against the novel Coronavirus pandemic."
Version 4.1 of the company's web-based portal (MMPortal) and REST API (MMPower) are available immediately, and all current customers have access to the new content at no additional charge. The MolecularMatch Knowledge Graph and content across the MolecularMatch knowledgebase have been enhanced with the following: 

Added support for antiviral drugs and drug classes

Added virology, emergency medicine and infectious disease related journals and publications (over 2,300 publication entries)

Added global registry clinical trials related to coronavirus/COVID-19 (over 360 trials)

MolecularMatch's clinical comprehension and ranking applied to this new data

The MolecularMatch COVID-19 database is updated every 2-3 days. The company is also exploring other ways to help battle this pandemic with new offerings to reach a wider base of users who can benefit from the MolecularMatch search engine.
About MolecularMatch 
MolecularMatch, Inc. is a Houston, Texas based clinical informatics SaaS company established in 2014. The company was founded on the vision of using tumor molecular profiling and outcomes from previously-treated patients to provide the best personalized treatment for current patients. MolecularMatch delivers personalized, evidence-based therapeutic guidance and clinical trials matched to each patient. Customers include molecular labs, health information systems, biopharma, second opinion and payer companies, as well as cancer centers across the globe. Visit us at molecularmatch.com or follow us on Twitter or LinkedIn.

"Our team has been working overtime to add support for coronavirus and COVID-19 clinical trials and publications," said Eric Pulaski, CEO of MolecularMatch



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

In the wake of the current health crisis, things like medical masks, disinfectants, and hand sanitizers are scarce. But Ryan Zamo, the 30-year-old entrepreneur behind Z Skin Cosmetics, has astonished customers across the globe with his ability to maintain stock of his Simply Sanitizer even while selling thousands of bottles weekly. Furthermore, on top of the massive increase in sales Z Skin Cosmetics has been donating dozens of bottles weekly to hospitals and healthcare workers in need, Zamo commented, "We never sold a lot of our sanitizer before the pandemic, but because we've become so blessed with this windfall of success, the least we can do is donate to those in need."
It seems a bit suspect that a small business can keep up with an influx of orders, while in contrast, large manufacturing plants seem to lag. We asked Zamo what his secret is to maintaining supply; he told us, "Well, we are a handcrafted organic skincare brand. That means we are constantly disinfecting everything and maintaining a sterile environment. Therefore, we always have ample stock of the ingredients needed to make our sanitizer." But besides having the ingredients, there is also one more aspect to his ability to keep up with the demand; he added, "You can have all the ingredients in the world, but that doesn't necessarily mean you'll be able to fill big orders. It's because we make every product to order, which means a few things. First, since we make our products, we don't have any "stock items," meaning nothing is just sitting around waiting to be sold. And second, that means we have no inventory, so we make the products as the orders are placed."
Furthermore, according to the business owner, over 90% of original customers have come back and ordered more units from him, he commented, "Our sanitizer is a sanitizer lotion, it gets the job done, but it doesn't dry out your hands. It moisturizes your hands too, and with the terrible weather conditions, it's a combination of two things everyone needs right now."
With the ability to maintain stock and keep orders going out, Z Skin Cosmetics has been on the top of its game. While other companies are back-ordered and unable to fill large orders, Zamo is busy working hard to get his customers their hand sanitizers within 2-3 days. Between major businesses ordering from Z Skin Cosmetics as well as a flood of global consumers in need of hand sanitizer, the entrepreneur seems to be keeping up well with the spike in orders.
For more information on their product, visit: 
https://zskincosmetics.com/collections/complete-systems/products/simply-sanitizer-6-oz
For more information on the company, visit: 
https://zskincosmetics.com/pages/who-and-how-z-skin-came-to-be
Contact: 
Michael Nore 
Nore.Marketing@ZskinCosmetics.Com

Furthermore, on top of selling thousands of bottles, Z Skin Cosmetics has been donating bottles weekly to hospitals and healthcare workers in need



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

MSA donated over 4,600 nitrile gloves in multiple sizes to the foundation on Monday. These gloves will be distributed across the St. Anthony medical network.
"Meta Special Aerospace is happy to be able to give back to our community during this time of need. The caregivers and medical personnel are giving tirelessly to our community and we wanted to do all we could to support that work," says Mike Bowen, VP Aviation Services, Meta Special Aerospace.
The medical community has been hit hard since the global outbreak of COVID-19. It's been an incredibly stressful time for those who work on the front lines of health care. Longer hours, weeks, and limited supplies have only added to this stress. Now more than ever, it's important for the community to come together and support the medical industry during this time of need.
"Support from community partners, such as Meta Special Aerospace, is monumental in helping our team of caregivers continue to serve and help those in need during the COVID-19 crisis," says Randy Cassimus, Director of Annual Giving, SSM Health St. Anthony Foundation.
Learn more about Meta Special Aerospace at http://www.metaspecialaerospace.com. 

[https://ww1]

"Support from community partners, such as Meta Special Aerospace, is monumental in helping our team of caregivers continue to serve and help those in need during the COVID-19 crisis," says Randy Cassimus, Director of Annual Giving, SSM Health St. Anthony Foundation.



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

Eu Natural, a leading wellness brand that creates plant-powered formulas to meet your body's needs, is excited to announce FERTILITY, the ultimate supplement bundle for male and female reproductive health.
According to the Centers for Disease Control and Prevention (CDC), about 6% of married women aged 15 to 44 years in the United States are unable to get pregnant after one year of trying with an additional 12% of women in the same age range having difficulty getting pregnant or carrying a pregnancy to term, regardless of marital status. Eu Natural is aligned with the notion that fertility challenges can be experienced by anyone, regardless of race, religion, sexuality or economic status.
"For parents looking for noninvasive measures to support pregnancy health, our FERTILITY bundle is a great place to start," said Vinay Amin, founder of Eu Natural. "We understand the struggles that come along with conceiving, so we decided to bundle all of our reproductive supplements together to make it easier for parents to start trying. The supplements give partners the support they need for optimum reproductive health and contain nothing but 100% pure, wholesome vitamins, minerals, and herbs with zero additives or fillers."
The bundle includes CONCEPTION, a multi-vitamin for mom and baby's future, including Vitamin D, zinc, iron, DHA, and folate folic acid. CONCEPTION MENcontains a full spectrum of vitamins and Pygeum Extract that work in concert to rapidly support sperm count. N-Acetyl Cysteine (NAC), Ashwagandha and Folate provide a gradual but potent boost to male fertility. The MOMMA supplement is a powerful probiotic, which promotes digestive, immune, and vaginal health.
Additionally, with every purchase of an Eu Natural supplement, they donate via their charity partner, Vitamin Angels, one year of vitamins for children under five, new mothers, and pregnant women who are at risk for malnutrition.
"Eu Natural's partnership with Vitamin Angels truly shows their commitment to making this world a healthier place," said Howard Schiffer, Vitamin Angels Founder and President. "As their business grows, they are helping even more at-risk mothers and babies around the world receive life-changing vitamins and minerals."
In 2019, Vitamin Angels was able to distribute vitamins to approximately 70 million children residing in more than 74 countries.
About Eu Natural 
Eu Natural was founded in 2013 to empower its customers and their health, creating powerful blends of herbs, vitamins, and minerals, each formulated to promote the best in health. The wellness brand's premium health supplements are made in the USA and follow Good Manufacturing Practices. They are made without any extra fillers, binders or artificial ingredients. Eu Natural uses only the purest and most potent natural ingredients. To learn more about Eu Natural and its supplements, visit https://store.eunatural.com.

[https://ww1]

We understand the struggles that come along with conceiving, so we decided to bundle all of our reproductive supplements together to make it easier for parents to start tryin



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

Era Living (http://www.eraliving.com), a Seattle-based operator of eight retirement communities, today announced that data from two rounds of broad-based COVID-19 testing at one of its communities, Ida Culver House Ravenna in Seattle, informed targeted preventative measures that continue to show promising low COVID-19 infection rates among residents of the community.- -
"Through partnership with the University of Washington Medical Center, we conducted two rounds of broad-based testing among all 80 residents at Ida Culver House Ravenna. That data continues to greatly inform our aggressive preventative measures and thus far and has kept infection rates very low—even when the risk for outbreak was high following two known infections in early March," said Nisan Harel, Vice President of Operations at Era Living.
"We know that elderly individuals, and those who care for them, are most at-risk for developing COVID-19 infections that are life-threatening," continued Harel. "It's time to allow broad-based testing for all residents and staff in retirement, nursing home and assisted-living facilities to help inform targeted preventative strategies to protect residents and staff, while also preserving valuable personal protective equipment."
Results from Rapidly-Deployed Early Testing Showing Positive Prevention Results 
On March 10th, 2020, just one day after learning that the Ida Culver House Ravenna community's first COVID-19 positive resident had passed away—and receiving news of a second positive resident—Era Living partnered with University of Washington Medical Center (UWMC) to deploy rapid, broad-based testing onsite for all staff and residents at the community.
The quick and thorough response enabled the immediate identification of three more residents and two staff members at the community who were positive for COVID-19. The residents were asymptomatic at the time of testing, and identifying the virus at this early stage enabled the Ida Culver House Ravenna team to strictly isolate them and put targeted, aggressive preventative measures in place.
Specifically, the Era Living team changed its staffing schedule at Ida Culver House Ravenna to avoid staff crossover to other residents, and ensured that staff who were still interacting with COVID-19 positive residents were fully protected with personal protective equipment (PPE). In addition, the following strategies were implemented to help inhibit further spread of the virus: 

Restricting non-essential visitors and screening essential visitors for risk factors.

Taking temperatures of all staff at the start of their shifts and all visitors.

Canceling dining room meals.

Canceling all resident activities, including bus outings to the grocery store.

Doubling frequency of surface cleaning and disinfectant protocols in common areas.

Reminding all residents and staff to practice rigorous hand hygiene and avoid touching eyes, nose, and mouth.

Strongly encouraging staff to take extra precautions in their personal lives given the vulnerability of the residents we serve (in advance of government orders). This includes, among other things, staying at home and avoiding large groups of people as much as possible.

Committing to transparent and frequent communication with our residents and staff.

To test the effectiveness of these strategies, a second round of follow-up testing was conducted on March 17th in partnership with UWMC. At that time, only one new resident was confirmed as COVID-19 positive, and three of our four previously-positive residents are now negative. Since the second round of broad testing on March 17th, only one new staff coronavirus case has presented at Ida Culver House Ravenna.
Era Living Pleas for Greater Testing Availability to Protect Elderly Communities and Workers 
As a result of these outcomes, Era Living is making an impassioned plea to local, state and government officials to begin enabling broad-based testing immediately for elderly individuals across retirement, nursing home and assisted living communities.
"It has been heartbreaking to watch the coronavirus situation unfold in communities around our state," said Harel. "We know from our own experiences—and by monitoring data from countries such as Germany and South Korea, who are successfully-fighting COVID-19 using broad-based testing—that identifying those infected early-on can dramatically change outcomes for the better."
"Prioritizing the availability of PPE for broad-based testing in community living environments for vulnerable people would be far less wasteful - and in our opinion, much more effective at curbing the spread of the virus - than trying to use PPE on everyone in our communities," continued Harel.

[https://ww1]
Two rounds of broad-based early testing for residents and staff in early March provided much-needed data that informed preventative measures and has helped keep infection rates low.

"Through partnership with University of Washington, we conducted two rounds of testing among all 80 residents at Ida Culver House Ravenna. That data continues to greatly inform our aggressive preventative measures and has kept infection rates very low—even when the risk for outbreak was high



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

More than 53,000 Americans will be diagnosed with oral cancer in 2020.
In honor of Oral Cancer Awareness Month this April, SmartMouth has partnered with Mediaplanet to help bring awareness to this disease through their Oral Health campaign, which launched last week.
In this month's issue entitled Oral Health, Emmy Award-winning voice actor, author, and singer Rob Paulsen describes his journey through his diagnosis, treatment, and recovery from throat cancer, and how he adjusted to his "new normal." As the spokesperson for Head and Neck Cancer Alliance's Oral, Head, and Neck Cancer Awareness Program, Paulsen stresses the importance of early detection and prevention, and empathizes with patients and survivors who have struggled with the disease.
Those suffering from oral cancer endure harsh side effects, from difficulty swallowing to loss of their voice. One of the most common ongoing side effects of many cancer treatments is dry mouth, which is caused by the destruction of the salivary glands.
SmartMouth offers two complimentary solutions for those suffering from dry mouth.
SmartMouth's resident dentist and ADA member Dr. Elizabeth Clary asserts, "Dry Mouth Activated Oral Rinse provides relief from the symptoms and discomfort of dry mouth, it moisturizes and soothes oral irritation, and it lubricates oral dryness."
In addition to the Dry Mouth Activated Oral Rinse, SmartMouth recently launched dual-action Dry Mouth Mints, which contain Zinc for oral health and Xylitol, a saliva stimulant. The convenient pouch design fits easily in your pocket for on-the-go dry mouth relief.
About SmartMouth Oral Health Laboratories 
SmartMouth Oral Health Laboratories manufactures and markets SmartMouth branded mouthwash, toothpaste and mints through national retailers and online. Headquartered in St. Louis, Missouri, SmartMouth has been working to eliminate and prevent bad breath since 1993.
For a special offer on Dry Mouth products, please visit https://www.smartmouth.com/dmoffer.
The Oral Health campaign was distributed by Mediaplanet through USA TODAY on March, 31 2020 and is published online here:
https://issuu.com/mediaplanet_usa/docs/oral_health_final_boston
https://www.futureofpersonalhealth.com/oral-health/head-and-neck-cancer-means-a-difficult-new-normal-for-many-survivors/

[https://ww1]
SmartMouth Dry Mouth Mints with Zinc

SmartMouth's resident dentist and ADA member Dr. Elizabeth Clary asserts, "Dry Mouth Activated Oral Rinse provides relief from the symptoms and discomfort of dry mouth, it moisturizes and soothes oral irritation, and it lubricates oral dryness."



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

baggallini, a handbag and travel luggage company known for its functional, organizational and durable nylon bags, is launching a charitable program in response to the shortage of protective gear related to the COVID-19 pandemic.
Due to an increasing number of infected patients and therefore a significant decline in the availability of masks, baggallini's parent company, RG Barry Corporation, in collaboration with its slipper brand Dearfoams, is donating 100,000 face masks to those healthcare workers who are battling the coronavirus pandemic in hospitals.
"Medical workers and first responders are putting their lives on the line every day during this pandemic and we want to help," said Scott Erdman, baggallini brand president. "The whole baggallini family is appreciative and humbled by these healthcare heroes who take care of us all."
In order to provide further relief and support to healthcare workers, baggallini also plans to launch a program on its website where consumers who purchase a bag at baggallini.com will automatically have a bag donated on their behalf. To aid in the fight against this virus, the program is meant to bring support to those frontline healthcare workers who are working daily to diligently and fearlessly help combat this crisis. baggallini will further support this initiative through extended communication on their website, social channels, and email marketing.
About baggallini: baggallini is a handbag, luggage, and travel company based in New York, NY. Founded in 1995, baggallini is known for its lightweight, durable, functional, and organizational bags. From the perfect work backpack to lightweight mini – and everything in between – you can count on our 
commitment to stress-free organization. Life is a journey. And no matter where it leads, we're with you every step of the way.

"Medical workers and first responders are putting their lives on the line every day during this pandemic and we want to help," said Scott Erdman, baggallini brand president. "The whole baggallini family is appreciative and humbled by these healthcare heroes who take care of us all."



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

Dearfoams, America's number one slipper company, is donating its cozy slippers to those in the medical field working on the frontlines amid the COVID-19 pandemic. Beginning on April 7, consumers on Dearfoams.com who purchase a pair of slippers will automatically have a pair of slippers donated to a healthcare worker on their behalf. Those in the medical community can redeem one free pair of slippers, while supplies last, through the website and have a pair shipped directly to them at no cost.
"All of us at Dearfoams are thinking of the brave workers who are caring for those suffering from this global pandemic," said Tricia Bouras, Dearfoams brand president. "We hope this donation of washable slippers will help those workers find some comfort after a long day on their feet. It's essential that we shift our day-to-day focus and do what we know is right to thank these deserving healthcare heroes."
Dearfoams' parent company RG Barry Corporation, in collaboration with its handbag brand baggallini, is donating 100,000 face masks to those on the medical frontlines nationwide as well. "We appreciate and give thanks to essential workers who are tirelessly bringing comfort to those in need," said Bouras. "It's humbling to see the need that exists to care for the community at large. It's also inspiring to see the nation coming together as one community to care for each other."
To further help ease stress and provide moments of comfort during this unprecedented time, Dearfoams is also launching "At Home on Dearfoams," a two-week Instagram series featuring self-care activities and wellness tips. For a full lineup of the events that begin Sunday, April 5, follow @Dearfoams on Instagram.
About Dearfoams: Dearfoams, a brand of RG Barry Corporation, was established in 1947 by visionary female entrepreneur Florence Melton who invented the world's first foam-soled, washable slipper. Dearfoams is headquartered in Pickerington, Ohio.

"We hope this donation of washable slippers will help those workers find some comfort after a long day on their feet. It's essential that we shift our day-to-day focus and do what we know is right to thank these deserving healthcare heroes," said Tricia Bouras, Dearfoams brand president.



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

LifeStation (http://www.lifestation.com), the premier medical alert company announced today it has partnered with The Blue Card (http://www.bluecardfund.org) to provide remote care services to Holocaust Survivors. The current COVID-19 Pandemic increases the dangers of social isolation more than ever, particularly for seniors in need. LifeStation leveraged their 24/7 Customer Care team to make check-in calls to Holocaust survivors serviced by The Blue Card to determine if they had any urgent requirements for food or medicine and to remind them that with LifeStation and Blue Card, they are not alone.
"We understand how important the support survivors receive from The Blue Card program is to their independence and well-being," said Laura Aiello, Director, LifeStation. "During this time of uncertainty, we were happy to offer our wellness checks to survivors to find out if they were having any difficulty getting medicine or groceries. We were then able to share that information back to The Blue Card, who could make arrangements to further support these seniors in need."
The mission of The Blue Card is to provide direct financial assistance, with utmost respect and ever mindful of their dignity, to needy Holocaust survivors in the United States.
Financial assistance is available on a monthly basis for most basic needs, as well as for emergencies, such as medical and dental care, special equipment, rent and utility shut offs. The organization's health precautionary services allow survivors to avoid institutionalization and remain in their homes for as long as possible.
"We are thrilled to partner with LifeStation," said Masha Pearl, Executive Director, The Blue Card. "By utilizing LifeStation's products and services, our members can maintain their independence longer, remain in their own homes, and better share their health and wellness needs with those dedicated to their care. Through this partnership, our members can engage with a proactive system designed to put their medical and emotional needs first."
Continued Ms. Aiello, "As we navigate the COVID-19 outbreak, our partners can rest assured that they can focus on the well-being of their employees, and families, with the knowledge that their members are in good hands with LifeStation."
For more information about how LifeStation can help your organization and its members stay both protected and connected, contact 800-446-3300.
About LifeStation 
LifeStation is one of the leading providers of medical alert monitoring and telehealth technology services in the United States. LifeStation's mission is to leverage innovative capabilities to transform the lives of seniors and help them live safely and independently. Of equal importance is the wellbeing of caregivers and providing them with the peace of mind they need.
About The Blue Card 
Founded in Germany in 1934, and reestablished in the United States in 1939, The Blue Card has distributed nearly $40 million to Holocaust survivors to date, with 100 percent of annual contributions made by individuals going directly to survivors. The Blue Card is certified by the Better Business Bureau (BBB), has the highest 4-star rating from Charity Navigator and was named as one of the best Jewish charities by Federal Times.

[https://ww1]

As we navigate the COVID-19 outbreak, our partners can rest assured that they can focus on the well-being of their employees, and families, with the knowledge that their members are in good hands with LifeStation



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

Nixxi, a biotech company deeply committed to tackling and improving human behavior and biological conditions through advanced analytics, announces the results of new research on its preterm birth biomarkers in the peer-reviewed publication Human Reproduction Open. The study demonstrates that a ratio of maternal steroid hormones, when tested in the first trimester, accurately predicts a pregnant woman's risk for having a spontaneous preterm birth prior to 32 weeks (called "very preterm birth"). Babies born at less than 32 weeks have higher rates of complications and a greater likelihood of long-term care needs, and these pregnancy outcomes result in significant costs to the healthcare system. The findings are important as early detection allows clinicians to identify those women at the greatest risk for preterm delivery and implement behavioral and clinical interventions to mitigate risk.
"Nixxi has taken a fresh look at more than 40 years of research in the area of preterm birth to identify opportunities to advance the science," said Avi Patil, MD, Nixxi founder and chief executive officer. "By utilizing an advanced targeted steroid metabolic approach, our team discovered an imbalance in hormonal pathways highly correlated to preterm delivery resulting in a promising new test that can be used early in pregnancy to identify women at risk for spontaneous preterm delivery less than 32 weeks' gestation. This data will arm healthcare providers with valuable insights on identifying their at-risk patient population and proactively caring for these patients with heightened needs."
About the Study 
Ninety-three pregnant women who had plasma samples obtained during the late first trimester/early second trimester were included in the study. Of those women: 

    28 delivered prior to 32 weeks

    40 delivered between 33-37 weeks

    25 delivered after 37 weeks

Plasma samples were processed for mass spectroscopy and the amount of progesterone and progesterone metabolites in the samples were measured. Mean values of each measured steroid metabolite were calculated and compared among women delivering less than 32 weeks, less than 37 weeks and greater than 37 weeks. Maternal serum levels of 11-deoxycorticsterone (DOC) measured during the late first trimester or early second trimester correlate with an increased risk for preterm delivery prior to 32 weeks. When the ratio of DOC to 16-alpha-hydroxyprogesterone was measured, the association with delivery prior to 32 weeks was stronger.
About Preterm Birth 
Preterm birth is defined as the delivery of a baby before 37 completed weeks of pregnancy. A full-term pregnancy term lasts between 37-40 weeks or about nine months. Preterm babies tend to have more health problems and stay in the hospital longer than babies born full-term. The earlier in pregnancy a baby is born, the greater the chance of serious health problems, both immediate and long-term, including slower growth, cerebral palsy, sudden infant death syndrome (SIDS), diseases of the ears and eyes and even blindness.
Preterm birth affects one in 10 pregnancies in the U.S. and the overall rate has continued to increase for the past four consecutive years. Preterm birth and its complications are the largest contributors to infant death in the U.S. and globally. In the U.S. alone, the annual economic burden associated with preterm birth amounts to $26.2 billion. The majority of these costs stem from those babies born before 32 weeks.
Common causes of preterm birth include a woman having had multiple pregnancies, infections and chronic conditions such as diabetes and high blood pressure. There could also be shared genetic factors among family members that affect risk. Women who live in poverty, both in low-income countries and more developed nations, also have a much higher risk. Often, however, no cause will be identified.
Other known risk factors for preterm birth include having had a prior preterm birth, pregnancy with twins or other multiples, a short interval between pregnancies, fertility treatments, and problems with the major organs involved in the pregnancy. Smoking, drug use, inability in maintaining a healthy weight and stress can all contribute to preterm birth risk as well. Lifestyle choices and decision-making play a critical role in eliminating some of these risk factors and give women a better chance of having a healthy pregnancy and baby.
About Nixxi 
Nixxi, based in Phoenix, AZ, is a biotech company deeply committed to tackling and improving human behavior and biological conditions through advanced analytics, led by a group of experienced, determined professionals with a variety of healthcare backgrounds.
Nixxi's mission is to reduce pregnancy risk and enhance neonatal outcomes through early and cost-effective testing paired with actionable insights for physicians and patients.
For more information or to see the full study, please go to http://www.nixxihealth.com.


* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

The number-one essential skin oil? Sebum. With no boutique purchase needed, because it's self-produced, released by our pores to coat and protect. "In the long run," notes Christina Smitley, a board-certified family nurse practitioner who specializes in dermatology with Advanced Dermatology PC, "people with 'oily' skin typically have 'younger' skin and develop fewer wrinkles. That said, many are understandably challenged by how to manage its shiny appearance. And, uncontrolled, oily skin can contribute to acne, this country's most common skin problem."
Sebaceous glands connect to our skin's pores and play a key maintenance role, producing sebum to keep our skin healthy and ward off dryness.
"There are a number of factors that can put sebum production into overdrive," explains Smitley, "including hormones, stress, diet, environment, and genes. Left untreated, excess sebum can contribute to clogged pores, triggering pimples. Balancing our skin's oil can help lessen the likelihood of a breakout."
Recent research has shone a light on the interplay between stress and diet and the activity of the sebaceous gland. "We're also learning more about different approaches for moderating oil production," observes Smitley, "as well as what to avoid."
With that in mind, she offers the following suggestions:
6 Tips on Controlling Excess Skin Oil:
1. Say no to scrubbing! "We can't wash the oil away," emphasizes Smitley. "In fact, overwashing triggers our skin to produce even more sebum. It's best to use gentle, non-soap cleansers and warm (not hot!) water, in limited doses: only twice a day and when sweaty. Gently use your fingers to wash, and then pat dry – no rubbing."
2. Exfoliating? Mind the mantle! "Careful exfoliating," observes Smitley, "can prevent sebum from clogging pores. Chemical-based exfoliants, such as glycolic or lactic acid, are typically more gentle than mechanical exfoliants, like brushes and scrubs. But, as with cleansing, we don't want to overdo it: For oily skin, at most, three times a week. And follow-on moisturizing is essential."
3. Moisturizing is a must! "Yes," states Smitley, "oily skin needs moisturizing too. Moisturizing helps prevent dryness that triggers sebum. The key is to use an oil-free, 'non-comedogenic' product that won't clog pores. Those with hyaluronic acid can help maintain hydration. Also, timing counts: Moisturize ASAP after cleansing, optimally within a minute and no more than three minutes after drying, to lock in your skin's moisture."
4. Help your sebaceous glands relax: "Stress and food choices," explains Smitley, "can put our sebaceous glands into overdrive. When we're stressed, we produce more of the hormones that turn on our sebum production. Likewise, foods that quickly break down into sugar trigger sebum. Sugar spikes are the result of more than dessert: white rice, pasta, potatoes, and bread all quickly break down to glucose. Moderation with these high-glycemic foods can help keep our sebaceous glands in balance."
5. Products? The bad – and the good: "Yes, our skin care products should be oil-free and non-comedogenic, as well as free from drying agents like alcohol," notes Smitley. "But we also want to take care that other products, like hair care and cosmetics, aren't introducing oils or irritants. In terms of what can help, gentle use of blotting paper (no rubbing!) can remove excess oil. And more recent research suggests that topical formulations with L-carnitine or green tea can limit the production of sebum."
6. Still frustrated? See an expert: "If home treatments aren't enough," says Smitley, "the dermatologist's office offers a wide range of interventions. Building a relationship with your skin specialist can also provide access to new techniques. For example, we're seeing research that shows that 'botox' treatments hold promise for controlling oily skin."
"Oily skin," concludes Smitley, "can be balanced so that our skin maintains the protection it needs and individuals have the control that they want."
Bio: Christina Smitley, FNP-C, is a family nurse practitioner with Advanced Dermatology pc, is board-certified through the American Academy of Nurse Practitioners.
Advanced Dermatology P.C. and the Center for Laser and Cosmetic Surgery (New York & New Jersey) is one of the leading dermatology centers in the nation, offering highly experienced physicians in the fields of cosmetic and laser dermatology as well as plastic surgery and state-of-the-art medical technologies. http://www.advanceddermatologypc.com

[https://ww1]
Christina Smitley, Family Nurse Practitioner

Many are understandably challenged by how to manage its shiny appearance. And, uncontrolled, oily skin can contribute to acne



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

Since launching on Kickstarter, Iso Life is excited to announce that IsoSpine has raised more than $40,000 in just under 3 days. The company aims to create high-quality, yet affordable products that will help people develop healthier habits and lifestyles. In an age where devices such as smartphones and laptops can encourage bad posture and result in back pain, a device like IsoSpine, that can be used at home has the potential to provide immense value for thousands of people.
The IsoSpine is a back traction device that uses acupressure pins to target specific areas on the back muscle groups and provide deep tissue massaging effects. This helps relax the excruciating tension in the muscles and stretches out the back. This method mimics the techniques that are used by chiropractors, but is available to IsoSpine users at a fraction of the cost.
Founder & CEO of Iso Life, Albert Shin stated that "Tests conducted by Iso Life have found that there are long term benefits of using a back traction device which includes: better posture, proper spinal alignment, and a drastic reduction in chronic back pain."
In order to use IsoSpine properly, there are a series of basic exercises that can be used in tandem with IsoSpine to maximize its effects. A rolling pin is included with each reward and can be mounted on the upper hole for upper back (thoracic) relief, and the lower hole for lower back (lumbar) relief. These exercises are available on the company's website and Kickstarter page.
IsoSpine Kickstarter prices begin at $64 for backers selecting the Early Bird reward which is limited to the first 50 backers. After that, prices go up to $69 for one. Any journalists, editors or social media influencers interested in receiving a sample to review are encouraged to reach out through IsoSpine's Kickstarter page.

[https://ww1]

"Tests conducted by Iso Life have found that there are long term benefits of using a back traction device which includes: better posture, proper spinal alignment, and a drastic reduction in chronic back pain."



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that Saleem Zafar, M.D., RoMIUS Urology in Toledo, OH, has been designated as a UroLift Center of Excellence. The designation recognizes that Dr. Zafar has achieved a high level of training and experience with the UroLift System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.
Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.
The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.
"Dr. Saleem Zafar has earned the UroLift Center of Excellence designation for his dedication to improving the lives of men who previously suffered from BPH symptoms and delivering superior patient outcomes with the UroLift System treatment," said Dave Amerson, president of the Teleflex Interventional Urology business unit.
Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.
Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.
About the UroLift System
The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.urolift.com.
About NeoTract | Teleflex Interventional Urology
A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.neotract.com.
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed to improve the health and quality of people's lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.
Teleflex is the home of Arrow, Deknatel, Hudson RCI, LMA, Pilling, Rusch, UroLift and Weck – trusted brands united by a common sense of purpose
# # #
For Teleflex Incorporated: 
Jake Elguicze, 610.948.2836 
Treasurer and Vice President, Investor Relations
Media: 
Nicole Osmer, 650.454.0504 nicole@healthandcommerce.com
*No instances of new, sustained erectile or ejaculatory dysfunction 
1. Roehrborn, J Urology 2013 LIFT Study 
2.McVary, J Sex Med 2016
MAC00968-01 Rev A

[https://ww1]

"Dr. Saleem Zafar has earned the UroLift Center of Excellence designation for his dedication to improving the lives of men who previously suffered from BPH symptoms and delivering superior patient outcomes with the UroLift System treatment," said Dave Amerson



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

Awarded to recognize Google Cloud partners who have made a positive impact on the world

MARLBOROUGH, MASS. (PRWEB) APRIL 06, 2020
Quantiphi, an award-winning applied artificial intelligence and data science software and services company, announced today that it has been named "2019 Social Impact Partner of the Year" by Google Cloud. Quantiphi was recognized for its achievements for working with nonprofits, research institutions, and healthcare providers, to leverage AI for Social Good.
"We are believers in the power of human acumen and technology to solve the world's toughest challenges. This award is a recognition of our mission driven culture and our passion to apply AI for social good," said Asif Hasan, Co-founder, Quantiphi. "Partnering with Google Cloud has given us the opportunity to work with the world's leading nonprofit, healthcare and research institutions and we are truly humbled by this recognition."
"We're delighted to recognize Quantiphi's commitment to social impact," said Carolee Gearhart, Vice President, Worldwide Channel Sales at Google Cloud. "By applying its capabilities in AI and ML to important causes, Quantiphi has demonstrated how Google Cloud partners are contributing to positive change in the world."
A few initiatives that helped Quantiphi earn this recognition: 

AI to Promote Tobacco-free Lifestyle - Partnered with one of the largest nonprofit public health organizations dedicated to tobacco cessation, to support its mission. Quantiphi used its AI expertise to automate the detection of tobacco imagery in popular media. Insights were published in academic journals to examine the correlation between the rise of tobacco use in young adults and its presence in popular media.

Assistive AI for Better Diagnostics for Brain Trauma Patients - Partnered with one of the world's leading academic health institutions to build a machine learning-powered solution that assists physicians in diagnosing life-threatening clots in the human brain with increased accuracy and speed.

Automated Tagging of Cancer Recurrence in Patients - Partnered with a large, multi-state non-profit health system to automate the process of tagging cancer recurrence in patients. This automation helps researchers with the availability of high quality outcomes data on cancer patients.

Quantiphi previously earned the Google Cloud Machine Learning Partner of the Year twice in a row for 2018 and 2017 and is a premier partner for Google Cloud and holds Specializations in machine learning, data analytics and marketing analytics.
About Quantiphi 
Quantiphi is an award-winning applied AI and data science software and services company driven by the desire to solve transformational problems at the heart of business. Quantiphi solves the toughest and the most pressing business problems by combining deep industry experience, disciplined cloud and data-engineering practices, and cutting-edge artificial intelligence research to achieve quantifiable business impact; making products smarter, customer experiences frictionless, and processes autonomous while uncovering anomalies, threats and risks that make businesses safer. For more on Quantiphi's capabilities, visit http://www.quantiphi.com
Follow us on LinkedIn

We are believers in the power of human acumen and technology to solve the world's toughest challenges. This award is a recognition of our mission driven culture and our passion to apply AI for social good," said Asif Hasan, co-founder, Quantiphi, Inc.




* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

Miracle Healthcare has announced that their Kickstarter campaign for Arebo, the one-touch activation body dryer has hit and surpassed its $10,000 funding goal.

CHICAGO (PRWEB) APRIL 06, 2020
Miracle Healthcare has announced that their Kickstarter campaign for Arebo, the one-touch activation body dryer has hit and surpassed its $10,000 funding goal. The campaign initially had a slow start, but is now average $4,000 per day in funding. The Arebo team has announced that they are now looking to ride the momentum to hit $100,000 in funding by the time the campaign comes to a close.
Eui Han Pak, Founder & CEO of Miracle Healthcare stated, "After researching what the wash routine habits are from people all around the world, we discovered that many people reuse towels in an unsanitary way. Therefore, I wanted to create a product that would help eliminate this issue and provide value for its users. With Arebo, people can dry themselves quickly without reusing the same towel over and over. The form factor also allows its users to start on the next step of their morning wash routine."
The Arebo can hold up to 330 lbs or 150 kg and has been designed to be used anywhere (bathroom, spa, pool, gym, etc). This dryer is also extremely useful for people who have recently undergone surgical procedures, pregnant women, and the elderly since these individuals are limited in their range of movement.
Kickstarter prices for the Arebo start at $220 and the company anticipates shipping to begin starting August 2020. Early bird prices are capped at 100 individuals. Once the cap is hit, prices will begin at $240 (30% off before it goes to retail). Any editors, journalists, or social media influencers interested in receiving a sample to review are encouraged to contact the creators through their Kickstarter page.

[https://ww1]

"After researching what the wash routine habits are from people all around the world, we discovered that many people reuse towels in an unsanitary way. Therefore, I wanted to create a product that would help eliminate this issue and provide value for its users.



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

Bug Busters, Inc. announces that it has been offering critical disinfection services to commercial & residential clients in our service area of Georgia to help combat the spread of the COVID-19 virus. Bug Busters mission is highlighted by four underline components "Customer Service...Development...Community Involvement...Technology." Never did we foresee a future where all four parts of our mission would be so necessary in the way it is now with the current COVID-19 crisis.
First things first: our team, customers, and vendors are all part of our family and they mean the world to us. Doing our part in this uncertain time is vital to our mission and company culture. At Bug Busters, that means utilizing technology to work remotely & communicate with our team to help mitigate the spread of the virus. Secondly, continue with customer service through our part of Public Health, while being cautious with non-essential person to person contact. Thirdly, community involvement with the development of a new services to stop the spread of germs with a professional disinfectant treatment.
As of March 20,2020 we have been offering a Disinfectant service with Nisus DSV. We have worked for the last several days to develop this new service for our community to help combat the spread of COVID-19. The disinfection service can be performed in a wide range of commercial venues including warehouses, distribution facilities, processing facilities, schools, office buildings, gyms, public buildings, and residential homes.
For more information on Bug Busters, Inc. disinfection services, visit https://bugbustersusa.com/nisus-dsv/ or call 678-752-9700.

[https://ww1]

"Our mission at Bug Busters is to work with our customers & communities to provide innovative approaches to achieve a pest free property while protecting the environments in which we all live and work, adding disinfection services is essential to our mission," says Court Parker, CEO Bug Busters, Inc




* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

Plasmid CDMO VGXI, Inc. Completes Manufacturing and Release of a Vaccine against COVID-19 in Record-Setting Time

THE WOODLANDS, TEXAS (PRWEB) APRIL 06, 2020
VGXI, an industry leading provider of GMP grade plasmid DNA for vaccines and gene therapies, announced it has completed manufacturing and release of a DNA vaccine to combat the COVID-19 pandemic. VGXI was selected by Inovio Pharmaceuticals in late January to produce the vaccine under a $9 million grant to Inovio from the Coalition for Epidemic Preparedness Innovations (CEPI). Rapid mobilization of efforts across both companies enabled a record-setting timeline to release and initiation of clinical testing for the novel DNA vaccine within just 2 months from the start of production and only 3 months from public release of the virus genetic sequence. The large scale manufacturing campaign has supplied thousands of vaccine doses up to 4 times faster than traditional plasmid DNA production would support.
As of today, nearly 1,300,000 cases of COVID-19 have been identified worldwide, with about 70,000 deaths. In the US, there have been over 330,000 cases and nearly 10,000 deaths. Travel, commerce, and daily life is disrupted around the world as countries implement policies to slow the spread of the virus. In parallel with these efforts, the race to make a safe, effective vaccine widely available is essential to overcoming the current crisis.
"The dedicated team at VGXI has worked tirelessly to meet this challenge," stated VGXI CEO Mr. Young Park. "Within a fraction of the typical manufacturing timeline, VGXI has manufactured and released a vaccine for human clinical testing. We are proud to be a part of the global effort to address the COVID-19 pandemic."
With the Phase 1 trial beginning in the US, the vaccine developer and VGXI client for the last 13 years, Inovio Pharmaceuticals, is also coordinating simultaneous clinical trials in China and South Korea. Additional large scale manufacturing of the vaccine at the VGXI facility has already been scheduled in 2Q 2020. Mr. Rob Juba, VP of Biological Manufacturing and Clinical Supply Management at Inovio Pharmaceuticals said, "We are delighted to be working with our long term manufacturing partner VGXI to expedite manufacture of our COVID-19 vaccine candidate INO-4800 and enable rapid clinical testing."
ABOUT VGXI, INC. 
As a leading provider of plasmid DNA manufacturing and development services, VGXI, Inc. has proven its ability to support urgent vaccine development timelines in response to past outbreaks such as Ebola, Zika, and other coronaviruses including Middle East Respiratory Syndrome (MERS). The company has a reputation of success in manufacturing DNA products under cGMP conditions for clinical trials in the US, EU, Asia, Canada, and Australia, and its cGMP and non-GMP products have passed rigorous reviews by several international regulatory agencies. VGXI's ability to work with unique requirements and create custom manufacturing solutions is based on its patented manufacturing process, flexible cGMP production facility, and experienced development team. VGXI, Inc. is a wholly-owned subsidiary CDMO of GeneOne Life Science, Inc. To learn more, visit https://www.vgxii.com.
ABOUT GENEONE LIFE SCIENCE 
GeneOne Life Science Inc. ("GeneOne" KOSPI: 011000) is an international DNA vaccine and product developer, and leading contract manufacturer of DNA plasmid-based agents for pre-clinical and clinical trials for global companies and institutions. It researches and develops DNA vaccines and products to prevent and treat incurable diseases in South Korea and internationally. The company is headquartered in Seoul, South Korea. VGXI, Inc., GeneOne's wholly-owned subsidiary located in Texas, is a leading cGMP DNA plasmid manufacturing facility. For more information, visit http://www.genels.com.
CAUTIONARY FACTORS THAT MAY AFFECT FUTURE RESULTS 
Materials in this press release contain information that includes or is based upon forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. Forward-looking statements relate to expectations or forecasts of future events. These statements can be identified by the fact that they do not relate strictly to historical or current facts. They include words such as "anticipate," "estimate," "expect," "project," "intend," "plan," "believe," and other words and terms of similar meaning in connection with a discussion of potential future events, circumstances or future operating or financial performance. In particular, these include statements relating to future actions, prospective products or product approvals, future performance or results of current and anticipated products, sales efforts, expenses, the outcome of contingencies such as legal proceedings, and financial results. Any or all of our forward-looking statements here or in other publications may turn out to be incorrect. They can be affected by inaccurate assumptions or by known or unknown risks and uncertainties. Many such factors will be important in determining our actual future results. Consequently, no forward-looking statement can be guaranteed, and forward-looking statements may be adversely affected by factors, including general market conditions, competitive product development, product availability, current and future branded and generic competition, federal and state regulations and legislation, manufacturing issues, timing of the elimination of trade buying, patent positions, litigations and investigations. Our actual results may vary materially, and there are no guarantees about the performance or valuation of GeneOne stock. It is also important to read the disclosure notice contained in many of the individual GeneOne documents available on the website, as many contain important information on such cautionary factors as of the date of the individual document. We undertake no obligation to correct or update any forward-looking statements, whether as a result of new information, future events or otherwise. You are advised, however, to consult any further disclosures we make on related subjects in our reports.

[https://ww1]

Within a fraction of the typical manufacturing timeline, VGXI has manufactured and released a vaccine for human clinical testing. We are proud to be a part of the global effort to address the COVID-19 pandemic.



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

The prominent sales milestone was achieved last month as families seek alternative proven methods to learn the fetal sex of their babies from the comfort of home.

LA JOLLA, CALIF. (PRWEB) APRIL 06, 2020
Gateway Genomics, leading developer of direct-to-consumer genetic tests that give families insight into their future children, reached 200,000 SneakPeek Early Gender DNA Tests sold in March, just months after attaining the 150,000-test landmark in late 2019.
"SneakPeek was launched as an ecommerce product, where a mom could order her kit online, collect a DNA sample from her home, mail it back for analysis at our lab, and receive her emailed boy-or-girl result, all in days," says Gateway Genomics CEO, Chris Jacob. "Direct-to-consumer is where the expertise of our company lies, and over the years we've optimized our product to be convenient and easy to use right at home. In the current environment of physical distancing, we're grateful to be able to provide families with an alternative solution to learn the gender of their babies that's perfectly suited to staying home and staying safe."
The SneakPeek Test by Gateway Genomics analyzes cell-free fetal DNA found in mom's blood to return just one answer – the gender of her unborn baby. This enables the test to use a very small amount of blood that can be collected at home. Results are emailed as fast as 72 hours after an order is placed online, with 99.1% accuracy for women who are at least 8 weeks into pregnancy, based on peer-reviewed studies.
"We understand this is a difficult situation and time, and not all families will want to or be able to visit their doctors to learn the fetal sex of their baby," continues Mr. Jacob. "Our goal is to ensure that DNA-based prenatal information is accessible and affordable. In these uncertain times, we're proud to deliver a product that gives parents the information they need to make plans, under their control. The SneakPeek Early Gender DNA Test provides a laboratory-proven at-home option to learn a baby's gender and share the joy with family and friends."
This year, Gateway Genomics was ranked #236 in the 38th annual Inc. 500|5000 list of fastest-growing private companies, #23 in the Health sector, in recognition of achieving 1,786% revenue growth in the last three years. The company's principal product, SneakPeek, is an easy-to-use DNA test that lets parents know the gender of their babies as early as 8 weeks into pregnancy, with 99.1% accuracy.
About Gateway Genomics
Gateway Genomics is a personal genomics company with the mission to develop leading-edge genetic tests that give families a new level of understanding about their future children. Since inception, more than 200,000 SneakPeek Early Gender DNA tests have been provided to help new parents bond with their babies, make plans, and connect with friends and family around them. Gateway Genomics is located in La Jolla, CA.

[https://ww1]
SneakPeek Early Gender At-Home DNA Test

In the current environment of physical distancing, SneakPeek At-Home provides families with an alternative way to learn their baby's gender that's perfectly suited to staying home and staying safe.



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

The national nonprofit organization, known for its fellowship programming for leaders of color, is shifting gears to raise funds throughout April, giving 100% of the proceeds to communities in need.

CHICAGO (PRWEB) APRIL 06, 2020
The Surge Institute, a national nonprofit organization that develops and connects emerging leaders of color in education, has launched a new fundraising campaign to support its fellows and alumni in their efforts to serve youth and communities impacted by the COVID-19 pandemic.
The organization launched the Surge Relief Fund on April 1, 2020, sharing the stories of several fellows and alumni who have had their work in youth service, teacher support, mentorship, and community resource distribution heavily stifled by the virus and shelter in place restrictions it has caused. 
Among the Surge Alumni impacted is Andrea Black, principal of Schmid Elementary on the South Side of Chicago. "Several of my families do not have access to things like a chromebook, a tablet, an iPad, so that they can connect virtually to their teachers," Black shared in a video message. "Your donation can allow that to happen."
Also affected is Randal Seriguchi, Jr., Executive Director of Urban Ed Academy, whose mission is to see at least one man of color teaching in every elementary school in San Francisco. "In the midst of a global pandemic, like other nonprofits, we're finding ourselves battling food insecurity and a digital divide," Seriguchi said. "We're dealing with the conversion to virtual classrooms, to virtual professional development opportunities . . . It's a scramble to make sure we continue to support those most vulnerable."
Through the new relief fund, Surge seeks to provide support to all of its fellows and alums who are directly serving communities heavily impacted by COVID-19, who are the most in need.  
  
The Surge Institute has established a webpage with more information about the campaign, including frequently asked questions and video testimonials from fellows and alumni. The fundraising effort will carry through the entire month, ending on April 30, 2020. Surge will distribute 100 percent of the funds to fellows and alumni on May 15, 2020.
In a heartfelt message from Surge Founder Carmita Semaan and Board President Darryl Cobb, the organization asked for donations and support. "Please be a trailblazer for this effort," Semaan and Cobb stated in the letter. "Take a moment to give, no matter the amount. Take a moment to share with as many people as you can. And please take a moment to be in connection and community with those who need your love and support."

[https://ww1]
Surge Alumni sharing their stories on why your donations are so important for their work.

"Take a moment to give, no matter the amount. Take a moment to share with as many people as you can. And please take a moment to be in connection and community with those who need your love and support." - Surge Founder Carmita Semaan and Board President Darryl Cobb."




* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

A new study, titled "Transgender youth's experiences and perspectives related to HIV preventive services," by researchers at The Fenway Institute, Boston College, the Centers for Disease Control and Prevention, Division of Adolescent and School Health Johns, and NORC, University of Chicago provides insight into transgender youth's experiences. Results will inform the development and testing of affirming, culturally competent, and youth-driven HIV prevention tools and educational resources for adults who provide healthcare and support services for transgender youth.

BOSTON (PRWEB) APRIL 06, 2020
A new study published today in the journal Pediatrics found that high rates of HIV transmission among transgender youth may be reduced through interventions that include training on how to provide gender-affirming care for health care practitioners working with adolescents; the inclusion of all gender identities, sexual orientations, and definitions of sex and sexual activity in sexual health education; and making it easier and more affordable for transgender youth to access health care. Data were collected during two, three-day asynchronous focus groups of 30 transgender youth age 13-24 from all regions of the United States.
"This study fills a critical gap in knowledge in how to design HIV prevention services for transgender youth who face complex social and structural inequalities in health care and education and experience higher rates of HIV as a result," said Holly B. Fontenot, PhD, PhD, RN/NP, FAAN, the lead author of the study and an associate professor of nursing at Boston College and adjunct faculty at The Fenway Institute. "Of particular interest is the unique role that parents, teachers, and school nurses have in the HIV prevention experiences of transgender youth."
Focus group participants who said their parents were supportive of their sexuality, gender identity, and sexual activity also said that they were more likely to receive appropriate sexual health information. But most reported that their parents would not use transgender-friendly terms when discussing their romantic relationships and said that they wished their parents and guardians would obtain the skills and knowledge to provide more and better support.
Youth repeatedly expressed the desire for sexual health education to be inclusive of sexual and gender minorities. They said that they wanted sexual health education with "gender neutral language, representation of different types of relationships, and information/statistics on LGBT health." They also said that they wanted instruction from adults who could facilitate "open, honest discussion" while also acknowledging the "silliness of the topic without invalidating how important the information is." Participants frequently asserted that sexual assault and consent should be a part of curricula.
"It's evident that health care providers, including school nurses who are skilled in caring for transgender youth, can be important sources of support for transgender youth," said Sean Cahill, PhD, a co-author of the study and the Director of Health Policy Research at The Fenway Institute. "For example, school nurses can support youth in school but also work with community partners to develop educational resource lists for youth and their parents and guardians."
Other major findings in the study include: 

Transgender youth report significant barriers to self-efficacy in sexual decision-making, with a majority describing communication with their romantic/sexual partner as challenging. One said, "I almost never ask for things because of what I think is internal pressure to be grateful. In my head, I'm like 'they're already willing to have sex with me, I shouldn't push my luck.'"

Transgender youth report concerns related to fear and safety in forming romantic and/or sexual relationships, noting that they had been harassed on social media and dating apps. Some participants said that dating as a transgender person is "scary as hell."

Transgender youth report that they understood the importance of HIV testing but that the costs of tests and fear of exposing their sexual activity and gender identity to parents were barriers to testing.

Transgender youth report many negative experiences with health care providers. One described a provider who did not understand "the difference between gender and sexual orientation." Another reported that a provider said that sex "isn't really sex if you're both girls." Most reported fear of encounters with disrespectful and uninformed providers."

Transgender youth report that they routinely accessed educational resources and social support online. However, one noted, "many teens aren't equipped to determine which sources are reputable and which ones aren't." Another mentioned, "porn [pornography] was [their] biggest teacher," and others agreed.

The study, titled "Transgender youth's experiences and perspectives related to HIV preventive services," was authored by researchers at The Fenway Institute, Boston College, the Centers for Disease Control and Prevention, Division of Adolescent and School Health Johns, and NORC, University of Chicago. The study provides insight into transgender youth's experiences. Results will inform development and testing of affirming, culturally competent, and youth-driven HIV prevention tools and educational resources for adults who provide healthcare and support services for transgender youth.
About Fenway Health & The Fenway Institute 
Since 1971, Fenway Health has been working to make life healthier for the people in our neighborhoods, the LGBTQ community, people living with HIV/AIDS and the broader population. The Fenway Institute at Fenway Health is an interdisciplinary center for research, training, education and policy development focusing on national and international health issues.

Of particular interest is the unique role that parents, teachers, and school nurses have in the HIV prevention experiences of transgender youth," said Holly B. Fontenot, PhD, PhD, RN/NP, FAAN, the lead author of the study and adjunct faculty at The Fenway Institute.



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

Enara Health, a technology-powered personalized weight loss program focused on sustainable results, today announced that it is expanding telehealth availability of its program to all residents in California, Texas and Illinois. This rollout represents an earlier-than-planned first stage of a national rollout of the Enara Health platform, a clinical weight loss program that takes a multi-faceted approach to obesity treatment.
The intent of this accelerated telehealth rollout is to give more Americans access to proven, physician-guided weight loss support during the COVID-19 pandemic as a key means of boosting patients' health and immune systems. Via Enara Health's unique telehealth interface, program participants will be able to connect with a team of doctors, dietitians and exercise specialists from their mobile phones and computers.
"Numerous studies have shown that nutrition, activity and stress management play a vital role in our immune defense against respiratory viruses, and our goal is to help Americans achieve optimal health to fight the virus," said Dr. Rami Bailony, Co-Founder and CEO of Enara Health. "Rather than viewing healthy eating, exercise and stress relief as something to be dealt with after this acute crisis is over, we need to reframe these practices as important prevention strategies."
Unlike most other weight loss programs that focus solely on diet or lifestyle modification, the Enara Health platform combines physician interactions, lifestyle evaluations, diet consultations and medication through a unique digital health platform. This precision medicine approach is designed to maximize results through personalized, data-driven recommendations.
Participants in the Enara Health precision weight loss program lose an average of 12.40% of their weight at 6 months and 13.99% at 18 months, a significant improvement over other digital health programs and on par with results seen in bariatric surgery patients.
The telehealth rollout of the Enara Health program beyond its first clinic in San Mateo, Calif., is possible due to newly forged relationships with specialized partner clinics in Texas (WellHealth locations in the Dallas-Fort Worth area) and Illinois (the Center for Adult and Pediatric Wellness in Orland Park). Once the COVID-19 pandemic recedes, local patients will also gain access to in-office physician consultations through these clinics.
"We have spent the past four years establishing, evaluating and fine-tuning Enara Health's clinical approach to weight loss at our clinic in San Mateo, Calif.," said Dr. Rami Bailony, Co-Founder and CEO of Enara Health. "The results we're now achieving have the potential to redefine obesity treatment as we know it. By expanding our program through progressive, like-minded clinics around the country, particularly in this time of crisis, we expect to dramatically improve lives while also decreasing the devastating stigma attached to obesity today."
Residents in California, Texas and Illinois can now enroll in the Enara Health program. Learn more at http://www.enarahealth.com.
About Enara Health 
Enara Health is building a data-driven platform and network to scale obesity treatment. Based in San Mateo, Calif., and operating since March 2015, Enara Health offers unique hybrid digital and in-person weight loss programs based on precision medicine. By combining mobile technology with health care visits and providing patients with personalized physician-driven medical weight loss programs, Enara Health routinely helps patients lose—and keep off—more than 15% of their baseline weight, which is far greater than the results seen with other e-health and m-health interventions. Learn more at http://www.enarahealth.com.

By expanding our program through progressive, like-minded clinics around the country, particularly in this time of crisis, we expect to dramatically improve lives while also decreasing the devastating stigma attached to obesity today.



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

Summit Hosting, a dedicated server cloud hosting company serving the U.S. and Canada, has launched a 90-day free, no contract required offer to assist businesses who may need enhanced remote accessibility to use Sage or QuickBooks at home due to the COVID-19 pandemic.

ATLANTA (PRWEB) APRIL 06, 2020
Today, Summit Hosting, a leading managed application cloud hosting company in North America, announced the launch of the 'Summit Cares' campaign to help small and mid-sized businesses who have been impacted by the COVID-19 (coronavirus) pandemic.
The Summit Cares campaign offers free Sage or QuickBooks cloud hosting to new customers now through June 30th, 2020, so businesses can run their financial operations remotely in accordance with social distancing. During the 90-day period, new customers will pay $0 in up-front costs, including no set-up fees, for a month-to-month dedicated server hosting subscription service. No 12-month commitment or contract is required to begin.
"We're all living in uncertain times right now and Summit Hosting understands the impact this has had, and will continue to have, on businesses in 2020," said Stanley Kania, CEO of Summit Hosting. "The ability to run your company from home and offer remote positions to employees is more important now than ever before. We want to help businesses have this remote flexibility without worrying about more costs during the economic strain the world is facing."
Under Summit Cares, Summit Hosting is also offering current customers the option to add an unlimited amount of users to their accounts at no additional cost until June 30th, 2020.
Summit Cares will be active until June 30th, 2020. After this date, hosting and user costs will revert to normal pricing.
All businesses who use Summit Hosting's services also get the advantage of dedicated servers, meaning they don't share their cloud server with other companies. Each business can partner with Summit Hosting's technical experts to customize their cloud environment to meet business needs.
Any U.S. or Canada-based business interested in hosting QuickBooks or Sage in the cloud at no cost for 90 days or learning more about Summit Cares should contact a hosting specialist by email at sales@summithosting.com or by phone at 888-244-6559.
About Summit Hosting 
Summit Hosting is the leading provider of managed application hosting on dedicated servers in the U.S. and Canada. At Summit, you'll never share resources with another company and you will be able to fully customize the cloud according to your unique business needs. Your experience with Summit Hosting begins with a knowledgeable U.S.-based sales team. They work with you one-on-one to understand your business, goals and hosting needs. Once they've developed the right solution to meet your objectives, Summit Hosting puts that plan into action with their technical team.
Visit https://www.summithosting.com for more information about Sage cloud hosting and QuickBooks cloud hosting services.

[https://ww1]

We want to help businesses have this remote flexibility without worrying about more costs during the economic strain the world is facing.



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

In an effort to help local healthcare providers overcome a global shortage of personal protective equipment (PPE) due to the COVID-19 pandemic, South Dakota School of Mines & Technology is 3D printing masks for Monument Health and other local healthcare providers.

RAPID CITY, S.D. (PRWEB) APRIL 06, 2020
UPDATE: In an effort to help local healthcare providers overcome a global shortage of personal protective equipment (PPE) due to the COVID-19 pandemic, South Dakota School of Mines & Technology is working to design masks that can be used by the local community.
The project began following a meeting between Mines alumnus Brad Haupt, Vice President of Supply Chain and Contract Management at Monument Health, Mines President Jim Rankin and others on Saturday, March 21. Haupt expressed a concern over the long-term shortage of masks at Monument Health, especially in light of the COVID-19 outbreak. President Rankin offered Mines resources to help.
The effort, which quickly ramped up, currently includes faculty and students in the South Dakota Mines departments of industrial, mechanical, chemical, biological and biomedical engineering as well as chemistry, biology and health sciences. The departments began by 3D printing prototypes. Those prototypes have led to new designs and collaboration that can lead to eventual mass manufacturing.
The mask now in design at Mines was first inspired by a 3D printed mask developed in Montana in mid-March. That design was shared with the public though the Billings Clinic Foundation.
Mines faculty took the design and will continue working with officials at Monument Health to ensure the masks will provide proper protection. Mines faculty are also working with area manufactures to possibly mass produce any approved designs.
Science and engineering involve a process of trial and error, and this effort is evolving quickly. Those with questions or a willingness to help can reach the university at mediarelations@sdsmt.edu.
Monument Health is also seeking PPE from any other members of the local community who may have extra on hand.

[https://ww1]

In just a couple of days we have brought together multiple departments on campus, faculty, staff, and student workers to address a dire need in our community.



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

Delve into the developing landscape of digital health wearables and FDA regulations that affect these products during our webinar April 21.

FALLS CHURCH, VA. (PRWEB) APRIL 07, 2020
FDA's Regulation of Digital Health Wearables & Sensors 
An FDAnews Webinar 
Tuesday, April 21, 2020 • 1:30-3:00 p.m. EDT 
https://www.fdanews.com/wearablesandsensors
The digital health wearable and sensors market is rapidly growing.
What is one's understanding of how and when the FDA is regulating these medical device products?
Get to know how these technologies are regulated by the FDA. And discover which innovative strategies one can implement to support faster, streamlined approvals for wearable and sensor products. 
Join FDAnews and experts Kristin Davenport and Christina Kuhn for a comprehensive overview of the FDA's regulation of digital health wearables and sensors:
●Evaluate the developing landscape for digital health wearables and sensors, including examples of the breadth and depth of their development processes 
●Determine which FDA's policies apply when wearables are regulated, including how to comply with the FDA's guidances on clinical decision support
●Specify differences between platforms and individual apps 
●Assess considerations for artificial intelligence and the intersection of artificial intelligence with the FDA regulation 
●Identify which medical device requirements are for regulated wearables
Implement innovative strategies for faster, streamlined approvals of your wearables and sensors.
Interested in registering multiple sites? 
Call 888.838.5578 in the U.S. or +1 703.538.7600 globally 
to learn about our special multisite discount.
Webinar Details: 
FDA's Regulation of Digital Health Wearables & Sensors 
An FDAnews Webinar 
Tuesday, April 21, 2020 • 1:30-3:00 p.m. EDT 
https://www.fdanews.com/wearablesandsensors 
Tuition: 
$287 per site
Easy Ways to Register: 
Online: https://www.fdanews.com/wearablesandsensors 
By phone: 888.838.5578 or 703.538.7600
About FDAnews: 
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

InstantGMP understands that biotech research companies are affected by the current COVID-19 crises and want to help. Today, we are announcing that we are offering COVID-19 Stimulus Grants to biotech companies involved in preclinical or clinical research.

CARY, N.C. (PRWEB) APRIL 07, 2020
We're all affected by the current COVID-19 crisis and we understand that preclinical and clinical research may be slowing down. InstantGMP, Inc. wants to help by awarding COVID-19 Stimulus Grants that can help biotech companies keep up with their tasks in a virtual environment.
The grant includes a subscription to the InstantQMS software, a full set of manufacturing and quality Standard Operating Procedures, an integration with a Learning Management Systemand 50 hours of Implementation support.
Here's everything that is included in InstantQMS Quality Management System: 

Incident Log

Complaint Log

CAPA Log

Audit Log

Training Log

Vendor Management

Contract Management

Document Management

File Vault

Full set of Standard Operating Procedures for a virtual biotech

Full set of templates and forms for vendor management

Integration with on-line learning management system

The software is an all-in-one quality and vendor management system that makes it easy to organize records and to keep traceability and training up to date. It comes complete with all the SOPs, templates and guided workflows that make it simple to get started and to stay in compliance with FDA and quality guidelines.
More information about the COVID-19 Stimulus Grants can be found at InstantGMP.com/covid-19-stimulus-grant.

[https://ww1]
COVID-19 Stimulus Grants for Biotech Research Companies

"We are committed to helping biotech companies get through this coronavirus pandemic and our software will help them more easily meet the FDA requirements for quality and vendor management," said Dr. Richard Soltero, President of InstantGMP.




* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

In light of the COVID-19 pandemic Compliancy Group has released free resources to ease the transition for businesses working from home. We understand that HIPAA-beholden entities have had to quickly adapt their businesses to work remotely, as such we are providing tools and guidelines on how to do so while remaining HIPAA compliant and secure.

GREENLAWN, N.Y. (PRWEB) APRIL 07, 2020
COMPLIANCY GROUP in its ongoing efforts to educate HIPAA covered entities, business associates, and managed service providers, has developed several resources to provide guidance on working from home.
With the COVID-19 outbreak, most businesses have had to scramble to adapt their businesses to work remotely. With the OCR limited waiver of HIPAA sanctions of penalties in the use of telehealth and telecommuting, it is important to understand how you can service patients and clients while maintaining HIPAA compliance.
Compliancy Group will be hosting a webinar to provide businesses with actionable tips for working from home, telehealth, telecommuting, and an explanation of changes in HIPAA enforcement during this crisis. We understand that it can be difficult to navigate HIPAA law on your own, which is why we are providing all of our resources for free.
In addition to the webinar, we will be providing daily articles on our blog to give you further guidance. We have also developed downloadable content for a telecommuting audit policy, as well as a bring your own device (BYOD) policy.
Compliancy Group's Provided Resources:
Webinar: 
HIPAA Tips on Working From Home, Telehealth, & Telecommuting
Downloadable Content: 
Telecommuting Audit Policy 
Bring Your Own Device (BYOD) Policy 
Free HIPAA Compliance Checklist
Articles: 
HIPAA Working from Home 
Telehealth Access Expanded Due to Coronavirus 
Telehealth and HIPAA: HIPAA Compliant Teleconferencing Tools 
The HIPAA Privacy Rule Waiver in an EmergencyCOVID-19 Phishing Emails
About Compliancy Group: 
HIPAA should be simple. That's why Compliancy Group is the only HIPAA software with expert Compliance CoachesTM holding your hand to simplify compliance. Built by auditors, Compliancy Group gives you confidence in your compliance plan to reduce risk, increase patient loyalty, and profitability of your organization.
Why Compliancy Group? 
HIPAA Audit Support, no client has ever failed an audit! 
Total Solution 
HIPAA Seal of Compliance 
Dedicated Compliance Coaches
Visit https://www.compliancy-group.com or call 855.854.4722 to learn how simple compliance can be.

[https://ww1]

"We recognized the need for resources to provide guidance during this time, for both the Healthcare industry and the people it serves. We are willing to do whatever we can to help, both as a company and individuals, to keep everyone's information and business safe during this difficult time."



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

Global developer and manufacturer of medical device solutions and technologies takes critical action to help strengthen the nation's public health response to the pandemic.

MAHWAH, N.J. (PRWEB) APRIL 06, 2020
As a leading developer and manufacturer of medical device solutions and technologies used in healthcare facilities around the globe, Mindray recognizes the extraordinary stress the coronavirus pandemic is creating within our nation's healthcare system. With its North American headquarters in Mahwah, New Jersey, adjacent to the epicenter of the pandemic, the Mindray North America team is experiencing the ravaging effects of the virus firsthand, through the eyes of our customers, our trusted partners and our dedicated employees and their families.
"The increased pressure being put on our nation's healthcare infrastructure is unprecedented, manifesting itself in many ways," said Mindray North America President, Wayne Quinn. "As a manufacturer dedicated solely to the medical industry, Mindray shares a social responsibility to actively and continuously participate in the fight against coronavirus; more specifically, we see our role in this healthcare crisis tying directly back to our mission – to make the most advanced healthcare technology attainable to all, and we continue to shift our organizational focus toward doing just this."
Given the extreme set of circumstances surrounding the coronavirus pandemic and the urgent need for ventilators, Mindray North America has put into action several key strategies to enable our customers to maximize the use of Mindray systems currently in place. The North American team has diligently worked with the US Food and Drug Administration (FDA) to gain clearance from the agency for conversion and off label use of Mindray A-Series anesthesia delivery systems as continuous ventilators. This immediately increases availability of critical mechanical ventilation across the country. In addition, we have also published procedures for switching the drive gas (utilized to fill the bellows required for mechanical ventilation) in the anesthesia/ventilator from oxygen to compressed air. The ability to implement this conversion helps healthcare providers to preserve oxygen, which is also in short supply, for use in directly treating patients.
Earlier this week, via an unprecedented global team effort, we not only successfully secured Emergency Use Authorization (EUA) from the FDA allowing import of our ventilators (which previously were not cleared for sale in the US), but also procured a defined supply of standalone ventilators, to be immediately shipped and distributed to key hospitals in New York City which are presently in dire need.
Finally, in anticipation of the increasing demand for vital signs, multi-parameter monitors (bedside and portable) and centralized monitoring systems, we have proactively ramped up production and supply of these products, while at the same time implementing procedures for simplified, rapid deployment of these systems. This pre-emptive move is enabling accelerated set up of ad hoc, ancillary treatment areas, while minimizing the need for onsite support and installation time.
The entire Mindray North America team remains fully committed to aiding our nation's response to this pandemic illness. As an essential business, we continue to work, each and every day supporting healthcare providers across the nation as they serve on the front lines, defending the health of our nation, one patient at a time.
About Mindray
Mindray is a leading developer, manufacturer and supplier of medical device solutions and technologies used in healthcare facilities around the globe. We believe we can change lives by making the most advanced healthcare technology attainable for all. We do this by empowering healthcare professionals through innovative, high-value solutions that help create the next generation of life-saving tools across three primary business segments: patient monitoring and life support, in-vitro diagnostics, and medical imaging. Mindray maintains its global headquarters in Shenzhen, China; Mindray North America is headquartered in Mahwah, New Jersey. Our Ultrasound Innovation Center is located in San Jose, California with additional facilities in major international markets around the world. For more information, please visit http://www.mindray.com.




* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

Virginia is the first state in 2020 to adopt "SUNucate" policies

ROLLING MEADOWS, ILL. (PRWEB) APRIL 06, 2020
Virginia's public school students will now be able to possess and use sunscreen on school buses, school property and at school-sponsored events without a note thanks to the passage of Senate Bill 44, signed by Governor Ralph Northam on March 31.
Virginia is the 25th state to incorporate policies from model legislation developed by the American Society for Dermatologic Surgery Association (ASDSA). The legislation is a key part of the SUNucate initiativethat addresses barriers to sunscreen use in school and camps and promotes sun-safe behavior. ASDSA advocated for this legislation together with the 60+ member SUNucate Coalition, including the Medical Society of Virginia and the Virginia Dermatology Society (VDS).
"I congratulate Virginia for adopting this important, common sense legislation that will help protect students from overexposure to the sun, which is essential to preventing skin cancer later in life," said ASDSA President Marc D. Brown, MD. "ASDSA looks forward to working with partners in the states that have not yet passed SUNucate policies to advocate for the removal of barriers to sunscreen use in schools that still exist."
"VDS was pleased to support this critical effort in Virginia," said ASDSA member and VDS Board member Farhaad Riyaz, MD. "Virginia's students will now have the opportunity to learn sun-safe habits from an early age."
The need for such legislation arose after concerns were raised by dermatologists and reports in the national media about broad "medication bans" that are in place in schools across the country requiring students to have a note or prescription from a physician in order to have these medications. Sunscreens are regulated as over-the-counter drugs under the Federal Food, Drug and Cosmetic Act, making them subject to these bans. Although these policies are meant to protect children, they also hinder them from accessing sunscreen during outdoor school activities and put them at risk of damaging sun exposure.
To learn more about SUNucate, visit http://asds.net/SUNucate.
# # #
About ASDSA 
With a membership of 6,400+ physicians, ASDSA is a 501(c)(6) association dedicated to education and advocacy on behalf of dermatologic surgeons and their patients. For more information, visit http://asds.net/ASDSA 
Follow @ASDSAdvocacy on Facebook, Twitter and Instagram! 

[https://ww1]

I congratulate Virginia for adopting this important, common sense legislation that will help protect students from overexposure to the sun, which is essential to preventing skin cancer later in life.



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

RESOLVE: The National Infertility Association will recognize National Infertility Awareness Week, April 19 through April 25, 2020. The movement brings together millions of Americans who want to remove the stigmas and barriers that stand in the way of building families. RESOLVE will rally the infertility community to raise awareness about the significant lack of access to family building options and emotional support for millions of women and men struggling to build a family.
"RESOLVE is committed to hosting the 2020 National Infertility Awareness Week. With so many live events cancelled because of COVID-19, people with infertility and those struggling to build a family need support more than ever," said Barbara Collura, RESOLVE's President/CEO. "Let's use NIAW to raise our voices, talk about the issues facing this community and make sure we continue to support those most in need."
Throughout NIAW, members of the infertility community will take to the internet to share their stories and lead the conversation about challenges to family building and methods of resolution. Through national media, social media, and fundraising, the infertility community will take action to increase awareness of infertility in order to remove stigmas and improve access to family building options.
RESOLVE's National Infertility Awareness Week 2020 is supported by its NIAW Partners: EMD Serono, Ferring Pharmaceuticals, First Response, Guerbet, Merck, and ORM Fertility.
NIAW became a federally recognized health observance by the Department of Health and Human Services in 2010. RESOLVE can provide experts for interviews on all aspects of infertility, as well as personal patient stories from women and men living with infertility. Find out more about NIAW at infertilityawareness.org.
About RESOLVE: The National Infertility Association: Established in 1974, RESOLVE: The National Infertility Association is a non-profit organization with the only established, nationwide network mandated to promote reproductive health and to ensure equal access to all family building options for men and women experiencing infertility or other reproductive disorders. One in eight U.S. couples of childbearing age has trouble conceiving or carrying a pregnancy to term. RESOLVE addresses this public health issue by providing community to these women and men, connecting them with others who can help, empowering them to find resolution and giving voice to their demands for access to all family building options. For more information, visit http://www.resolve.org.

[https://ww1]

People with infertility and those struggling to build a family need support more than ever.



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

Rochester Institute of Technology is leading an effort involving local companies and healthcare experts to produce a prototype ventilator designed to help meet the continuing surge of respiratory cases as a result of the coronavirus.
According to Nabil Nasr, associate provost and founding director of the Golisano Institute for Sustainability (GIS), the collaborative project between RIT researchers—working in tandem with regional experts and healthcare providers—resulted in the creation of an emergency prototype ventilator that will help doctors and nurses on the front lines in the medical treatment of patients fighting COVID-19.
The prototype ventilator plugs into the oxygen source available in most hospital rooms or into a tank of oxygen. Laboratory testing so far has shown performance successfully meeting clinicians' requirements for COVID-19 patients.
"This has been a collaborative effort between the project team and the clinicians working together with only one focus: meeting the needs of our community and beyond," Nasr said.
He credited U.S. Congressman Joseph Morelle with getting the project started three weeks ago when Morelle called him immediately after receiving a briefing about the critical ventilator shortage from New York Gov. Andrew Cuomo.
"Rochester has always been a leader in innovative technology—and now, we are using our unique expertise to help fill a critical need for ventilators during the global COVID-19 pandemic," Congressman Morelle said. "In times of crisis, we must come together to help our fellow Americans. I am profoundly grateful to RIT for their collaboration and commitment to this project, which will have life-saving implications for our community and our country."
Nasr moved quickly to assemble a team comprising nearly two dozen research engineers and staff at GIS as well as senior engineers from the Center for Integrated Manufacturing Studies (CIMS) and the New York State Pollution Prevention Institute (NYSP2I), along with several RIT co-op students.
Led by Michael Thurston, director of the New York State Center of Excellence in Advanced and Sustainable Manufacturing at RIT as well as technical director and research faculty at GIS, team members have worked virtually around the clock with project partners since mid-March to develop the prototype ventilator for production, pending final U.S. Food and Drug Administration (FDA) approval.
"Our partners promised all of their resources and made their facilities available to help us," said Nasr, who has worked in the fields of sustainable manufacturing, remanufacturing and sustainable product development for more than 30 years and is considered an international leader in those disciplines.
The team identified a proven, simpler portable ventilator, continued to source materials, and modified it to fit COVID-19 cases before designing a prototype unit and a manufacturing plan. It then was tested and demonstrated for doctors from Rochester Regional Health on March 30.
After making a number of modifications to the prototype based on feedback from doctors, RIT is working with collaborators from the University of Rochester assisting with final FDA approvals and providing feedback on certain ventilator functions.
Nasr cited additional collaborators for their significant efforts, including RIT Trustee and Vice Chair David J. Burns, principal and founder of Global Business Advisory Services LLC; G.W. Lisk; Mark Schiesser, principal of Adaptive Automation; and Appcon Group, Inc.
"The modification of the device needed significant testing and consultation with the clinicians," he said. "We are at the final phase of testing and units are being produced in small numbers for validation. We expect that we will be ready for a higher number within a few weeks."
Nasr added the research team has opted for an injection molding process—made possible by consultation with Century Mold, Tessy Plastics Corp., Harbec Plastics and Currier Plastics—in the manufacturing of the units and he estimated that the tooling would "last up to a million cycles."
"So once we can get the production moving with our manufacturing partners, we could meet the needs of medical facilities in the U.S. and beyond," he said. Realizing that time is critical to get the prototypes produced as soon as possible, Nasr noted, the team working on the prototype ventilator transferred all design knowledge and documentation as well as prototyped parts to a large manufacturer to use its supply chain to produce the prototype ventilator in high volume. The team is continuing to support the manufacturer to ensure a fast production cycle. 
He's hopeful that RIT's tireless work over the past month will go a long way in the ongoing fight against the coronavirus pandemic.
"The hospitals are the ones on the front lines of this medical battle," Nasr said. "It has been an emotional rollercoaster to hear their stories and see what the doctors, nurses and patients are going through. It's been extremely tough. It's such a crisis."
For more information, contact Rich Kiley at 585-880-7227, Rich.Kiley@rit.edu, or on Twitter: @rakiley.

[https://ww1]
The prototype ventilator plugs into the oxygen source available in most hospital rooms or into a tank of oxygen.

"Rochester has always been a leader in innovative technology—and now, we are using our unique expertise to help fill a critical need for ventilators during the global COVID-19 pandemic. ... I am profoundly grateful to RIT." - U.S. Congressman Joseph Morelle




* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

Rochester Institute of Technology is leading an effort involving local companies and healthcare experts to produce a prototype ventilator designed to help meet the continuing surge of respiratory cases as a result of the coronavirus.
According to Nabil Nasr, associate provost and founding director of the Golisano Institute for Sustainability (GIS), the collaborative project between RIT researchers—working in tandem with regional experts and healthcare providers—resulted in the creation of an emergency prototype ventilator that will help doctors and nurses on the front lines in the medical treatment of patients fighting COVID-19.
The prototype ventilator plugs into the oxygen source available in most hospital rooms or into a tank of oxygen. Laboratory testing so far has shown performance successfully meeting clinicians' requirements for COVID-19 patients.
"This has been a collaborative effort between the project team and the clinicians working together with only one focus: meeting the needs of our community and beyond," Nasr said.
He credited U.S. Congressman Joseph Morelle with getting the project started three weeks ago when Morelle called him immediately after receiving a briefing about the critical ventilator shortage from New York Gov. Andrew Cuomo.
"Rochester has always been a leader in innovative technology—and now, we are using our unique expertise to help fill a critical need for ventilators during the global COVID-19 pandemic," Congressman Morelle said. "In times of crisis, we must come together to help our fellow Americans. I am profoundly grateful to RIT for their collaboration and commitment to this project, which will have life-saving implications for our community and our country."
Nasr moved quickly to assemble a team comprising nearly two dozen research engineers and staff at GIS as well as senior engineers from the Center for Integrated Manufacturing Studies (CIMS) and the New York State Pollution Prevention Institute (NYSP2I), along with several RIT co-op students.
Led by Michael Thurston, director of the New York State Center of Excellence in Advanced and Sustainable Manufacturing at RIT as well as technical director and research faculty at GIS, team members have worked virtually around the clock with project partners since mid-March to develop the prototype ventilator for production, pending final U.S. Food and Drug Administration (FDA) approval.
"Our partners promised all of their resources and made their facilities available to help us," said Nasr, who has worked in the fields of sustainable manufacturing, remanufacturing and sustainable product development for more than 30 years and is considered an international leader in those disciplines.
The team identified a proven, simpler portable ventilator, continued to source materials, and modified it to fit COVID-19 cases before designing a prototype unit and a manufacturing plan. It then was tested and demonstrated for doctors from Rochester Regional Health on March 30.
After making a number of modifications to the prototype based on feedback from doctors, RIT is working with collaborators from the University of Rochester assisting with final FDA approvals and providing feedback on certain ventilator functions.
Nasr cited additional collaborators for their significant efforts, including RIT Trustee and Vice Chair David J. Burns, principal and founder of Global Business Advisory Services LLC; G.W. Lisk; Mark Schiesser, principal of Adaptive Automation; and Appcon Group, Inc.
"The modification of the device needed significant testing and consultation with the clinicians," he said. "We are at the final phase of testing and units are being produced in small numbers for validation. We expect that we will be ready for a higher number within a few weeks."
Nasr added the research team has opted for an injection molding process—made possible by consultation with Century Mold, Tessy Plastics Corp., Harbec Plastics and Currier Plastics—in the manufacturing of the units and he estimated that the tooling would "last up to a million cycles."
"So once we can get the production moving with our manufacturing partners, we could meet the needs of medical facilities in the U.S. and beyond," he said. Realizing that time is critical to get the prototypes produced as soon as possible, Nasr noted, the team working on the prototype ventilator transferred all design knowledge and documentation as well as prototyped parts to a large manufacturer to use its supply chain to produce the prototype ventilator in high volume. The team is continuing to support the manufacturer to ensure a fast production cycle. 
He's hopeful that RIT's tireless work over the past month will go a long way in the ongoing fight against the coronavirus pandemic.
"The hospitals are the ones on the front lines of this medical battle," Nasr said. "It has been an emotional rollercoaster to hear their stories and see what the doctors, nurses and patients are going through. It's been extremely tough. It's such a crisis."
For more information, contact Rich Kiley at 585-880-7227, Rich.Kiley@rit.edu, or on Twitter: @rakiley.

[https://ww1]
The prototype ventilator plugs into the oxygen source available in most hospital rooms or into a tank of oxygen.

"Rochester has always been a leader in innovative technology—and now, we are using our unique expertise to help fill a critical need for ventilators during the global COVID-19 pandemic. ... I am profoundly grateful to RIT." - U.S. Congressman Joseph Morelle




* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

WHAT: Connecticut companies that are working on COVID-19 will participate in a virtual (online) panel discussion, open to the public, on the current state of therapeutic and vaccine pipelines, new developments and future plans.
The panel is presented by BioCT and hosted by AdvanceCT. "As the world eagerly awaits a vaccine to COVID-19, we greatly appreciate the efforts of our Connecticut bioscience companies to develop a solution," Dawn Hocevar, BioCT president and CEO, said. "We look forward to hearing their insights during this discussion."
WHEN:         
Wednesday, April 8, 2020 
10:30 AM – 12:00 PM EDT
WHO:         
Panelists: 

Mark Noe, PhD, Vice President of Medicine Design, Pfizer

Mark Adams, PhD, Professor & Director, General Manager Microbial Genomic Services, The Jackson Laboratory

Bijan Almassian, PhD, President & CEO, CaroGen

Eric Kabrams, 4Catalyzer

Anil Diwan, PhD, Executive Chairman & President, NanoViricides

Gary Mathias, Co-Founder & CEO, Thetis Pharmaceuticals

Moderator: 
Mostafa Analoui, PhD, Executive Director of Venture Development, Office of the Vice President for Research & Technology Incubation Program (TIP), UConn
WHERE:    Register here.
FORMAT: Panel discussion (with audio and video of panelists and moderator) followed by a Q&A during which registrants may pose questions through virtual chat.     
FEE: Free
INVITEES: Open to the public

[https://ww1]

As the world eagerly awaits a vaccine to COVID-19, we greatly appreciate the efforts of our Connecticut bioscience companies to develop a solution.




* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

STOP COVID-19 seeks ways to accelerate researchers, scientists, and healthcare and life sciences professionals in the fight against the current coronavirus pandemic

NEW YORK (PRWEB) APRIL 06, 2020
Today, ConsenSys Health announced the Stop COVID-19 Virtual Hackathon launching April 13 and running until May 11, 2020. The hackathon is co-sponsored by Gitcoin, Hyperledger, ConsenSys, One Million Developers, and OpenMined, leveraging blockchain and other emerging technologies to improve data access and veracity for researchers, healthcare experts, and life sciences professionals attempting to better understand and stop COVID-19 and prevent future pandemics. ConsenSys Health is seeking to accelerate the launch of operational technology as part of the fight against COVID-19, and has issued a call for hundreds of healthcare and life sciences leaders worldwide to serve as mentors, lending their industry expertise to Web3.0 technologists as they come together to develop solutions.
"In the face of the COVID-19 crisis, our goal for this global competition is to bring together healthcare and life sciences domain experts with engineers from three open source software communities: Ethereum, Hyperledger, and OpenMined. Working together for the first time with a very specific toolset, this interdisciplinary group will rapidly create highly-relevant solutions with the potential to have both immediate- and long-term positive impact," said Heather Leigh Flannery, Founder and Chief Executive Officer of ConsenSys Health. "The core of our effort is to leverage converging innovations like blockchain, tokenization, zero-knowledge cryptography, and federated machine learning to advance immediate and long-term public health goals while preserving individual privacy."
The STOP COVID-19 Hackathon solutions will be evaluated by each phase of the pandemic they address, leveraging the model proposed by McKinsey & Company: Resolve, Resilience, Return, Reimagination, and Reform. The healthcare and life sciences expert volunteers serving as mentors will help software developers understand key topic areas in those phases. Some of these areas include clinical trials for treatments and vaccines, global screening data, vulnerable and at-risk populations, identity provenance and consent, privacy-preserving location tracking, and supply chain optimization for ventilators and other vital medical supplies.
The Hackathon is hosted on Gitcoin, a platform for developers to collaborate and monetize their skills while working on open source projects through bounties, grants, and hackathons. Gitcoin has facilitated over 4 million dollars of value transfer for open source work within their community of 36,000 developers. For those looking to compete, the prize money for the STOP COVID-19 Hackathon totals $20,000, including $10,000 for first place, $7,000 for second place and $3,000 for third place. Winning entries will be fast-tracked for additional funding sources through Gitcoin and ConsenSys grants, as well as other funding opportunities within ConsenSys Health. For those looking to learn more about blockchain, ConsenSys Academy is offering two full weeks of training for free to novice Web 3.0 developers who want to get up to speed quickly to contribute to the hackathon. Kaleido, an industry leading enterprise blockchain platform, will be available for "Technical Tuesday" and "Walkthrough Wednesday" virtual sessions throughout the Hackathon, and ConsenSys product Infura will also have open hours with engineering every Thursday.
"To take on the challenges brought forth by COVID-19, it's vital to marshall experts from across disciplines and markets," said Brian Behlendorf, executive director at Hyperledger. "This Hackathon brings together the medical and scientific communities and elite developers with the singular goal of developing operational solutions, built on cutting-edge software, to mitigate damage and speed recovery from this pandemic. Hyperledger fully embraces this opportunity to help accelerate innovation on this front and will engage its community and technologies in this incredibly important work."
Starting April 6, Hackathon participants will be able to join Q&A-based virtual panels with mentors from academia, public and private sector healthcare and life sciences organizations to better understand the problem space, as well as identify mentors as the right fit for future endorsements of projects. Close collaboration of industry mentors and software engineers ensures that the solutions generated will meet the complex requirements of the healthcare and life sciences ecosystem.
The confirmed judges for the Hackathon to date include Joseph Lubin, Founder and CEO of ConsenSys and Co-Creator of Ethereum; Brian Behlendorf, Executive Director of Hyperledger; Dr. Alex Cahana, Chief Medical Officer and EMEA Market Leader of ConsenSys Health; Dr. Sean Manion, Chief Scientific Officer of ConsenSys Health, Dr. Jonathan Holt, Chief Medical Informatics Officer of ConsenSys Health, and Debbie Bucci, Director, Patient-Mediated and Institutional Data Exchange at ConsenSys Health.
To join the STOP COVID-19 Hackathon as a mentor, partner or participant, visit ConsenSysHealth.com/COVID-19.
To learn more about the development resources and training available, register to join an introductory virtual event on Monday, April 6 at 12 EDT.
About ConsenSys Health 
ConsenSys Health is a spin-off from ConsenSys, one of the world's largest blockchain companies, focused on solving the biggest problems in healthcare. We are part of an ecosystem of technology and industry partners seeking to drive positive, inclusive change in healthcare and the life sciences. As a member of the Covid-19 Healthcare Coalition, we are committed to developing solutions to fight the current pandemic and advance the healthcare ecosystem to protect our future privacy and security. For more information, please visit http://www.consensyshealth.com.
About Gitcoin 
Gitcoin is a community and platform for developers to collaborate and monetize their skills while working on Open Source projects through bounties. 

ConsenSys Health issued a call for hundreds of healthcare and life sciences leaders worldwide to serve as mentors, lending their industry expertise to Web3.0 technologists as they come together to develop solutions.



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

elluminate COVID-19 Analytics support FDA guidance, proactive monitoring and impact analysis of COVID-19 on clinical trial participants for ongoing studies

MANSFIELD, MASS. (PRWEB) APRIL 06, 2020
eClinical Solutions LLC, a leading global provider of cloud-based enterprise software and software-driven clinical data services, today announced an addition to its elluminate platform, COVID-19 Analytics. These analytics help sponsors proactively manage the risks of COVID-19 for their ongoing clinical trials. The visualizations provide real-time trial information based on numerous data sources, allowing trial managers to focus on those participants and sites most likely experiencing COVID-19 related symptoms and impact.
With the FDA's recently released guidance on the conduct of clinical trials for medical products during the COVID-19 pandemic, upholding the safety of trial participants, maintaining compliance and minimizing risks to trial integrity are pressing issues for sponsors to manage in their ongoing studies. elluminate COVID-19 Analytics help clinical teams comply with FDA recommendations by enabling sponsors to identify missed visits and forecast upcoming future visits, including those for dosing, which have a greater likelihood to be missed based on a variety of data sources. This allows clinical teams to identify the sites and patients that may need additional resources and support, such as remote visits and additional supplies, to help sustain ongoing participation in the study.
"We developed elluminate COVID-19 Analytics based on feedback from clients looking to expand their use of elluminate for immediate insights on the pandemic's impact with their ongoing clinical trials," said Raj Indupuri, CEO of eClinical Solutions. "After hearing similar needs across clients, we rapidly developed a validated, rich analytics app with smart visualizations that can be used for any trial. We are inspired by how hard the research community is working both to find a treatment for COVID-19 and to ensure critical new therapies in development continue to progress. We believe these analytics help minimize risks with trial conduct and help sponsors make better decisions during this time."
elluminate COVID-19 Analytics are now available and complimentary for all existing elluminate clients. New clients can use them for a reduced rate. For more information on elluminate COVID-19 Analytics, eClinical Solutions is hosting a live webcast on Wednesday, April 8 at 11 am EDT/8 am PDT. Visit https://www.eclinicalsol.com/webinars/elluminate-covid-19-analytics to register.
About eClinical Solutions LLC 
eClinical Solutions is a leading global provider of cloud-based enterprise software and software-driven clinical data services. The elluminate platform provides life sciences companies with greater control of their clinical trial data. elluminate software and data driven services have been used by more than 100 life sciences companies. For more information, visit http://www.eclinicalsol.com.

"We developed elluminate COVID-19 Analytics based on feedback from clients looking to expand their use of elluminate for immediate insights on the pandemic's impact with their ongoing clinical trials," said Raj Indupuri, CEO of eClinical Solutions.



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

Lumiata, a provider of AI-powered software for the healthcare industry, today announced the successful completion of their 2019 SOC 2 Type 2 examination, together with their 2019 HIPAA security compliance assessment. The effort reflects their long-standing commitment to data security, while giving them a competitive edge in their industry.
"Lumiata takes the security of our data and our customers' data seriously," noted Jessica McCarthy, Vice President of Marketing for Lumiata. "We have completed the annual SOC 2 audit successfully and consecutively six times, [and] are unique within our vertical."
Lumiata took a proactive approach to compliance, and now security assessments are becoming increasingly prevalent within the healthcare space – especially among organizations that handle patient data records and clinical risk information.
"Healthcare requires security diligence," explained Saurav Chatterjee, VP of Engineering and Security Officer for Lumiata. "SOC 2 compliance assures our customers that we treat their data with the highest level of integrity and are committed to their members' privacy."
Lumiata was audited against the AICPA Trust Services Criteria for Security, Availability, and Confidentiality. The examination provided assurance regarding the effectiveness of the company's controls over a period of time. Meanwhile, the HIPAA Security Compliance Assessment confirmed that the company follows appropriate procedures for storing, processing, and handling their clients' protected health information.
The examination was completed by the professional and independent third-party audit firm, 360 Advanced, Inc. "They have been an outstanding partner," noted McCarthy.
About Lumiata
Based in the heart of Silicon Valley, Lumiata is an Artificial Intelligence company purpose-built for the healthcare industry. Powered by over 100 million patient data records, clinical, risk, and financial algorithms, Lumiata employs some of the nation's leading data science and machine learning talent. Lumiata enriches payers' and providers' analytic and predictive capabilities with tools and pre-trained models that help to manage healthcare costs and risk. For more information, visit lumiata.com or follow @lumiata on Twitter.
For Lumiata inquiries, please contact:
Jessica McCarthy 
Vice President of Marketing 
jessica@lumiata.com
About 360 Advanced 
360 Advanced is "Making Better Businesses" through their national Cybersecurity and Compliance offerings. Services provided include SOC 1, SOC 2, SOC 3, SOC for Cybersecurity, CSA STAR, HIPAA/HITECH, ISO 27001, PCI-DSS, HITRUST CSF, Microsoft SSPA Attestation, Penetration Testing, GDPR, CCPA and more. In certain states, 360 Advanced may operate under the name of Hiestand, Brand, Loughran, P.A. to meet State Board of Accountancy requirements. To learn more about 360 Advanced, visit http://www.360advanced.com.
For more information on compliance solutions, contact Jim Brennan at jbrennan@360advanced.com. 

"Lumiata takes the security of our data and our customers' data seriously," noted Jessica McCarthy, Vice President of Marketing for Lumiata. "We have completed the annual SOC 2 audit successfully and consecutively six times, [and] are unique within our vertical."



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

Enhancements allow hospitals to quickly and easily take physical inventories of personal protective equipment (PPE), identify and locate on-hand inventory, and export data for reporting

EAGAN, MINN. (PRWEB) APRIL 06, 2020
Three weeks after offering its inventory management platform free of charge to hospitals battling the COVID-19 pandemic, Jump Technologies today announced enhancements that address the rapidly changing needs of hospital supply chain. The new capabilities are designed to allow hospitals and health systems to quickly automate physical inventories and essential reporting of crucial supplies, including personal protective equipment (PPE).
According to John Freund, CEO of Jump Technologies, recent enhancements to the company's JumpStock platform allow hospitals to: 
●    Generate a single report to forecast days of supply, show performance against allocations, and see current outstanding orders and average daily velocity; 
●    Quickly and easily identify and locate on-hand inventory; 
●    See where inventory is going and who's using it; 
●    Identify potential hoarding of supplies; and 
●    Export data for reporting requirements to management and government agencies.
"We have heard frequently since this pandemic that clear communication and data about inventory levels is critical, because when nurses and other frontline staff know what's available, they can better plan how they use supplies to keep everyone safe," said Freund. "We commend the efforts of all hospital and supply chain workers across the country who are pushed beyond their limits day in and day out. We hope that by automating key workflows and providing free access and training on how to use our supply chain solution, we can help hospitals manage the valuable resources they need to protect healthcare workers and give patients the best possible treatment."
According to Freund, the JumpStock solution runs in the cloud and leverages any Android or iOS device for recording inventory transactions. In addition, tracking COVID-19 supplies does not require access to sensitive patient information.
Jump Technologies will continue to offer free access to the platform through June of 2020, at which time they will reassess the market needs. Hospitals and health systems can access this free solution by filling out a form at http://www.jumptech.com/covid19. A representative from Jump Technologies will contact the hospital to discuss setup options, configure the account, and upload data.
###
About Jump Technologies 
Jump Technologies creates safe, simple, and cost-effective solutions that help hospitals reduce stockouts, overordering, and waste while increasing inventory turns and improving billing accuracy across a facility or system. The company's JumpStock solution facilitates data-driven decision making that allows hospitals to save time, free up cash, and improve nurse satisfaction with supply chain. To learn more, visit http://www.jumptech.com or call (888) 373-7226. Follow Jump Technologies on LinkedIn and Twitter @JumpTechNews.
Media contact: Barbara Tabor, APR / (651) 230-9192 / barbara@taborpr.com 

We hope that by automating key workflows and providing free access and training on how to use our supply chain solution, we can help hospitals manage the valuable resources they need to protect healthcare workers and give patients the best possible treatment.



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

Jvion, a leader in clinical AI, announced today that Jay Deady, former CEO of Recondo (acquired by Waystar) and Awarepoint (now part of CenTrak), will succeed founder Shantanu Nigam as Jvion's Chief Executive Officer. Shantanu will transition to his new role as Executive Chairman of the Board. Jay's demonstrated leadership in healthcare IT will help scale the company through the next stage of growth, while Shantanu will continue to support Jvion as Executive Chairman of the Board.
"With a proven track record of leading innovators in AI for healthcare, Jay is uniquely qualified to carry on our mission to prevent avoidable patient harm," said Shantanu. "He shares our values and purpose, and will help maintain everything that sets Jvion apart. It's been an honor founding and building Jvion, and I'm looking forward to working with Jay as we scale the company and grow the impact of the Jvion AI CORE across the care continuum."
Jay Deady has been a leader, product visionary, and innovator in healthcare IT for nearly 30 years. Jay's most recent role was as CEO of Recondo, a leading AI revenue cycle company, where he and the team focused on growth and product innovation that ultimately moved Recondo from last to first in KLAS client satisfaction. Recondo was acquired by Waystar in December 2019. Prior to Recondo, Jay served as CEO of Awarepoint, a clinical technology and software company, where he grew the company into the leading technology provider in the caregiver and patient asset-flow and capacity-management market. Prior to Awarepoint, Jay held leadership positions at Eclipsys (now Allscripts), McKesson Provider Technologies, Cerner Corporation and ADAC Healthcare.
"AI is transforming healthcare. Shantanu and his fellow co-founders have done an excellent job building a team and developing the technology to accelerate that transformation," said Jay. "Jvion has achieved incredible results in advancing clinical AI that can impact patient lives, augment clinical decisioning and lower the costs of care. The company is uniquely positioned as a result of its ability to deliver both predictive to prescriptive insights and real-time interventions within existing clinical workflows. It was an easy decision to join this amazing team, and I look forward to championing Jvion as it leads the next wave of clinical AI adoption."
Shantanu has led Jvion since 2010, when he founded the company to address the pervasive problem of preventable patient harm. His passion for AI and building innovative teams has led Jvion from a startup to the market leader in clinical AI, with the Jvion AI CORE deployed in about 50 health systems and over 300 hospitals across the country. As Executive Chairman of the Board, Shantanu will continue to influence Jvion's direction as he finds new avenues to champion the use of AI in healthcare.
In the midst of the COVID-19 pandemic, Jay joins Jvion during a turbulent time for healthcare. As CEO, he will lead Jvion's ongoing efforts to support hospitals and providers through the crisis. Jvion recently released two solutions to help it's customers and the community more broadly. The COVID Community Vulnerability Map is a publicly available tool to help community health leaders strategize a proactive pandemic response to protect vulnerable populations. Also available are its AI-powered COVID Vulnerability Patient Lists that rank hospital patient populations based on risk for the most severe outcomes post infection. Patients are classified by their risk of hospitalization, end organ failure, and mortality as a result of infection.
About Jvion: 
Jvion enables healthcare organizations to prevent avoidable patient harm and lower costs through its clinical AI solution. An industry first, the Jvion Machine goes beyond simple predictive analytics and machine learning to identify patients on a trajectory to becoming high risk and for whom intervention will likely be successful. Jvion determines the interventions that will more effectively reduce risk and enable clinical action. And it accelerates time to value by leveraging established patient-level intelligence to drive engagement across hospitals, populations, and patients. To date, the Jvion Machine has been deployed across about 50 hospital systems and 300 hospitals, who report average reductions of 30% for preventable harm incidents and annual cost savings of $6.3 million. For more information, visit http://www.jvion.com.

[https://ww1]

Jvion has achieved incredible results in advancing clinical AI that can impact patient lives, augment clinical decisioning and lower the costs of care... It was an easy decision to join this amazing team, and I look forward to championing Jvion as it leads the next wave of clinical AI adoption.



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

Clinical AI Leader Jvion Names Industry Veteran Jay Deady as Chief Executive Officer



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

Heal the Healers Now," a new national initiative to bring the stress-reducing Transcendental Meditation (TM) technique to medical professionals who are battling the coronavirus pandemic, was launched today by two nonprofit groups: the Center for Health and Wellness of the David Lynch Foundation and the US TM Organization.
A New York Times article published on March 31 titled "Nurses Die, Doctors Fall Sick and Panic Rises on Virus Front Lines," reported that "The coronavirus pandemic, which has infected more than 30,000 people in New York City, is beginning to take a toll on those who are most needed to combat it: the doctors, nurses and other workers at hospitals and clinics. In emergency rooms and intensive care units, typically dispassionate medical professionals are feeling panicked as increasing numbers of colleagues get sick."
"With COVID-19 testing our healthcare system's technology, infrastructure and most importantly human resources, the doctors and nurses taking care of the scared and sick patients – at great risk to themselves – deserve the very best tools to manage their health that we can provide them," said Bob Roth, Chief Executive Officer, the David Lynch Foundation.
"Throughout the years, 5,000 doctors and nurses have learned the TM technique. The goal of the David Lynch Foundation is to teach many thousands more of these heroes over the coming year."
"Save the doctors, save the nurses!" said filmmaker David Lynch, chair of the David Lynch Foundation. "This initiative will teach these courageous healthcare providers Transcendental Meditation so they can strengthen their immune systems, stay safe and continue to help others."
Even before the pandemic, a Harvard report called physician burnout "a public health crisis that urgently demands action," with several surveys putting the rate of provider burnout as high as 70 percent. The American Academy of Family Physicians linked burnout to higher rates of medical errors, substance abuse and addiction and suicide among physicians.
Today, the situation is far worse and demands well-documented, innovative approaches to address this crisis. "Transcendental Meditation is an evidence-based, non-pharmacological intervention for this devastating public health crisis," said Stuart Rothenberg, MD, Medical Director of the Center for Health and Wellness.
"The Center for Health and Wellness has a long track record of providing TM instruction to first responders, including police, firefighters, and military personnel. Today, our doctors, nurses, and other healthcare providers are true first responders—they are on the frontlines in a literal life-or-death battle against a pandemic that threatens the very life of society," Dr. Rothenberg said.
Heal the Healers Fund
The Center has established the "Heal the Healers Now Fund" with all money raised used to deliver the meditation to healthcare providers at no charge. Those interested in supporting the initiative can visit HealTheHealersNow.org.
Deep relaxation and stress reduction
Transcendental Meditation is an easy-to-learn, enjoyable-to-practice mental technique for deep relaxation and stress-reduction that has been successfully offered in medical schools, academic and VA medical centers, hospitals, military academies, substance abuse centers, prisons and other settings, according to the TM.org website.
Instruction in the TM technique for healthcare providers includes eight hours of specialized training by a trauma-informed teacher, which includes one class of personalized instruction, as well as a comprehensive, one-year follow up program to ensure the provider is gaining maximum results. The technique is practiced for 15-20 minutes twice a day. Training will begin once health authorities give the greenlight for teaching medical workers onsite.
Celebrities including Jerry Seinfeld, Ellen DeGeneres, Oprah Winfrey, Katy Perry, Tom Hanks, Hugh Jackman, Patrick Stewart, Paul McCartney, Ringo Starr, Sting, Russell Brand, Laura Dern, Lena Dunham, Naomi Watts, Mary-Louise Parker, Amy Schumer and Bill Hader practice Transcendental Meditation and support the work of the David Lynch Foundation to bring the meditation for free to at-risk adults and youth.
Unique state of "restful alertness"
"TM produces a unique neurophysiological state that combines deep metabolic rest with heightened mental alertness. This state of deep relaxation, which researchers have termed 'restful alertness,' is a potent antidote to stress," Dr. Rothenberg said.
Over 400 peer-reviewed published studies on TM have documented improvements in a wide variety of stress-related disorders, as well as significant improvements in cognitive function and overall health and well-being. The National Institutes of Health and the Department of Defense have awarded nearly $30 million in grant support for research on TM.
For example, a recent $2.4 million study funded by the Department of Defense found TM markedly reduced symptoms of PTSD among meditating veterans. Results of the randomized controlled trial were published in The Lancet Psychiatry in November 2018.
Ten million people of all ages, nationalities and religions, including tens of thousands of healthcare providers, have learned TM. The TM-based "Healthcare Provider Wellness Program" has been offered in hospitals and clinics nationwide, most recently at Weill Cornell Medical Center-New York Presbyterian Hospital in New York City, with significant reductions in physician burnout, insomnia and symptoms of post-traumatic stress over a three-month period in those practicing the TM technique.
Eric J. Nestler, MD, PhD, Director of the Friedman Brain Institute at the Icahn School of Medicine at Mount Sinai in New York, learned TM six years ago. "TM has tremendous potential for healthcare providers to reduce burnout and increase job satisfaction and productivity," Dr. Nestler said.
Patty J. Lee, MD, is Chief of the Division of Pulmonary, Allergy and Critical Care at Duke University Medical Center in Durham, North Carolina. "I am leading an entire division of physicians through this CoV19 crisis—and TM has been my anchor. I am now petitioning our entire health system to train all our healthcare providers in TM," Dr. Lee said.
Track record in healthcare programs
The TM technique has been adopted in healthcare provider wellness programs as a stand-alone approach or as an adjuvant therapy to make existing programs more effective. These programs include: 

Loyola University's Stritch School of Medicine in Chicago Medical students are offered a for-credit elective program entitled, "Physician Wellness through Transcendental Meditation." To date, more than 350 medical students have learned TM, with more students learning all the time based on positive reports. A randomized controlled trial of 42 academic faculty physicians at Loyola Stritch performed over a four-month period found significant improvements in overall burnout, depression and insomnia in the TM group compared to controls.

Weill Cornell Medical Center-New York Presbyterian Hospital in New York City A pilot study of physicians in the Emergency Medicine Department found significant reductions in physician burnout, insomnia and symptoms of post-traumatic stress over a three-month period in those practicing TM.

Norwich University in Northfield, Vermont A six-year study on cadets at America's oldest military college (and the home of ROTC) has found significant reductions in perceived stress, hyper-vigilance and depression, and increases in psychological resilience in TM participants.

Donating services to healthcare providers
Dr. Rothenberg said the "Heal the Healers Now Fund" will allow certified TM teachers to provide the instruction to learn to meditate at no cost to doctors, nurses and other workers, as well as offer a comprehensive, one-year follow up program to ensure the providers are gaining maximum benefit from their practice.
For more information, and to make a tax-deductible donation to "Heal the Healers Now Fund," please visit HealTheHealersNow.org or contact Heroes@DavidLynchFoundation.org
For media inquiries, contact Dan Knitzer at The TASC Group at dan@thetascgroup.com or 973-978-3956


* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

Same-Day Dental Implants in Berkeley, CA, Made Possible by Dr. Keith Chertok and Straumann



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

Due to scientific and economic developments, medicine has experienced tremendous changes in the last 250 years. Passionate about understanding these changes for the betterment of current patient care, author Anthony M D'Agostino, MD of Alexian Brothers Behavioral Health Hospital has expertly compiled a history of psychiatry to showcase the realities of our health care system in his book, "The Curious Case of the Alexian Brothers Behavioral Health Hospital".
A respected medical professional with over 45 years of experience in psychiatry, D'Agostino shares his expert insights, extensive research and personal testimony to shed a light on a health care system that needs to continue to change to provide the best care for patients. With a focus on the evolution of health coverage, this book creates an important dialogue on the subject to examine its role in the practice of psychiatry.
US Review of Books praises the book: "The book is steeped in insight with its analytical focus and depth of information... it flows in the presentation and is a fascinating read, especially for those in the field of mental health services, not just psychiatry."
Exploring the history of psychiatric treatments, impact of the Alexian Brothers in the past 700 years, effects of managed care and more, D'Agostino's findings create a compelling look at the past to showcase what is in store for the future of psychiatric care.
"The Curious Case of the Alexian Brothers Behavioral Health Hospital" is the perfect read for those interested in medical history along with healthcare professionals in any field of medicine. To learn more, please visit https://www.anthonydagostinomd.com
"The Curious Case of the Alexian Brothers Behavioral Health Hospital: And Other Controversies in Psychiatry" 
By Anthony M D'Agostino, MD 
ISBN: 9781532037801 (softcover); 9781532037818 (electronic) 
Available at the iUniverse Online Bookstore, Amazonand Barnes & Noble
About the author 
Anthony M D'Agostino, MD served as Chair of the Department of Psychiatry at Alexian Brothers Medical Center in Elk Grove Village, Illinois from 1979 to 1999 and CMO at the Alexian Brothers Behavioral Health Hospital in Hoffman Estates, Illinois from 1999 to 2011. He received his medical degree from the University of Illinois College of Medicine, interned at the Los Angeles County General Hospital and completed residencies in General and Child Psychiatry at the University of Illinois, Chicago, the University of California, Los Angeles, and The University of Wisconsin, Madison.
He was President of the Illinois Psychiatric Society in 1986-87 and served on the Health Insurance and Ethics committees for much of 2 decades. At the national level, he was an Illinois delegate on the Assembly of the American Psychiatric Association from 1996 to 2002 where he also served as Vice Chair of its Managed Care Committee. He is a Distinguished Fellow of the American Psychiatric Association and has practiced Psychiatry at Alexian Brothers Hospitals for over 40 years and continues to do so.
Contact: 
LAVIDGE – Phoenix                         
Courtney Vasquez 
480-306-7065 
cvasquez(at)lavidge(dot)com

[https://ww1]
Book Cover

A respected medical professional with over 45 years of experience in psychiatry, D'Agostino shares his expert insights, extensive research and personal testimony to shed a light on a health care system that needs to continue to change to provide the best care for patients



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

eDriving, a global provider of driver risk management programs, has launched a dedicated COVID-19 Resource Center to help organizations around the world keep their at-work drivers safe as they are relied upon to keep the world moving through the global pandemic.

CAPE MAY, N.J. (PRWEB) APRIL 06, 2020
Many people who drive for work are continuing to leave their homes to ensure that essential supplies and services reach those in need during this difficult time. eDriving's COVID-19 Resource Center helps managers address the additional challenges currently being faced. It includes a complimentary eLearning course, webinar, manager guides and driver tips to help protect the safety of those driving for work.
"Globally, many organizations with at-work drivers are now finding that they're on the "front line", said Ed Dubens, Founder/CEO of eDriving. "And with the biggest driver risks now including hygiene, professional/social distancing and stress/fatigue, driver safety and risk management have taken on a whole new meaning. Our new COVID-19 Resource Center has a range of resources to help organizations keep their teams fit and healthy."
eDriving's new seven-minute complimentary eLearning course, COVID-19: Defensive Driving Tips and Best Practice, is available in 32 languages, with quick and easy tips for drivers who continue to work during the COVID-19 pandemic. It also includes a five-question quiz to lock in key learnings.
Topics covered include: 

Personal/vehicle hygiene and sanitization best practices

Advice on off-limits locations and staying safe during rest breaks

Social distancing, customer interactions and unsafe working spaces

The importance of defensive driving

Avoiding distractions behind the wheel

Prioritizing well-being

Links to latest best practices from the CDC (Center for Disease Control) and WHO (World Health Organization)

COVID-19 Webinar 
On Thursday April 16, eDriving will host a webinar, Protecting your Drivers During the COVID-19 Pandemic. In the webinar, eDriving's SVP of Risk Engineering, Jim Noble, and Snow Advisory's Environment, Health, Safety & Sustainability guru, Teri Snow, CSP, will discuss the unprecedented risks currently faced by at-work drivers and recommend the steps organizations can take to help keep drivers safe and healthy during this time.
Driver Safety Tips and Manager Guides 
eDriving's COVID-19 Resource Center also includes Global Workplace and Driver Safety Tips, as well as Manager Guides on topics including 'Maintaining Driver Morale', 'Effective Communication with Fleet Drivers', 'Helping Fleet Drivers Stay Focused on Road Safety' and 'Prioritizing Driver Well-being'.
Visit eDriving's COVID-19 Resource Center.
About eDriving 
eDriving helps organizations to reduce collisions, injuries, license violations and total cost of fleet ownership through a patented driver risk management program.
Mentor by eDriving is a smartphone-based solution that collects and analyzes driver behaviors most predictive of crash risk and helps remediate risky behavior by providing engaging, interactive micro- training modules delivered directly to the driver in the smartphone app. As part of a broader risk management platform, Virtual Risk Manager, eDriving provides organizations with everything they need to establish safety as a strategic imperative, and support drivers and managers as they strive to create a crash-free culture.
eDriving is the driver risk management partner of choice for many of the world's largest organizations, supporting over 1,000,000 drivers in 96 countries. Over the past 24 years, eDriving's research-validated programs have been recognized with over 90 awards around the world.

[https://ww1]

Our new COVID-19 Resource Center has a range of resources to help organizations keep their teams fit and healthy



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

Curiox Biosystems in conjunction with STEMCELL Technologies today announced a new system that will help researchers develop vaccines to SARS-CoV-2, the virus that causes COVID-19.
A new configuration of the Laminar Wash HT1000 System will allow scientists to completely process blood samples from COVID-19 positive patients in a safe environment. The package will consist of an updated Laminar Wash HT1000 system, Buffer Exchanger, and STEMCELL Technologies' EasySep RBC Depletion Reagent.
Laminar Wash technology enables researchers to more accurately study immune responses for vaccine research and clinical trials without the need for centrifugation, eliminating the aerosolization of potentially infectious samples. Laminar Wash technology is especially helpful in flow cytometry applications in vaccine research. The new HT1000 configuration allows containment of blood samples within a biosafety cabinet, ensuring the protection of laboratory staff and other samples.
"We are always aspiring to help scientists perform their research in a more accurate and safe manner" said Dr. Namyong Kim, CEO of Curiox Biosystems.
Traditionally, unwanted red blood cells (RBCs) are removed from blood samples using lysis buffers, which can be harmful to white blood cells, the cells responsible for immune response. By working with STEMCELL Technologies' RBC depletion kits, researchers can easily remove unwanted RBCs from blood samples without the need for lysis, resulting in superior data quality.
"It is always a proud moment when the reagents and tools we develop can help enable scientific discoveries and treatments. This new application will facilitate the safe processing of blood samples so that researchers can better understand the immune response to current and future infectious disease outbreaks" said Dr. Andy Kokaji, Director of Immunology at STEMCELL Technologies.
Enabling safe and efficient handling of virus-positive blood samples ultimately helps patients by accelerating treatment and vaccine research. The new package of products is available starting, March 23, 2020. Curiox and STEMCELL Technologies are offering to assist institutions in obtaining the product as easily as possible, with donations considered in some cases.
About Curiox Biosystems
Curiox Biosystems is a bioinstrumentation company spun out of the Agency for Science, Technology, and Research (A*STAR) in Singapore. Curiox has become a leader in the development and commercialization of innovative assay platforms based on its expertise in surface chemistry and engineering. Curiox's vision is to accelerate the progress of life sciences, drug discovery and diagnostics through the miniaturization and improved automation of bioassays.
About STEMCELL Technologies
STEMCELL Technologies is Canada's largest biotechnology company. STEMCELL supports life sciences research with high-quality cell culture media, cell separation technologies, instruments, accessory products, and educational resources. STEMCELL's products are used globally by scientists advancing the stem cell, immunology, cancer, regenerative medicine, microbiology, and cellular therapy fields. Find more information at http://www.stemcell.com




* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

As the COVID-19 crises deepens, Children's Miracle Network Hospitals is committed to ensuring 170 children's hospitals have the resources they need to care for the most vulnerable kids. Critical donations are needed to provide protective gear, equipment, charitable care and support services at Children's Miracle Network Hospitals. Staples US Retail has partnered with CMN Hospitals to collect personal protective care equipment or donations to help local member hospitals fund their greatest needs.
Donations of new, unused, unopened personal protective equipment such as N95 respirator face masks, disposable face masks, face-shield, eye protective wear, isolation or surgical gowns can be dropped off at participating Staples stores. Donations will be shipped to the local Children's Miracle Network Hospital to help caregivers. Protective gear is essential to ensure the safety of hospital workers who are caring for the most vulnerable patients at children's hospitals.
"We are grateful for Staples help to ensure local children's hospitals have the resources they need. Kids can't wait to get treatment. When you donate personal protection equipment or funds through our partnership with Staples, CMN Hospitals are able to keep caregivers and kids safe during this crisis," says Teri Nestel, Interim President & CEO of Children's Miracle Network Hospitals.    
Equipment can be dropped off only at participating, open Staples stores, or monetary donations are accepted at cmnh.co/staples to help member hospitals fund their greatest needs. Please visit Staples.com for store hours.
Children's Miracle Network Hospitals and Staples are committed to following the safety guidelines outlined by the CDC, federal, state, and local authorities. Customers should follow appropriate social distancing and other public health guidelines when dropping off PPE donations. Visit http://cdc.gov/coronavirus for more information.
About Children's Miracle Network Hospitals 
Children's Miracle Network Hospitals raises funds and awareness for 170 member hospitals that provide 32 million treatments each year to kids across the U.S. and Canada. Donations stay local to fund critical treatments and healthcare services, pediatric medical equipment and charitable care. Since 1983, Children's Miracle Network Hospitals has raised more than $7 billion, most of it $1 at a time through the charity's Miracle Balloon icon. Its various fundraising partners and programs support the nonprofit's mission to save and improve the lives of as many children as possible. Find out why children's hospitals need community support and identify your member hospital at CMNHospitals.org
About Staples Retail 
Staples US Retail supports lifelong achievement for small businesses and consumers with the products and resources they need for continued professional and personal growth. With a focus on community and shared learning, Staples retail locations serve millions of customers from entrepreneurs and small businesses to parents, teachers and students. For more information about Staples US Retail and to stay up to date on weekly deals and events, please visit us in store or online at staples.com.

We are grateful for Staples help to ensure local children's hospitals have the resources they need. Kids can't wait to get treatment.



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

P-Cure Ltd (Shilat, Israel), a developer and supplier of the comprehensive 360°-gantry-less adaptive proton therapy solution, announced that the European Parliament approved the CE marking for the P-ARTIS System enabling the company to market and sell the product in Europe. The P-ARTIS System is a vital development for enhanced patient treatment and is part of the newly developed full P-Cure proton therapy system currently being submitted for FDA clearance.
P-ARTIS is the only 360°-gantry-less image guided positioning system that enables planning and performs accurate image guided positioning of patients in the seated position for radiation therapy in general, and proton therapy in particular. The unique system for the first time brings to market a solution that allows for virtually limitless use of proton therapy in a gantry-less, compact configuration that fits into any radiation oncology department reducing the capital and operating costs. The solution includes an in-room vertical 4D CT, real time x-ray, robotic Six Degrees of Freedom positioning, and software that orchestrates the integrated operation of the patient-centric system.
Use of P-ARTIS 360°-gantry-less solution significantly enhances the possibility of bringing the benefits of proton therapy to patients around the world. The availability of proton therapy is severely limited because of the high capital costs, resulting in its being available to less than one percent of patients who could potentially benefit from it. According to Michael Marash, P-Cure CEO, "The P-Cure System will expand the availability of proton therapy with improved clinical outcomes to all cancer care institutions. By using our system, more healthcare providers will be able to integrate the technology, and more patients will gain access to this life saving technology. For the first time, the P-Cure System will substantially reduce the cost and size of a single room or multi-room expandable center, and dramatically reduce the time from planning to treatment."
Use of P-ARTIS 360°-gantry less, full body solution is a paradigm shifting change from the current method of treatment with the patient in the horizontal position. "The benefits of treating patients in a seated position include greater patient comfort, less internal organ movement, better saliva drainage and a better position for breathing for asthmatic and other patients experiencing impaired breathing. It may also deliver less collateral radiation to sensitive organs while enabling greater accuracy in proton beam delivery," said Dr. Marash.
About P-Cure: 
P-Cure is the innovative provider of a compact 360°-gantry-less, full body proton therapy solutions for better clinical effectiveness of proton therapy at a fraction of the current capital and operating costs. P-Cure continues to develop advanced solutions with a focus on adaptive therapy and real time motion management. P-Cure's first product was cleared by the FDA in 2010, addressing the unmet clinical needs in North America, China, and Europe. P-Cure works both with the existing and new cancer centers to establish advanced proton therapy capabilities. For further information, contact: Maayan Bendel, VP Business Development, P-Cure Ltd., +972 52 749 2110, Maayan.bendel@p-cure.com.


* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

OB2me (a division of 2me Healthcare), has changed the delivery of prenatal care for women throughout their pregnancy and childbirth. We are the first concierge obstetrical practice in the Atlanta area. We provide quality prenatal care at a time and place convenient for our patients. Our board-certified, experienced providers use state-of-the-art equipment and follow recommended practice guidelines from American College of Obstetrics and Gynecology (ACOG) and American College of Nurse Midwives (ACNM). Our providers are also available to you throughout your labor and delivery experience in a hospital setting at Northside and North Fulton Hospital. Sorry, we do not offer home birth services. Learn more at 2mehealthcare.com.

MARIETTA, GA. (PRWEB) APRIL 06, 2020
Healthcare has taken a sudden and dramatic turn these last few weeks, and doctor's offices across the world are having to close or accept the risk of spreading the COVID-19 virus in their offices. Many OB/GYN offices that have remained open are not allowing expectant moms' partners to attend their prenatal visits with them. Hospitals are also determined to decrease exposure risk by restricting support people for laboring woman to one person for their entire hospital admission.
From the patient's perspective, it's a tough decision: They can either seek prenatal or gynecological care and risk becoming infected with COVID-19, or NOT seek these essential services and risk their baby's health or their own health.
Thankfully, there's a new service being offered through OB2me that enables women to get the care they need without putting them and their babies at undo risk and without the need to change doctors.
OB2me provides prenatal and GYN visits in the comfort and safety of women's homes. Our provider will send a visit summary report to her primary OB/GYN care provider after each visit, so while using OB2me, she won't need to switch providers. OB2me's services are offered at a flat fee, paid per visit, with no obligation to continue services.
Also, NO ONE wants to RISK going to the hospital unnecessarily during this COVID-19 pandemic. So in addition to providing standard prenatal visits, on April 1st OB2me began offering in-home triage services for expectant women who may be unsure if it's time to go to the hospital to deliver. The Ob2me provider will go to the expectant mother's home and provide a thorough labor check to help them decide if it really is time to go to the hospital. This will prevent unnecessary risky and expensive hospital admissions for false alarms and help the mother stay home with their support system in the early phases of labor.



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

In honor of Parkinson's Awareness Month, the full month of April, the World Parkinson Coalition (WPC) is holding its first ever virtual Parkinson's Sing-A-Long led by WPC Choir Director, Judi Spencer. Past members of the WPC Choir who performed at the 4th and 5th World Parkinson Congresses will come together with up to 500 other members of the global Parkinson's community on four occasions to sing together in April.
The WPC hosts the most unique international scientific conference in the Parkinson's space. Every three years the WPC brings together basic scientists, neurologists, general physicians, nurses, rehab specialists, clinicians, as well as people with Parkinson's (PwP) and their care partners to learn about Parkinson's, build collaborations, and expand our understanding of a disease that impacts more than 10 million people worldwide.
"While the World Parkinson Congress is a scientific meeting, creativity plays a unique role in the overall program," said Elizabeth Pollard, WPC Executive Director. "Each WPC offers a variety of creative endeavors to complement the science and research. We believe that by weaving creativity into one's wellness plan, individuals can have a better quality of life. Not only do artistic endeavors help exercise the mind, they bring great joy to the artist and to those around the artist."
Many people with Parkinson's experience symptoms that impact their speaking and swallowing. The weakening of the muscles in the throat can cause people with Parkinson's to experience loss of voice, decreased ability to project their voice and may lead to swallowing and respiratory complications. While all people with Parkinson's are encouraged to work with a Speech Language Pathologist from the day of diagnosis, there are many fun things that patients can do on their own to support the voice training they receive, such as joining a choir and engaging in regular singing activities.
The WPC Parkinson's Sing-A-Long is a way to support the global Parkinson's community by encouraging them to continue to use and exercise their voices even while self-isolating due to COVID-19. Registration and details can be found at https://wpc2022.org/choir
Parkinson's Sing-A-Long Dates 
Thursday, April 9, 2020 at 5PM ET 
Thursday, April 16, 2020 at 1PM ET 
Thursday, April 23, 2020 at 5PM ET 
Thursday, April 30, 2020 at 1PM ET
"Leading the WPC Choir has always brought me such joy," said choir director, Judi Spencer of Seattle, Washington, USA. "I always look forward to the choir coming together at each World Parkinson Congress, and am pleased we can bring them together virtually in this way. The joy of singing is so important for health and wellness and has a magical way of lessening the emotional toll of self-isolation."
Learn more about the Parkinson's Sing-Along and WPC Choir at https://wpc2022.org/page/choir
About the World Parkinson Coalition and WPC 2022 
The World Parkinson Coalition Inc. provides an international forum for learning about the latest scientific discoveries, medical practices, caregiver initiatives and advocacy work related to Parkinson's disease. The triennial World Parkinson Congresses provide a space for the global Parkinson's community of researchers, clinicians, health care professionals, people with Parkinson's and their care partners to meet in person, network, and discuss advances in Parkinson's research, improve understanding and promote advocacy worldwide, while influencing future research and care options. The WPC 2022 will attract more than 4,500 delegates.
About Parkinson's Disease 
Affecting nearly one million Americans and 10 million people worldwide, Parkinson's disease is the second-most common neurodegenerative disease after Alzheimer's. There is no cure for Parkinson's and 60,000 new cases are diagnosed each year in the United States alone.


* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

The San Diego labor law attorneys at Blumenthal Nordrehaug Bhowmik De Blouw LLP filed a class action lawsuit against Hy-Lang Electric California, Inc., alleging the company failed to pay accurate wages, failed to provide required meal and rest breaks, and was in violation of the Private Attorneys General Act. The Hy-Lang Electric California, Inc. lawsuit, Case No. 37-2020-00012543-CU-OE-CTL, is currently pending in the San Diego County Superior Court for the State of California. A copy of the complaint can be accessed by clicking here.
According to the class action complaint's allegations, Hy-Lang Electric California, Inc. failed and continues to fail to accurately calculate and pay PLAINTIFF and the other members of the CALIFORNIA CLASS for their overtime worked. DEFENDANT also failed to record and pay employees for the actual amount of time worked, meaning the time during which an employee was subject to the control of an employer. Additionally, as a result of their rigorous work schedules, PLAINTIFF and other CALIFORNIA CLASS Members were from time to time unable to take of duty meal breaks and were not fully relieved of duty for meal periods. The lawsuit also alleges DEFENDANT failed to reimburse for required business expenses incurred by PLAINTIFF. Under California Labor Code Section 2801, employers are required to indemnify employees for all expenses incurred in the course and scope of their employment.
PAGA is a mechanism by which the State of California itself can enforce state labor laws through the employee suing under the PAGA who do so as the proxy or agent of the state's labor law enforcement agencies. An action to recover civil penalties under PAGA is fundamentally a law enforcement action designed to protect the public and not to benefit private parties. The purpose of PAGA is not to recover damages or restitution, but to create a means of "deputizing" citizens as private attorneys general to enforce the Labor Code.
For more information about the class action lawsuit against Hy-Lang Electric California, Inc., or if you would like to know if you qualify to make a claim, please contact attorney Nicholas J. De Blouw today by calling (800) 568-8020.
Blumenthal Nordrehaug Bhowmik De Blouw LLP is a labor law firm with law offices located in San Diego County, Riverside County, Los Angeles County, Sacramento County, and San Francisco County. The firm has a statewide practice of representing employees on a contingency basis for violations involving unpaid wages, overtime pay, discrimination, harassment, wrongful termination and other types of illegal workplace conduct.


* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

A technical bulletin from 3M has shown that KN95 disposable face mask respirators are the "equivalent" of US NIOSH N95 masks. As a result, the FDA is now allowing importation of Chinese KN95 face mask respirators in order to fill the desperate lack of supply faced in the U.S. Med Lab Supply has sprung into action to make KN95 disposable face mask respirators available to Health Care Workers, First Responders, and those who feel they are at a high risk.

POMPANO BEACH, FLA. (PRWEB) APRIL 06, 2020
The alarm has been sounded regarding the desperate shortage of PPE, especially N95 rated masks, for Health Care Workers and First Responders. The shortage is so severe, that many doctors, nurses, and first responders are being asked to use the same mask for multiple shifts, which puts them at much greater risk for exposure and infection.
In response to the crisis, the CDC has listed KN95 masks as an alternative to N95 masks and after comparing the masks, a technical bulletin from 3Mconfirms that "it is reasonable to consider China KN95....as equivelant to US NIOSH N95 and European FFP2 respirators."
Although the KN95 masks are in greater supply than any other mask in the world, until Friday, the FDA had still delayed regarding approval of their importation. The main concern seemed to be related to the possibility of fraudulent products.
However, Greg Blackledge, C.E.O. of Med Lab Supply, states, "Med Lab Supply ensures that the KN95 masks that they are importing are manufactured by an FDA registered company and due to our vetted procurement process, including requiring safety certificates and lab reports, we can guarantee the highest level of Authenticity and Quality Control throughout the purchasing and supply chain process. And although these masks do not presently have a 510k FDA clearance, they are CE certified for FFP2 protective mask (EN 149-2001), and they meet KN95-level requirements (GB 2626-2006), which meet the same standards as NIOSH N95."
He continues, "Our mission has always been to do our best to make sure that we remain a valuable resource to our loyal customers, especially our Health Care Workers, and First Responders. Obviously, we are not a non profit organization and we have many workers relying on our company to pay their bills, however, that does not change our sense of community and our desire to help our neighbors. Our top priority is, and will always be people, not profit. Now that the FDA has approved the importation of these high quality KN95 masks, it is our mission to import as many of them as possible in order to make them available to everyone who desperately needs them. We are also providing very special discounts to those individuals who have the credentials of a Health Care Worker or First Responder. We also offer custom bulk purchasing quotes to hospitals, clinincs, urgent care facilities, as well as police and fire departments."
As a result, many customers have expressed appreciation for the effort that Med Lab Supply has made to keep vitally needed supplies in stock while maintaining the consistently ethical pricing practices it operates its business with.

[https://ww1]
KN95 mask pic

5 Stars! Amazing Product! I have been searching for a quality mask and found it. Review by Isabella D. (verified buyer) on April 4, 2020



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

LifeDNA, Inc., a pioneering personal genomics company, has initiated a coronavirus study aimed at understanding why certain individuals and racial/ethnic groups are more prone to the infection and may suffer a more severe course of COVID-19.
"COVID-19 has upended daily life for citizens around the globe," said Cyril Moukarzel, CEO of LifeDNA, Inc. "Based on genetics, certain individuals and populations may be impacted more severely. LifeDNA's scientists are working tirelessly to add to the body of knowledge regarding the effect of these genetic variations."
Honolulu-based LifeDNA is collaborating with molecular epidemiologist Maarit Tiirikainen, Ph.D., Associate Professor at the University of Hawai'i at Mānoa. The study will initially focus on the multi-ethnic population of Hawai'i and genetic variants of the ACE2 gene as they relate to infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19.
"There have been major differences in the rates of SARS-CoV-2 infection and the severe disease between the different geographic regions since the beginning of the COVID-19 pandemic, even among young individuals," Dr. Tiirikainen said. "Epidemiological studies—so-called Genome Wide Association Studies (GWAS)—indicate that populations carry different variants of the ACE2 gene. This variation in the gene coding for the ACE2 receptor may have an effect on the number of ACE2 receptors on the lung cells, as well as on how effectively the virus binds to the receptor. There may also be genetic differences in immune and other important genes explaining why some people get more sick than others."
For more than three years now, LifeDNA has been utilizing published GWAS data to provide reports on the association of genetic variants to various human traits. In this global health crisis, LifeDNA will focus its scientific resources on determining why certain individuals and ethnic populations seem more prone to the SARS-CoV-2 infection and may also have a more severe course of the COVID-19 disease. The differences in the severity of the disease may also have an effect on future lung cancer incidences in different populations, especially when augmented by smoking.
The genotyping for the study will be done at the Kaka'ako Genomics and Bioinformatics Shared Resource (co-directed by Dr. Tiirikainen) at the University of Hawai'i Cancer Center.
LifeDNA expects that the findings of its study will allow for identifying the most vulnerable individuals and populations ahead of time in future SARS virus-family outbreaks. The company also envisions pharmacogenomics collaborations on life-enhancing and lifesaving preventive therapeutics, such as those utilizing CRISPR-Cas9 gene editing technology. While LifeDNA has yet to initiate formal partnership dialogue, companies with this relevant domain expertise include CRISPR Therapeutics AG, Editas Medicine, Inc. and Intellia Therapeutics, Inc.
About LifeDNA 
LifeDNA is a leading personal genomics company headquartered in Honolulu. The company's mission is to help people lead healthier and more fulfilling lives by unlocking the power of their unique DNA. LifeDNA's offerings include a self-administered, cheek swab DNA test kit and reports on 137 traits in the following categories: health, personality, fitness, nutrition and skin. Consumers who have already taken a DNA test with 23andMe, Ancestry or MyHeritage may upload their DNA raw data files (DNA test results) to gain deeper insight with LifeDNA's critically acclaimed reports. LifeDNA is headquartered in Honolulu and privately backed by Markowitz Trust and other investors. Learn more at http://www.lifedna.com. Like LifeDNA on Facebook at https://www.facebook.com/golifedna/. Follow LifeDNA on Twitter @golifedna.
About the University of Hawai'i Cancer Center 
The University of Hawai'i Cancer Center through its various activities, cancer trial patients and their guests, and other visitors adds more than $54 million to the O'ahu economy. It is one of only 71 research institutions designated by the National Cancer Institute. Affiliated with the University of Hawaiʻi at Mānoa, the Center is dedicated to eliminating cancer through research, education, patient care and community outreach with an emphasis on the unique ethnic, cultural, and environmental characteristics of Hawai'i and the Pacific. Learn more at http://www.uhcancercenter.org. Like UC Cancer Center on Facebook at http://www.facebook.com/UHCancerCenter. Follow the UH Cancer Center on Twitter @UHCancerCenter.

Based on genetics, certain individuals and populations may be impacted more severely. LifeDNA's scientists are working tirelessly to add to the body of knowledge regarding the effect of these genetic variations.



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

As a response to the COVID-19 pandemic, Curvo is expanding limited-time free access to Lookup by Curvo, its new unbiased clinical product research and market pricing solution.

EVANSVILLE, IND. (PRWEB) APRIL 07, 2020
Curvo Labs, Inc., an industry-leading technology platform for the healthcare supply chain, announced today the accelerated release of Lookup by Curvo, a new, unbiased clinical product research and market pricing solution built for hospital supply chain and value analysis professionals.
Lookup by Curvo provides holistic clinical product intelligence for the modern supply chain. Users can instantly search over 1.2 million unique products, view a device's cost and safety information within a second, and use a dynamic price spray graph to visualize market competitiveness. The unbiased solution provides insight into over $22 billion in trailing twelve months clinical supply purchase data and gives hospital teams the information they need to engage in data-driven decisions with clinicians and suppliers. The ability to research product alternatives, prices and suppliers within Curvo's data intelligence is what the company hopes will help hospitals in this critical time of need.
Curvo CEO Andy Perry says, "During this incredibly trying time, hospital supply chains are not merely dealing with product shortages of masks and personal protective equipment, but they also must contend with price gouging and suspicious sources. As a company, we have been working to best help our customers deal with the COVID-19 pandemic. We have decided to leverage our product development pipeline, our network and our data assets in any way we can. We have been excited about this product for a while, and we are happy to widen its free release to assist in a time of crisis."
Paul Sas, Vice President of Supply Chain, Purchasing & Construction Management at Palomar Health, had this to say: "I have been absolutely blown away with the Lookup by Curvo solution. Throughout my ten years of consulting, I watched many companies try to build a visualization utility, and none of them succeeded like Curvo has. Curvo took a traditional benchmarking tool and turned it on its head – and best of all, it is incredibly easy to use. I'm impressed!"
Ben Peyronnin, Product Manager, explains it this way: "There is no other resource in the industry that brings this many points of data together while remaining this easy to use. Lookup by Curvo pulls data from FDA UDI, Device Recalls, MAUDE reports, Orthopedic Network News classifications and pairs them with market pricing details for unmatched transparency. And, with zero IT support or integration required, supply chain teams can benefit immediately."
Today, Curvo is announcing free access to this new product from now until July 31st for any healthcare provider organization. Supply chain, value analysis, materials management, and procurement teams may use this powerful solution completely free of charge for a limited time to assist during COVID-19 supply chain challenges.
Sign up for access to Lookup by Curvo here for complimentary access through July 31st: https://curvolabs.com/lookup/.
Suppliers of PPE or other clinical devices who are interested in making their product catalog available free of charge to users of the Lookup by Curvo utility may contact Ben Peyronnin at lookup@curvolabs.com.
About Curvo Labs 
For clinical supply chain teams who don't have access to the data in the way they need it, the people that can understand how to leverage the data, or the technologies to enable timely execution, Curvo Labs powers the partnership between clinicians & supply chain to optimize spend, maximize quality, & make a dent in the cost of healthcare. Curvo is a Software-as-a-Service company that provides supply chain teams at hospitals and health systems with trustworthy data, collaborative technology, and trackable savings.
Find out what Curvo can do for your organization today and visit https://curvolabs.com/.

"Throughout my ten years of consulting, I watched many companies try to build a visualization utility, and none of them succeeded like Curvo has. Curvo took a traditional benchmarking tool and turned it on its head – and best of all, it is incredibly easy to use. I'm impressed!" - Paul Sas."



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

The drug development company says it has reached another milestone in its efforts to facilitate much needed cannabis clinical trials.

ST. PETERSBURG, FLA. (PRWEB) APRIL 08, 2020
Ever eager to facilitate its drug development and FDA clinical trials, MMJ International Holdings will make history by being what it claims is the first cannabis company to import highly concentrated medical marijuana extracts into the United States for clinical trial use.
The US-based company said Tuesday that it has facilitated the shipment to a specialty pharmaceutical gel cap manufacturing company for further testing and development of its proprietary formulation of MMJ-001 and MMJ-002. MMJ International Holdings is developing an oral drug product from natural whole plant extract derivatives from the marijuana plant containing THC and CBD. MMJ will be utilizing its new product for a FDA approved clinical trials in multiple sclerosis (MS) and Huntington's disease (HD). The US Drug Enforcement Agency's approved MMJ to ship the compounds for its clinical trials.
Most recently MMJ International Holdings has negotiated a deal with MMJ BioPharma Cultivation,Inc who has applied for the much coveted DEA federal marijuana growers license. Under the terms of the deal, MMJ BioPharma Cultivation will be supplying pharmaceutical grade marijuana for MMJ International Holdings future pharmaceutical drug development needs. Once the medication is approved by the FDA it will be sold in pharmacies.
MMJ International Holdings also has been awarded the FDA Orphan Drug award which means that MMJ has demonstrated its promise for the diagnosis and or treatment of rare diseases or conditions. Orphan designation qualifies MMJ International Holdings for various development incentives provided by the Orphan Drug Award, including tax credits for qualified clinical testing.
As stated by MMJ's CEO, Duane Boise, ″MMJ's DEA approval and FDA Orphan Drug award are milestone that the company has meet as we continue to set industry standards. MMJ has established a leading position in the development of plant-derived cannabinoid therapeutics through its proven drug discovery and development processes, intellectual property portfolio and regulatory and manufacturing expertise″.
Dr. Elio Mariani, MMJ's director of drug development stated that "MMJ International Holdings continues its process of scientific drug development and discovery by FDA protocol development processes, intellectual property portfolio and DEA regulatory manufacturing guidelines". "We firmly believe that our MMJ natural whole plant derived molecules with a unique combination of pharmacological properties will be FDA approved as a safe and effective prescription drug that can be of great benefit in treating patients with MS and HD diseases," .
Tim Moynahan the company chairman stated that "Patients in the MMJ International holdings clinical trials will receive gelatin capsules containing THC and CBD daily. MMJ International Holdings has several academic institutions preparing to study cannabis in Multiple Sclerosis and Huntington's disease." MMJ clinical trials will provide the necessary data to prove that cannabis can treat essential tremors, a neurological disorder that causes involuntary shaking. Tim Moynahan further stated that "Ultimately, there's so much interest in THC and CBD as a treatment modality, so MMJ will be providing the clinical research data necessary to prove patient dosing, safety, and efficacy."
In conclusion Duane Boise stated "We are pleased with the DEA 's cooperation and support to facilitate our company mission to service the unmet needs of patients suffering from these chronic diseases."
Contact:
Michael Sharp 
561-627-9455
SOURCE: MMJ International Holdings

[https://ww1]
MMJ, DEA Meeting

Duane Boise stated "We are pleased with the DEA 's cooperation and support to facilitate our company mission to service the unmet needs of patients suffering from these chronic diseases."




* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

With water and wastewater critical to fighting the coronavirus (COVID-19) pandemic, water utilities are swiftly employing plans to prevent service disruptions and assist households struggling to pay water bills, according to a recent survey conducted by the American Water Works Association (AWWA).
Ninety-seven percent of the 532 responding utilities have measures in place or in development to keep essential field workers on the job. Ninety-five percent of the responses indicate they are assessing options for staff shift change policies to incorporate social distancing at the workplace.
The two most pressing challenges reported by utilities are social distancing of workforce and supply chain issues for personal protective equipment (PPE). Nearly 40 percent of utilities reported disruptions in the supply chain for PPE, and nearly three quarters are expecting disruptions in the future.
Conducted online from March 25-30, this marks the second in a series of surveys of how AWWA member organizations are adapting to impacts from the COVID-19 pandemic. The second survey of AWWA member organizations generated 615 responses, including from 532 different utilities and 81 non-utility responses (consultants, manufacturers, service providers and others). The responses offer a near real-time assessment of how water sector organizations are currently managing risks of the COVID-19 pandemic.
To assist customers impacted by the economic fallout of COVID-19, more than 90 percent of responding utilities have suspended water shut-offs and about 67 percent are waiving late fees. Additionally, some utilities indicate they are providing payment plan options, waiving charges like service fees, and a few are considering rate reductions or forgiving payments for one billing cycle.
The survey also showed utilities are concerned about potential revenue challenges, with 64 percent of utilities expecting financial implications in the coming months and about 10 percent are already seeing revenue reductions. AWWA and other water sector organizations are advocating for the inclusion of water sector funding in future stimulus bills.
Sixty-seven percent of utilities reported that they have business continuity plans in place, and another 20 percent are currently developing them. AWWA is encouraging utilities to take advantage of Business Continuity Planning for Water Utilities: Guidance Document (AWWA, Water Research Foundation, U.S. EPA, 2013) in assessing their plans.
AWWA is offering resources to assist utilities with dealing with the challenges that arise during the pandemic at awwa.org/coronavirus.
Established in 1881, the American Water Works Association is the largest nonprofit, scientific and educational association dedicated to managing and treating water, the world's most important resource. With approximately 51,000 members, AWWA provides solutions to improve public health, protect the environment, strengthen the economy and enhance our quality of life.


* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

Today RED Company founder and President, Carmela Roth, announced the launch of her sourcing website to support businesses looking to quickly source healthcare supplies. Due to her long-standing relationships within the life sciences and healthcare industry, RED Company has been sourcing goods internationally and making them available to U.S. businesses in a seamless manner for years through its division known as RED Swag.    
"We've been supplying hand sanitizer, wet wipes, first aid kits and disaster prepaRED kits to companies for years. We have international and domestic suppliers ready to tap into. It is my passion to deliver a high-touch approach, creative cost savings, flexibility and tenacity to each customer. This is more important than ever, especially given our service-centric company culture in this very difficult time," said Roth.
In addition to the WFH kits, WOFH (work out from home) kits, stay well kits and traditional healthcare items Roth has been selling via RED Swag, the new site will also carry: 

Masks and Face Shields

Hand Sanitizer

Shoe Covers

Isolation Gowns

The website, COVID-19HealthGear.com, will serve to support those public and private sector entities looking to source health gear more efficiently.
About Carmela Roth 
As RED Company's founder and President, Carmela Roth brings over 30 years of experience and dedication in meeting planning, special event production, sourcing and logistics.
In 2017, Roth was named to the Board of Directors for Diversity Alliance for Science, a platform to identify, attract and develop small and/or diverse businesses to drive inclusive procurement practices in corporate, academic and governmental entities within the life science and healthcare industries. RED Company has been recognized as one of the LA Business Journal's Top 100 Women-Owned Businesses for the last seven years and their Top 100 Fastest Growing Companies for three. In 2016, RED Company earned recognition in Inc. 500's 5000 Fastest Growing Private Companies in the US.
RED Company's service-centric culture and desire to give back is marked through its Power-full Acts of Compassion and Kindness initiatives through their recently launched RED PACK Program.
To interview or collaborate with Roth, please email carmela.roth@redcompany.com or covid19@redcompany.com.




* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

Black Jaguar-White Tiger Foundation, the global non-profit is launching a line of true full-spectrum hemp products exclusively for pets. The new range, Black Jaguar-White Tiger Hemp consists of a chewable tablet and tincture available in a morning and night dosage.
This is the first human and animal product the foundation has launched.
"It is my great Honor, to finally introduce to you, what I consider to be the finest line of Hemp Products in the world; both for Animals and Humans. My Foundation has been Blessed to have been Loved and supported by millions of people around the world. They send us their Love, their Blessings, and when they can, their economic support," said Founder Eduardo Serio.
In the coming days, Black Jaguar-White Tiger Foundation will start distributing the products from bjwthemp.com. Customers in North America will be able to provide the best dose of wellness for their pets.
Black Jaguar-White Tiger Hemp is the only whole plant-based hemp pet product on the market. Using American grown hemp, the tincture and tablets are made via a process that uses a low temperature and no harmful chemicals. In doing so, the healing power of the plant is kept intact and the product provides a true entourage healing effect. Other plant products are further blended to ensure pets receive the right dose of wellness at the right time. The product is then tested before packaging, in which customers can view the results from a QR code online.
The true full-spectrum pet tablets come in a bacon flavor and are available in an AM and PM chew. The AM chew provides a boost of energy throughout the day, while the PM chew, helps a pet settle down to promote deep sleep.
Much like the tablets, the tincture is available in an AM and PM version. In one fast-acting drop, a pet will receive a dose of energy during the day and a restorative sleep throughout the night. It can be given directly or added to food. The tincture is suitable for anxious and stressed pets and can help ease long car rides. It is made of a blend of cannabinoids, omega fatty acids, and vitamins—all vital for wellbeing.
"When Existence gave me the idea of using Hemp on some of our kids, I called Seth and Kamal and partnered with them. We put together what in our opinion will be the biggest game-changer in the Hemp industry. I can't wait for you to try it. Many more products will be incorporated as time goes by. For now, be sure to know that you are giving the absolute best Hemp on the Planet."
The pet tablets retail for $44.99 and the tincture retails for $39.99, which is available for purchase online only.
"I donated all of my future proceeds, which are close to 50% of the total, to my kids. The Black Jaguar-White Tiger Foundation owns the shares that initially belonged to me. In the end, all I do is for my kids, so better that they own it than me. It's all for love," said Serio.

[https://ww1]
Plant-Based Hemp Oil for Pets

For now, be sure to know that you are giving the absolute best Hemp on the Planet."



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

Team Novo Nordisk, the world's first all-diabetes professional cycling team, and Beyond Type 1, a global nonprofit organization changing what it means to live with diabetes, announced a partnership that will bring the two organizations together around in-person events and online activations to inspire, educate and empower everyone affected by diabetes.
Beyond Type 1 is a nonprofit organization changing what it means to live with diabetes. By leveraging the power of social media and technology, Beyond Type 1 empowers people to both live well today and support a better tomorrow. Through peer support programs, global campaigns, and digital platforms, Beyond Type 1 is uniting the global diabetes community across both type 1 and type 2 diabetes, helping to change what it means to live with chronic illness.
"This is one of the most symbiotic and natural partnerships in the history of the Team Novo Nordisk and we are eager to see what we can do together to change what it looks like to live with diabetes," said Team Novo Nordisk CEO and Co-Founder Phil Southerland. "We've enjoyed watching Beyond Type 1's growth over the past five years and can't wait to empower our combined communities to keep chasing their dreams with diabetes."
Recently Beyond Type 1 announced that it would expand its collection of websites, resources, and unique content into five new languages: Dutch, French, German, Italian, and Swedish. This builds upon its existing English and Spanish content.
2020 marks Team Novo Nordisk's eighth season racing as part of the International Cycling Union (UCI) ProSeries, which takes them to numerous countries around the world in Europe, USA, Africa, and Asia as they race to change diabetes. Team Novo Nordisk has more than three dozen athletes and ambassadors from 18 different countries within its pipeline. This includes six native French speakers, six native Spanish speakers, five native Dutch speakers, two native German speakers, and two native Italian speakers.
"Team Novo Nordisk's international cyclists offer tremendous inspiration, showcasing how people with diabetes can compete at the highest of levels," said Beyond Type 1 CEO Thom Scher. "We're thrilled to be working together to serve new communities globally, working together to provide education and raise awareness for everyone impacted by diabetes."
By combining the strengths and expertise of the two organizations, this partnership will focus on high-value and engaging digital content that empowers the global diabetes community.
About Team Novo Nordisk 
Team Novo Nordisk is a global all-diabetes sports team of cyclists spearheaded by the world's first all-diabetes professional cycling team. In 2012, Phil Southerland, co-founder and CEO of the team, and global healthcare company Novo Nordisk, came together to create Team Novo Nordisk, based on a shared vision to inspire, educate and empower people around the world affected by diabetes. For more information, go to http://www.teamnovonordisk.com.
About Beyond Type 1 
Beyond Type 1 is a nonprofit organization changing what it means to live with diabetes. By leveraging the power of social media and technology, Beyond Type 1 empowers people to both live well today and support a better tomorrow. Through peer support programs, global campaigns, and digital platforms, Beyond Type 1 is uniting the global diabetes community across both type 1 and type 2 diabetes, helping to change what it means to live with chronic illness.
###
Media Contacts: 
Fitzalan Crowe for Team Novo Nordisk 
Fitzalan.crowe@teamnovonordisk.com 
+1-703-596-2020
Dana Howe 
Director of Brand Communications, Beyond Type 1 
press@beyondtype1.org

[https://ww1]

"This is one of the most symbiotic and natural partnerships in the history of the Team Novo Nordisk and we are eager to see what we can do together to change what it looks like to live with diabetes," said Phil Southerland.



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

Advanced Threat Prevention Leader Adds Capabilities for Hardening Popular Remote Collaboration Applications Such As Zoom, Microsoft Teams, Slack, Skype and WebEx

BE'ER SHEVA, ISRAEL AND BOSTON (PRWEB) APRIL 07, 2020
Morphisec, the leader in Advanced Threat Prevention, today announced it has added capabilities for hardening popular remote collaboration applicationssuch as Zoom, Microsoft Teams, Slack, Skype, and WebEx as enterprises respond to COVID-19 and rapidly shift to work-from-home environments. The Morphisec Unified Threat Prevention Platform addresses potential security vulnerabilities with these tools by preventing exploits, fileless attacks, or zero-days with its Moving Target Defense technology.
"The rise in use of enterprise collaboration platforms during the coronavirus pandemic continues to skyrocket," said Andrew Homer, VP of Security Strategy at Morphisec. "However, as we've learned over the last few weeks, the exponential use of these solutions by remote workers has stretched the attack surface and exposed some serious security vulnerabilities. That's why we're excited to provide CISOs and cybersecurity professionals a deterministic approach to protecting these now mission-critical applications for their remote employees, without impacting system performance or impeding business operations."
Malicious actors targeting and exploiting security vulnerabilities on these collaboration tools can lead to Remote Code Execution (RCE). This exponential threat enables attackers to inject malicious code on an employee endpoint that is running a collaboration tool on either their device or through a browser plugin. Within the current enterprise work-from-home landscape where employees are much more likely to use non-hardened, personal devices, this is especially dangerous. Attackers can easily obtain admin privileges on personal devices to gain control of the endpoint and access an enterprise network.
Morphisec's Unified Threat Prevention platform is an ideal solution for cybersecurity professionals tasked with securing remote workforces as it doesn't rely on network controls or threat identification like antivirus solutions to prevent advanced attacks. Instead, its Moving Target Defense technology perpetually hides key memory resources from attackers without the need to recognize threats. It hardens these tools applications through scrambling the locations of .dlls, memory structures, and commonly used resources, which protects them from exploitation. Just as important as the protection, is that these hardened applications function normally without disruption.
"The vast majority of cybercriminals follow usage patterns and build exploit tools that can be delivered via the documents, applications, and tools that are depended on the most," added Homer. "For a long time that has meant zero-day and unknown attacks delivered via traditional paths such as Office and Adobe. However, with those business solutions increasingly hardened and patched to thwart against advanced threats, and demand for remote collaboration tools rapidly increasing, attackers are putting collaboration applications in their crosshairs. Given patching cycles are significantly slower for these types of applications, a layer of deterministic prevention to protect against in-memory and evasive malware attacks is urgently needed."
The new protection for collaboration tools comes on the heels of Morphisec announcing that its Unified Threat Prevention platform is free to license for enterprise work-from-home employees during the COVID-19 response. To help enterprises secure their rapidly evolving remote workforce during these unprecedented times, Morphisec has made its Moving Target Defense technology, free for remote employees through June 1.
Enterprises interested in taking advantage of Morphisec's free offer to secure their remote workforces and employee use of business collaboration applications during the response to COVID-19 can inquire here.
About Morphisec
Morphisec offers an entirely new level of innovation to customers in its Endpoint Threat Prevention product, delivering protection against the most advanced cyberattacks. The company's patented Moving Target Defense technology prevents threats others can't, including APTs, zero-days, ransomware, evasive fileless attacks and web-borne exploits. Morphisec provides a crucial, small-footprint memory-defense layer that easily deploys into a company's existing security infrastructure to form a simple, highly effective, cost-efficient prevention stack that is truly disruptive to today's existing cybersecurity model. 

[https://ww1]
Morphisec Logo

Given patching cycles are significantly slower for these types of collaboration applications, a layer of deterministic prevention to protect against in-memory and evasive malware attacks is urgently needed.



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

Advanced Threat Prevention Leader Adds Capabilities for Hardening Popular Remote Collaboration Applications Such As Zoom, Microsoft Teams, Slack, Skype and WebEx

BE'ER SHEVA, ISRAEL AND BOSTON (PRWEB) APRIL 07, 2020
Morphisec, the leader in Advanced Threat Prevention, today announced it has added capabilities for hardening popular remote collaboration applicationssuch as Zoom, Microsoft Teams, Slack, Skype, and WebEx as enterprises respond to COVID-19 and rapidly shift to work-from-home environments. The Morphisec Unified Threat Prevention Platform addresses potential security vulnerabilities with these tools by preventing exploits, fileless attacks, or zero-days with its Moving Target Defense technology.
"The rise in use of enterprise collaboration platforms during the coronavirus pandemic continues to skyrocket," said Andrew Homer, VP of Security Strategy at Morphisec. "However, as we've learned over the last few weeks, the exponential use of these solutions by remote workers has stretched the attack surface and exposed some serious security vulnerabilities. That's why we're excited to provide CISOs and cybersecurity professionals a deterministic approach to protecting these now mission-critical applications for their remote employees, without impacting system performance or impeding business operations."
Malicious actors targeting and exploiting security vulnerabilities on these collaboration tools can lead to Remote Code Execution (RCE). This exponential threat enables attackers to inject malicious code on an employee endpoint that is running a collaboration tool on either their device or through a browser plugin. Within the current enterprise work-from-home landscape where employees are much more likely to use non-hardened, personal devices, this is especially dangerous. Attackers can easily obtain admin privileges on personal devices to gain control of the endpoint and access an enterprise network.
Morphisec's Unified Threat Prevention platform is an ideal solution for cybersecurity professionals tasked with securing remote workforces as it doesn't rely on network controls or threat identification like antivirus solutions to prevent advanced attacks. Instead, its Moving Target Defense technology perpetually hides key memory resources from attackers without the need to recognize threats. It hardens these tools applications through scrambling the locations of .dlls, memory structures, and commonly used resources, which protects them from exploitation. Just as important as the protection, is that these hardened applications function normally without disruption.
"The vast majority of cybercriminals follow usage patterns and build exploit tools that can be delivered via the documents, applications, and tools that are depended on the most," added Homer. "For a long time that has meant zero-day and unknown attacks delivered via traditional paths such as Office and Adobe. However, with those business solutions increasingly hardened and patched to thwart against advanced threats, and demand for remote collaboration tools rapidly increasing, attackers are putting collaboration applications in their crosshairs. Given patching cycles are significantly slower for these types of applications, a layer of deterministic prevention to protect against in-memory and evasive malware attacks is urgently needed."
The new protection for collaboration tools comes on the heels of Morphisec announcing that its Unified Threat Prevention platform is free to license for enterprise work-from-home employees during the COVID-19 response. To help enterprises secure their rapidly evolving remote workforce during these unprecedented times, Morphisec has made its Moving Target Defense technology, free for remote employees through June 1.
Enterprises interested in taking advantage of Morphisec's free offer to secure their remote workforces and employee use of business collaboration applications during the response to COVID-19 can inquire here.
About Morphisec
Morphisec offers an entirely new level of innovation to customers in its Endpoint Threat Prevention product, delivering protection against the most advanced cyberattacks. The company's patented Moving Target Defense technology prevents threats others can't, including APTs, zero-days, ransomware, evasive fileless attacks and web-borne exploits. Morphisec provides a crucial, small-footprint memory-defense layer that easily deploys into a company's existing security infrastructure to form a simple, highly effective, cost-efficient prevention stack that is truly disruptive to today's existing cybersecurity model. 

[https://ww1]
Morphisec Logo

Given patching cycles are significantly slower for these types of collaboration applications, a layer of deterministic prevention to protect against in-memory and evasive malware attacks is urgently needed.



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

In the wake of the coronavirus outbreak, the CBDfx leadership team decided to make an immediate impact the best way they know how: by manufacturing bottles of high-quality hand sanitizer as a response to nationwide shortages, and delivering them free to all customers.

LOS ANGELES (PRWEB) APRIL 07, 2020
Today, CBD industry leaders CBDfx announced they are turning their manufacturing prowess towards the mass creation of an item that's desperately needed: antiseptic hand sanitizer. CBDfx is now mass producing bottles of hand sanitizer and providing it to their customers for free when they shop on the company's website.
"It's time for those that can, to step up and help their communities impacted by COVID-19," stated CBDfx co-founder and CEO Ali Esmaili. "In the wake of a nationwide shortage of something as important as hand sanitizer, businesses like CBDfx with access to manufacturing facilities should contribute much-needed supplies like this. CBDfx always puts the health and wellness of our customers and community first, and we hope that this small gesture makes the lives of our customers a little bit easier during this difficult time."
CBDfx Hand Sanitizer is included free of charge with all orders on CBDfx.com through the end of April. The sanitizer follows FDA guidelines and contains 75% isopropyl alcohol which kills 99.9% of most illness causing germs. The sanitizer does not contain CBD.
About CBDfx: CBDfx is a Southern California-based company founded on providing high quality, organically sourced CBD products to customers in a wide variety of formats. CBDfx is a market leader in the CBD industry and was founded on the belief that everyone should have access to the layered functional benefits of CBD. CBDfx's mission is to empower both new and experienced CBD users by providing access to products that are always organic, refreshingly innovative, and thoughtfully crafted to provide the purest experience possible.



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

Medical testing has been moving toward disposable sensors to help prevent the outbreak of infection and cross contamination between patients for some time now. The pandemic of 2020 has shown us in tragic realtime the urgent need for disposable sleep sensors.
Dymedix Disposables is a comprehensive line of disposable respiratory effort, airflow, EEG, EMG and movement sensor products for the sleep and neurodiagnostic community. This exclusive line of disposable sleep sensors are based on our patented technology using polyvinylidene fluoride (PVDF) which delivers very fast, and extremely reliable signals. All products are compatible with all PSG and EEG systems and AASM and JACHO compliant.
The Dymedix Disposables product line includes:
Disposable Airflow Sensors 
TRIPLEPLAY DISPOSABLE PVDF AIRFLOW SENSORS Extreme sensitivity and response time. Responds to changes in both temperature and pressure providing accurate detection of Apnea, Hypopnea, UARS and Snore, all with one sensor. Designed for use with a TriplePlay FM airflow filtration module. 
Disposable Respiratory Effort Belts
FASTTRACK EFFORT PACK is the first and only completely disposable respiratory effort solution. Each FastTrack Effort Pack includes single use Chest and Abdomen effort belts incorporating our cut-to-size Button-Hole strap system. Plug and Play, Throw it Away.
PERFECTFIT3D EFFORT BELTS A very affordable respiratory effort system that incorporates PVDF effort modules with Button-Hole connectors to where disposable effort belt material is connected. PerfectFit 3D is a perfect semi-disposable solution for PSG and HST respiratory effort applications. Half the cost of RIP.
SNUGGLEFIT INFANT EFFORT SYSTEM is a disposable respiratory effort system designed specifically for infants. The SnuggleFit responds to both strain and pressure making it extremely sensitive, and incorporates our disposable cut-to-size Button-Hole disposable belt material.
Disposable EEG Electrodes 
PRECISION GOLD DISPOSABLE EEG ELECTRODES Disposable gold plated EEG cup electrodes at a very affordable price. Designed with a flat rim and rounded edges for exceptional patient comfort, especially during extended monitoring. Includes a flexible and durable hub connector with strain relief. Available in 4 different lengths.
Disposable EMG and Movement Sensors 
ACCUSNORE is the only disposable snore sensor available. Using PVDF technology the AccuSnore sensor provides superior sensitivity compared to conventional piezo snore sensors. The adhesive backing allows for multiple placement locations during testing to ensure accurate capture of snoring activity.
MOTIONWAVE DUAL EMG PATCH is the only completely disposable pre-measured dual EMG electrode patch. No snaps and no lead wires to clean. Use it once and discard the entire sensor, wires and all.
TRIPLECHIN EMG PATCH A completely disposable chin EMG electrode patch. Three electrodes perfectly spaced with an adhesive backing for easy application and reliable EMG signals. Available in both adult and pediatric sizes.
XM EXTREMITY MOVEMENT SENSOR A PVDF based adhesive movement sensor used for upper and lower extremity movement monitoring. No more electrodes coming off or ECG artifact during testing. The XM sensor is extremely sensitive and will respond to even the most subtle PLMS movements.

[https://ww1]

The pandemic of 2020 has shown us in tragic realtime the urgent need for disposable sleep sensors.



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

A new study, published in the British Journal of Nutrition, adds to the growing body of research linking consumption of wild blueberries to benefits in the mood of adolescents. The study, led by Professor Claire Williams from the School of Psychology & Clinical Language Sciences at the University of Reading, UK, builds upon the group's earlier research on wild blueberry's beneficial effects on mood and depression in children and young adults. The team's findings add to an emerging area in nutrition and psychology research, examining the potential for some foods and dietary components to have a positive impact on mood and a reduction of depression symptoms. The interaction between diet and mood is a new and exciting area of science which has not yet been widely explored.
"This is an exciting finding that underscores the potential for wild blueberries to make a difference to people with depression," said Claire Williams, Professor of Neuroscience, University of Reading. "Here we showed that four weeks of a daily wild blueberry intervention reduced depression symptoms in a community of adolescents. More extensive studies are clearly required to replicate and extend these findings, not only in healthy participants, but also in clinically referred samples, to assess the potential for use of deeply colored berries as a practical and cost-effective intervention."
Study Overview
The study, entitled "Effect of 4 weeks daily wild blueberry supplementation on symptoms 
of depression in adolescents" furthers Williams' research to address a major social problem: depression in young adults. It is well known that older children and teenagers undergo a vulnerable period in their cognitive and emotional development, which requires special attention and would benefit from additional research.
The study tested the hypothesis that there is an association between the intake of anthocyanin-rich wild blueberries and mood. In this study, children between the ages of 11 and 17 were split into two groups; one group consumed wild blueberries and the other group consumed a placebo. After four weeks of daily consumption the researchers administered rigorous questionnaires where the young participants provided a self-assessment of certain mood parameters.
Based on the self-report questionnaires, the young study participants who consumed wild blueberries documented a beneficial effect on their mood and reported less depression symptoms, compared to the placebo group. The results also showed, that children and teenagers do not consume the recommended daily amount of fruits and vegetables.
These findings were broadly consistent with other research, including that of the Williams' team, showing that consuming whole, healthy foods (like wild blueberries) can benefit the brain and behavior. The findings also support evidence obtained from population studies where greater consumption of fruit and vegetables is associated with a lower risk of depression. Overall, this study accompanies 20 years of research, which connects better overall health with the consumption of wild blueberries.
Anthocyanins and Other Flavonoids Affect Cognitive Function
Anthocyanins and other food flavonoids are being investigated for their various health benefits. Anthocyanin flavonoids are the pigments responsible for the purple, blue, red hues of some berries. Anthocyanins are extremely abundant in wild blueberries which is easily seen by the berry's deep pigmentation. Anthocyanins have antioxidant and anti-inflammatory properties, as well as other health effects which have been demonstrated using several experimental approaches. Results suggest that, in the brain, anthocyanins provide benefits by: 

Improving cerebral blood flow

Regulating glucose delivery to the brain

Reducing inflammation and oxidative stress to brain neurons

Improving the function of neurons in transmitting signals in the brain

Comments from the Wild Blueberry Association of North America (WBANA)
"Although food and mood research is still an emerging area of study, each bit of research that comes out gets us a little further and guides researchers to the next area of study," said Kitty Broihier, MS, RD, Nutrition Advisor for the Wild Blueberry Association of North America. "The connection between wild blueberries and mood is a novel area of exploration, and Professor Williams' team's work on mood and behavior in children and teens is encouraging. Until more is known about the impact of food on mental health, parents can feel good about helping their children establish healthy eating habits to support cognitive development and wellbeing throughout life, such as eating plenty of colorful plant-based foods, like Wild Blueberries, each day."
With a growing body of research on wild blueberries and cognitive function in young people that has been published by Williams and team, interest in possible links between food and mental health will undoubtedly gain momentum in the science community. Two related studies by Williams and team are referenced in these releases:

New Wild Blueberry Study Indicates Potential Mood-Boosting Effect in Young Adults and Children, 2017

New Study Suggests Wild Blueberries Boost Memory and Concentration in Elementary School Children, 2015

About WBANA
The Wild Blueberry Association of North America (WBANA) is a trade association of growers and processors of Wild Blueberries from Maine and Canada who are dedicated to bringing the Wild Blueberry health story and unique Wild Advantages to consumers and the trade worldwide. WBANA is dedicated to furthering research that explores the health potential of Wild Blueberries. For twenty years WBANA has hosted the Health Research Summit in Bar Harbor, a worldwide gathering of renowned scientists and researchers whose work is leading the way to learn more about the health benefits of Wild Blueberries. Their findings are documented in a growing number of published studies on the potential health and disease-fighting benefits of Wild Blueberries. For news, recipes, and related health information about Wild Blueberries, visit http://www.wildblueberries.com. For the latest updates, read our blog. Visit us on Facebook or on Twitter.

Until more is known about the impact of food on mental health, parents can feel good about helping their children establish healthy eating habits to support cognitive development and wellbeing throughout life, such as eating plenty of colorful plant-based foods, like Wild Blueberries, each day.




* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

On March 13, Ladue News published its Platinum List 2020, revealing the winners as voted on by readers in a range of categories highlighting the St. Louis area, from food to fashion. In the services section, West County Plastic Surgeons of Washington University was honored in the "Cosmetic Surgery" category as a runner up, positioning the practice among the "best of the best" cosmetic surgery options in St. Louis.
The call for readers' nominations went out on Jan. 1, with the nomination period open until Jan. 11. Any business that received a nomination was put onto a ballot, and readers were next asked to vote on the "platinum standouts" among the nominees between Jan. 12 and 22. After the votes were tallied, the winners were announced in the mid-March Ladue News issue devoted to the Platinum List, which also highlighted days spas and dry cleaners, restaurants and retail businesses, and dozens more shops and services.
Unfortunately, the celebratory Ladue News Platinum List Party scheduled for the Coronado Ballroom for March 12 was cancelled to protect the health of vendors, guests, and staff in the midst of the current COVD-19 pandemic. Still, the West County Plastic Surgeons team members are celebrating the honor and humbled by the recognition, especially because locals have so consistently voted for them over the past decade. The practice has received this accolade every year since 2017, as well as in other prior years—and took the top spot in 2015's Platinum List.
West County Plastic Surgeons of Washington University is led by Dr. Terry Myckatyn and Dr. Marissa Tenenbaum, both of whom are plastic surgeons certified by the American Board of Plastic Surgery and regularly included in Best Doctors, Inc.'s annual "Best Doctors in America" lists. Dr. Myckatyn and Dr. Tenenbaum both perform cosmetic surgery on the face, body, and breasts, as well as offer breast reconstruction.
The practice offers a range of services, including cosmetic breast surgery, breast reconstruction, surgical and nonsurgical body contouring, and face procedures, as well as injectables, laser and light treatments, and spa services for skin care.
As part of Washington University Physicians, a controlled affiliate of the Washington University School of Medicine in St. Louis, West County Plastic Surgeons strives for excellence in compassionate and high-quality patient care.
Learn more about St. Louis' West County Plastic Surgeons of Washington University by calling or sending a message online.


* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

Physician's Resource Services (PRS) is proud to announce the newest addition to their team, Underwriting Specialist Jenna Underwood. In this role, Mrs. Underwood prioritizes her day around supporting clients' needs by making the transition process between carrier and agent as smooth as possible.
Mrs. Underwood's past experience provides an outlook in which she thrives when offering significant attention to detail in fast-paced environments. This skillset allows Mrs. Underwood, along with the rest of the PRS team, to support their clients' needs and objectives in an extremely efficient, successful, and cost-effective manner.
"I am excited to join the Physician's Resource Services team!" she said, "I believe my ability to go above-and-beyond to make sure each client's needs are met, along with my experience in a fast-paced environment, will continue to help our clients feel more secure in their policies – ultimately allowing them to live a more comfortable life."
Physician's Resource Services, based in Austin, TX, serves residents, fellows and practicing physicians with disability insurance and other resources. PRS is dedicated to helping doctors and other professionals create effective investment, insurance and wealth accumulation strategies for each individual to protect and grow their income. To learn more about PRS and their unique approach in serving their clients, visit https://www.physiciansrs.com/.

"I believe my ability to go above-and-beyond to make sure each client's needs are met, along with my experience in a fast-paced environment, will continue to help our clients feel more secure in their policies – ultimately allowing them to live a more comfortable life."




* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

On March 13, Ladue News published its Platinum List 2020, revealing the winners as voted on by readers in a range of categories highlighting the St. Louis area, from food to fashion. In the services section, West County Plastic Surgeons of Washington University was honored in the "Cosmetic Surgery" category as a runner up, positioning the practice among the "best of the best" cosmetic surgery options in St. Louis.
The call for readers' nominations went out on Jan. 1, with the nomination period open until Jan. 11. Any business that received a nomination was put onto a ballot, and readers were next asked to vote on the "platinum standouts" among the nominees between Jan. 12 and 22. After the votes were tallied, the winners were announced in the mid-March Ladue News issue devoted to the Platinum List, which also highlighted days spas and dry cleaners, restaurants and retail businesses, and dozens more shops and services.
Unfortunately, the celebratory Ladue News Platinum List Party scheduled for the Coronado Ballroom for March 12 was cancelled to protect the health of vendors, guests, and staff in the midst of the current COVD-19 pandemic. Still, the West County Plastic Surgeons team members are celebrating the honor and humbled by the recognition, especially because locals have so consistently voted for them over the past decade. The practice has received this accolade every year since 2017, as well as in other prior years—and took the top spot in 2015's Platinum List.
West County Plastic Surgeons of Washington University is led by Dr. Terry Myckatyn and Dr. Marissa Tenenbaum, both of whom are plastic surgeons certified by the American Board of Plastic Surgery and regularly included in Best Doctors, Inc.'s annual "Best Doctors in America" lists. Dr. Myckatyn and Dr. Tenenbaum both perform cosmetic surgery on the face, body, and breasts, as well as offer breast reconstruction.
The practice offers a range of services, including cosmetic breast surgery, breast reconstruction, surgical and nonsurgical body contouring, and face procedures, as well as injectables, laser and light treatments, and spa services for skin care.
As part of Washington University Physicians, a controlled affiliate of the Washington University School of Medicine in St. Louis, West County Plastic Surgeons strives for excellence in compassionate and high-quality patient care.
Learn more about St. Louis' West County Plastic Surgeons of Washington University by calling or sending a message online.
CONTACT: 
314.996.8800


* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

Luminare, a Houston-based health technology and software company, has rallied to join the fight against COVID-19. Utilizing its patented platform developed for detecting sepsis, the company rapidly developed and deployed Quickscreen, a web-based software platform, utilized to pre-screen for COVID-19 in at-risk populations. By partnering with community organizations to offer assistance and expertise, Luminare is focused on preventing further spread of the virus.
Offered free of charge for any individual or organization in need, CheckForCorona.com has been translated into eight different languages and screened more than 100,000 patients across every continent on the planet.
"We already had a very robust platform, Sagitta, that is used by nurses and doctors for critically evaluating patients in hospitals for sepsis. By utilizing the platform to pre-screen for COVID-19, we saw an opportunity to serve people and help both first responders and the public health authorities during this crisis by reducing the pressure on the healthcare and testing systems," said Sarma Velamuri, M.D., CEO of Luminare.
The goal of CheckForCorona.com is to help people self-assess, better understand their symptoms, and avoid unnecessary phone calls to already overwhelmed call centers. The website has already saved more than 50,000 superfluous phone calls to date. Additionally, Quickscreen provides communities and organizations a method of collecting valuable epidemiological data that can help shed light on the transmission and severity of coronavirus in specific locations.
Locally, the platform has been adopted by Harris County Public Health, the City of Houston, Fort Bend County, with pending agreements with additional counties, cities, and organizations in Texas.
"We have had a fantastic response to the solution in the face of limited availability of swab and blood tests," said Dr. Velamuri. "Thousands of people who otherwise would have spent hours sitting in their car waiting for a test only to be turned away, or those experiencing long wait times on hold waiting for a call center nurse, are now instead able to know their appropriate action based on zip code in just 30 seconds. The epidemiological data we have collected is incredibly valuable, and we want to help state and national authorities get ahead of the curve by predicting disease hotspots weeks before testing will show where our efforts should be directed.
"Another advantage is the unique identifier per assessment result that is completely anonymous and can be used for tying incidence data to an individual test without the burden of scrubbing identifiable patient information for public reporting," Dr. Velamuri concluded.
Luminare is also working with Houston's Healthcare for the Homeless and is providing a web-based tool to allow frontline workers to triage homeless residents for quarantine, testing or other care.
Interested hospitals and community organizations needing a platform to assist with self-assessment and coronavirus screening should contact Luminare here.
About Luminare 
Luminare's, founded in 2014 in Houston, Texas, is on a mission to stop sepsis deaths and morbidity in hospitals through efficient, software-driven detection. Sagitta, the software platform focused on preventing sepsis, is named after arrow in Latin. Deployed in Texas and Arkansas hospitals, Sagitta has decreased sepsis mortality rates. Hospitals have reported that no patients have developed septic shock since deployment, in-patient code-blue events decreased by 27 percent, and emergent intubations and rapid response calls decreased by 11 percent. In Long Term Acute Care facilities, the rate of sepsis re-admissions went to zero.
Luminare has partnered with the Centers for Disease Control and Prevention on the interoperability showcase on sepsis to demonstrate the platform's advantages to effectively move patient care. The company was awarded the Most Promising Web & IT company in the U.S. in 2017 by Jones School of Business at Rice University and is also an alum from cohort X6 of the Texas Medical Center's accelerator, TMCX+ To learn more visit https://www.luminaremed.com.

[https://ww1]

We saw an opportunity to serve people and help both first responders and the public health authorities during this crisis by reducing the pressure on the healthcare and testing systems.



* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

GAP Solutions, a leading provider of professional, scientific, and operational support to Health and Human Services (HHS) and the Federal Government, has been awarded a prime contract by the National Institutes of Health, National Heart, Lung, and Blood Institute (NHLBI). The Blanket Purchase Agreement (BPA) has a five-year base period of performance and a total potential value of $50 million.
As the third largest institute at the NIH, NHLBI provides global leadership for research, training, and education programs to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals so that they can live longer and more fulfilling lives. GAP Solutions is prepared to immediately deliver a highly qualified, mission-driven professional, scientific, and operational workforce capable of supporting NHLBI's life-saving and innovative scientific and clinical research.
"We are dedicated to supporting the mission and needs of NIH customers," said Martin Rathmann, GAP Solutions' Senior Vice President for Growth and Strategy. "Evolving our service delivery in response to customer insights is central to our approach and has paved the way for continued growth across the NIH's Institutes and Centers." Greg Bice, GAP Solutions's Vice President for Scientific and Technical Programs, added: "The NHLBI is synonymous with research excellence and the relentless pursuit of groundbreaking fundamental discovery science; we are proud to have the opportunity to support NHLBI's research, training, and education programs to promote the prevention and treatment of heart, lung, and blood diseases."
###
About GAP Solutions 
GAP Solutions has over 20 years of experience supporting our clients' unique mission requirements, including scientific and clinical research, scientific program management, and training and education throughout HHS Operating and Staff Divisions and the DOD. GAP Solutions leads and manages System One Federal Services, a unified delivery mechanism that leverages the diverse, scalable, and innovative capabilities of System One into a single, unified solution for our Federal partners. With access to over 450 specialized recruiters, GAP Solutions in uniquely prepared to support our client missions as science, technology, and medicine continue to evolve.

"Evolving our service delivery in response to customer insights is central to our approach and has paved the way for continued growth across the NIH's Institutes and Centers." - Martin Rathmann, Senior Vice President for Growth and Strategy".




* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

In this free webinar, the speakers will give an overview of the role of Tau in disease progression and discuss the importance of Tau PET imaging in clinical trials and the challenges of implementing it. They will also report on recent research addressing the optimization of Tau PET analysis methodologies.

TORONTO (PRWEB) APRIL 07, 2020
Join Victor L. Villemagne, Associate Professor, Department of Molecular Imaging and Therapy, The Florey Institute of Neuroscience and Mental Health, The University of Melbourne and Richard Manber, Biomarker Scientist, IXICO in a live webinar on Friday, April 24, 2020 at 10am EDT (3pm BST/UK).
In recent years, there has been an increasing focus on investigating the role of Tau in the onset and progression of Alzheimer's Disease (AD), and in other neurodegenerative diseases associated with the accumulation of pathological misfolded Tau, such as progressive supranuclear palsy (PSP) and frontotemporal lobar degeneration (FTLD). Studies using recently introduced second-generation Tau tracers suggests that these tracers are binding to Tau with higher specificity compared to previous tracers, leading to increased interest in Tau within clinical studies. However, it's still unclear what role Tau imaging will play in clinical trials: should Tau be used as a clinical endpoint; and how does it link to other biomarkers such as amyloid-beta, with some studies suggesting that amyloid-beta triggers the spread of Tau beyond the MTL region.
Given that the majority of Tau studies have been conducted using first-generation PET tracers, which had shown high incidences of off-site binding, it will be important to review the current data to understand what we know about Tau in AD and how second-generation tracers are being applied in clinical studies. Additionally, this webinar will cover the steps being taken to advance Tau PET operational and analytical methodologies in AD clinical studies and other Tau-related neurodegenerative diseases.
For more information or to register for this event, visit Optimization of Tau PET Imaging for Alzheimer's Clinical Development.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com 
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

[https://ww1]
Xtalks Life Science Webinars

It will be important to review the current data to understand what we know about Tau in AD and how second-generation tracers are being applied in clinical studies.




* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com

Operations management platform enables hotels to support health and safety compliance for those looking to help communities in need

FRANKLIN, TENN. (PRWEB) APRIL 07, 2020
Quore, the leading provider of workflow management and productivity tools for hotels, today announced its Quore Aid Program for any hotel converting its property into a COVID-19 isolation ward or temporary medical facility. Quore has adapted its suite of solutions to allow for adherence to local and national healthcare guidelines to support housing facilities as they determine the right precautions each hotel isolation ward should follow in order to ensure the health and safety of staff, medical professionals and guests.
Individual states, counties and municipalities are actively seeking properties that are largely vacant due to growing Stay-At-Home mandates to serve as COVID-19 isolation wards. The goal is to relieve the pressure on hospitals, allowing them to focus treatment on the sickest of patients, and non-severe cases can be moved to an isolation ward. Hotels are prime real estate for these facilities, as most business and vacation travel has been cancelled.
Hotel isolation wards may be used for various scenarios, including for recovering patients, individuals exposed to the virus that may or may not show symptoms, moderately ill people awaiting test results, and individuals that may not be able to self-isolate in a home due to high-risk family members or personal homelessness.
"We want to support communities across the country in their efforts to stop the spread of COVID-19, and enable our hotel customers to contribute in a safe and secure way," said Scott Schaedle, Founder and CEO of Quore. "Not only does our platform help properties optimize operations, but it enables staff and guests to communicate with little-to-no physical interaction. We're providing a baseline of health and safety precautions each property or location needs to update to be in compliance with local and national guidelines, so each property can quickly adapt to new mandates and remain focused on its new role in ending this pandemic."
The Quore platform enables hotel management and staff to limit face-to-face interactions, implement mobile communications with guests, and access modifiable templates that guide staff through recommended and/or mandated procedures that are updated in real time. These include isolation room set up and turnover, hand and hygiene protocol, trash collection, sanitation requirements, signage placement and other actions to ensure the highest level of health and safety compliance throughout the property.
For more information on how Quore is addressing specific operational needs in the current crisis, please click here or contact Richard Bradbury Richard.Bradbury@quore.com.
About Quore 
Quore is an award-winning, cloud-based hotel quality optimization solution, providing the right tools to empower hotels of any size to make operations more efficient and improve guest experiences. Founded in 2012, it is the first solution ever to combine state-of-the-art technology and intuitive design to better manage all aspects of the guest experience, including preventative maintenance, guest requests and complaints, work orders, housekeeping and workforce/shift communication. Quore's software is used by more than 4,400 hotels in the U.S., and it supports hotels from the industry's largest brands, including IHG, Marriott, Hilton and Choice. The Franklin, Tennessee-based company is privately owned and was named one of America's Best Startup Employers by Forbes.

[https://ww1]
Quore Aid Program




* Work from Home and START YOUR OWN blog site, business or personal website, or e-commerce store at www.mochahost.com